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In this thesis, a series of studies are reported that investigated different aspects of the 
genetics of eating disorders. In general, three eating disorders are distinguished, anorexia 
nervosa (AN), bulimia nervosa (BN) and eating disorders not otherwise specified (EDNOS) 
(for DSM-IV (1994) criteria see Appendix A).  
 
Anorexia nervosa  
 
AN is characterized by a severely low body weight (85% or less than expected based on 
age and height) intense fear of weight gain, a distorted body image and amenorrhoea. Two 
subtypes of AN are distinguished: the restricting type, and the binge-eating/purging type. In 
contrast to the binge-eating/purging type, individuals with the restricting type do not 
regularly engage in eating binges and purging behaviors, like self-induced vomiting, or the 
misuse of laxatives or diuretics. Instead individuals with restricting type AN achieve and 
maintain low body weight through restriction of energy intake (fasting) and/or increased 
energy expenditure (excessive exercise). 
 
Table 1.1 Prevalence and prognosis factors of eating disorders and other psychiatric disorders 


















AN 0.3 0.9-2.2 4.0-5.9 1.7-8.0 47 32 20 
BN 1.0 1.5-1.7 0.32-3.9 1.7-9.3 66.5 21.6 11.9 
EDNOS - - 5.2 1.8 - - - 
BED 1.0 3.5 - - - - - 
a Prevalences reported for women 
 
 AN mainly affects young women and generally starts during puberty or early 
adulthood. As can be seen in Table 1.1 prevalences for AN in women are low (Bulik et al., 
2006; Hoek, 2006; Hoek & Van Hoeken, 2003; Hudson et al., 2007; Keski-Rahkonen et al., 
2007). The mortality rate, on the other hand, is high in AN and the prognosis is poor, only 
half of the patients with AN fully recover (Crow et al., 2009; Harris & Barraclough, 1998; 
Nielsen et al., 1998; Steinhausen, 2002; Sullivan, 1995). Reported Standardized Mortality 
Ratios in AN are about twice as high in comparison to affective disorders (1.7), 
schizophrenia (1.6) and psychiatric illness in general (2.2) (Harris & Barraclough, 1998). 
So despite the rarity of AN, it is a severely debilitating disorder with a high impact.  
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 Despite substantial efforts to identify causal pathways for AN, very little is known 
about the aetiology of this disorder. In longitudinal and cross-sectional studies, several risk 
factors have been identified for AN, including being female, dieting, negative self-
evaluation and perfectionism (Bachner-Melman et al., 2007; Jacobi et al., 2004). In 
addition, results from both family and (population-based) twin studies suggest that genetic 
factors also play a substantial role in the development of AN (Bulik et al., 2006; Bulik et 
al., 2010; Slof-Op 't Landt et al., 2005), with heritability estimates ranging from 28 to 76%, 
as is shown in Table 1.2.  
 
Table 1.2 Variance (%) accounted for by genetic, shared environmental and non-shared environmental factors of 
eating disorders and important related features in population-based twin studies. 




AN 28-76 0-5 24-52 
BN 30-83 0-41 17-50 
Binge eating disorder 39-57 0-13 42-61 
Self-induced vomiting 8-70 0 30-92 
Perfectionism 29-42 0-19 58-68 




The main characteristics of BN are recurrent episode  of binge eating and inappropriate 
compensatory behaviors. In addition, an undue influe ce of body weight and/or shape on 
self-evaluation is present. In purging type BN self-induced vomiting, misuse of laxatives or 
misuse of diuretics are used in order to prevent weight gain. Excessive exercise and fasting 
are the main compensatory behaviors for nonpurging type BN.  
 Although slightly more common than AN, BN is also characterized by a low 
prevalence (Table 1.1; Fairburn & Beglin, 1990; Hoek & Van Hoeken, 2003; Hudson et al., 
2007; Keski-Rahkonen et al., 2009). Almost 70% of patients with BN fully recover in a 
period of 4 to 10 years (Steinhausen & Weber, 2009). Despite the fact that the uncertainty 
of the estimates is larger, the mortality rates in BN appear to be two times lower than the 
rates reported in AN, but the reported Standardized Mortality Ratios again appears to be 
about 1.5 times higher than those reported for other mental illnesses (Crow et al., 2009; 
Harris & Barraclough, 1998; Papadopoulos et al., 2009; Steinhausen & Weber, 2009).  
 For BN, female sex, childhood obesity, negative self-evaluation, perfectionism and 
dieting are considered potent risk factors (Fairburn et al., 1997; Jacobi et al., 2004; 
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Lilenfeld et al., 2000). Furthermore, most twin studies have yielded substantial heritability 
estimates, ranging 30 to 83%, for BN in women (Slof-Op 't Landt et al., 2005). The 
remaining variance was primarily accounted for by non-shared environmental factors 
(Table 1.2). In sum, genetic factors also appear to contribute to the liability of BN. 
 
Eating disorders not otherwise specified 
 
The majority of eating disorder patients (about 60% of those representing for treatment) do 
not meet strict DSM-IV diagnostic criteria for either AN or BN, and therefore belong to the 
eating disorder not otherwise specified (EDNOS) category. The EDNOS category can be 
distinguished into three subcategories. The first category are cases that closely resemble 
AN or BN but just fail to meet their diagnostic threshold. The second category represents 
cases that show similar clinical features of AN andBN only in a different combination. 
Binge eating disorder (BED) is the third category of EDNOS, and is characterized by the 
occurrence of binge eating in the absence of regular compensatory behaviors (Fairburn & 
Bohn, 2005).  
 Only few epidemiological studies were performed for the total category of EDNOS. 
Therefore it is unknown how prevalent EDNOS is in the community (Table 1.1). Recently, 
a crude mortality rate of 5.2% was reported for EDNOS (Crow et al., 2009), indicating that 
the severity and clinical impact of this eating disorder is not less than that seen in AN or 
BN. BED is the most intensively studied category of EDNOS. As shown in Table 1.1, the 
prevalence reported for BED appears to be higher than e prevalences of both BN and AN 
(Hoek & Van Hoeken, 2003; Hudson et al., 2007).  
 Reported risk factors for BED are negative self-evaluation, stressful life events, 
adverse childhood experiences, childhood obesity and repeated exposure to negative 
comments from family members about shape, weight or eating (Fairburn et al., 1998; Pike 
et al., 2006; Striegel-Moore et al., 2005). As presented in Table 1.2, twin studies obtained 
moderate heritability estimates for BED (Javaras et al., 2008; Mitchell et al., 2010; 
Reichborn-Kjennerud et al., 2004b). No twin studies have been performed to evaluate the 
contribution of genetic factors to the liability ofthe total category of EDNOS.  
 
Overlap among different types of eating disorders 
 
It is clear that the different types of eating disorders share a number of attitudes and 
behaviors. It has even been hypothesized that eating disorders essentially share the same 
core psychopathology: over-evaluating eating, shape, weight and their control (Fairburn et 
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al., 2003). An important other symptom that is shared among the different types of eating 
disorders (AN purging type, BN, and EDNOS) is self-induced vomiting (SV). Individuals 
with an eating disorder engage in SV as a method to lose body weight or prevent weight 
gain, following regular meals or as a compensatory action following binge eating. 
Prevalence of vomiting within clinical samples of individuals with AN ranged between 31 
and 39% (Ben-Tovim et al., 1989; Garner et al., 1993), whereas the rate in clinical samples 
of individuals with BN has been estimated to be over 90% (Ben-Tovim et al., 1989). 
Comparable to the eating disorders itself (Table 1.2), moderate to high heritability estimates 
have been shown for SV (Sullivan et al., 1998a; Wade et al., 2008b). It has been reported 
that the symptom of SV is associated with higher BMI, greater clinical severity and higher 
novelty seeking (Dalle Grave et al., 2009; Reba et l., 2005). 
 
Table 1.3 Crossover rates (%) between the different types of eating disorders  
 End diagnosis 
 AN BN EDNOS BED 
Start diagnosis     
AN  - 9-36 17 0 
BN 4-27 - 22 1 
EDNOS 10 16 - - 
BED 0 16.4 - - 
 
 Eating disorders are not static diseases; rather there is a continuous process of 
diagnostic crossover between the different types. The crossover rate is the percentage of 
patients whose initial eating disorder diagnosis (AN,BN, EDNOS or BED) changes into a 
different eating disorder diagnosis. Crossover rates mong the different types of eating 
disorders are presented in Table 1.3. In general, there is a considerable rate of cross-over 
between AN, BN and EDNOS, ranging between 4 and 36%(Eddy et al., 2008; Fichter & 
Quadflieg, 2007; Milos et al., 2005; Steinhausen & Weber, 2009; Tozzi et al., 2005). For 
BED the crossover to BN was around 16%, while the converse cross-over was close to 
zero. There was no crossover between BED and AN, and BED may thus be considered a 
different disease entity.  
 In addition to the cross-over rate between eating d sorders, family studies have shown 
that AN and BN do not aggregate independently within families, the risk of developing 
both disorders is elevated in family members of individuals with an eating disorder 
(Lilenfeld et al., 1998; Strober et al., 2000). Therefore, it has been hypothesized that AN, 
BN, but also subthreshold forms of eating disorders (EDNOS) share risk and liability 
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factors. As shown in a Swedish twin study, approximately half of the genetic factors 
contributed to liability of both AN and BN (Bulik et al., 2010). To further explore the 
shared liability between eating disorders it would be interesting to investigate the genetic 
contribution of the variance in a combined phenotype of disordered eating behaviours and 
attitudes as well. The role of body weight should also be taken into account, since body 
weight is closely linked to eating behaviours and even appears to be a risk factor for the 
development of eating disorders (Jacobi et al., 2004). Unique genetic and environmental 
factors may determine the state of expression of the eating disorder (e.g. the restrictive 
fasting in AN or the self-induced vomiting seen in AN purging type, BN, and EDNOS). 
The shared genetic factors may influence predisposing behavioural features that are shared 
among the different types of eating disorders, like perfectionism and impulsivity. 
 
Possible predisposing personality traits for eating disorders 
 
A personality feature that consistently characterizes patients with AN and/or BN is 
perfectionism (Cassin & von Ranson, 2005). Perfectionism ‘involves high standards of 
performance which are accompanied by tendencies for overly critical evaluations of one’s 
own behavior’ (Frost et al., 1990). Perfectionism i an important risk factor for both AN 
and BN, and although less pronounced it also appears to contribute to the vulnerability of 
BED (Fairburn et al., 1997; Jacobi et al., 2004; Lilenfeld et al., 2000; Striegel-Moore et al., 
2005). As can be seen in Table 1.2, moderate to substantial heritability estimates have also 
been reported for perfectionism (Tozzi et al., 2004). In addition, elevated levels of 
perfectionism were observed in relatives of individuals with AN and BN (Lilenfeld et al., 
2000; Woodside et al., 2002). These findings suggest that perfectionism may be of potential 
aetiological relevance for eating disorders.  
 Impulsivity has also regularly been associated with eating disorders. Impulsivity can be 
defined as the tendency to deliberate less than most pe ple of equal ability before taking 
action (Dickman, 1990). High impulsivity appears to be a prospective risk factor to BN, 
whereas low impulsivity (or high control) seems to be associated with AN (Casper et al., 
1992; Cassin & von Ranson, 2005; Claes et al., 2002; Steiger et al., 1991; Stice, 2002). 
Table 1.2 shows that almost half of the variance in impulsivity was accounted for by 
genetic factors (Hur & Bouchard, Jr., 1997; Pedersen et al., 1988; Seroczynski et al., 1999). 
In a large group of individuals with AN and BN Favaro et al. (Favaro et al., 2005) found 
that the presence of purging behaviour (self-induce vomiting and laxative use) was 
associated to impulsivity. Results from a large meta-analytic review support these findings 
(Fischer et al., 2008). In addition, Wade et al. (2008b) reported that novelty seeking, which 
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is closely related to impulsivity (Cloninger et al., 1993), predicted self-induced vomiting in 
a large twin study. In a meta-analysis all dimensio f impulsivity were significantly 
associated to bulimic symptoms (effect sizes r 0.08- .3 ) (Fischer et al., 2008). A latent 
profile analysis in patients recovered from AN (both restricting as well as binge-purging 
type) and BN showed that a separate cluster could be i entified based on impulsivity 
(Wagner et al., 2006). Thus, high impulsivity scores p rsist in some individuals after 
recovery from an eating disorder. It is possible that high impulsivity also precedes the onset 
of the eating disorder, indicating that this feature could also be of aetiological relevance. 
 
Genetic study designs 
 
Several approaches exist to identify genes involved in a trait with a heritable component 
(for an overview see Slagboom & Meulenbelt, 2002). Depending on the frequency and 
penetrance of the genetic variation underlying the dis ase a study design should be selected. 
Extended family designs are optimal to detect rare v iants with high penetrance mutation 
by model based linkage. In linkage analysis, the segregation of alleles in families together 
with the affected phenotypes are investigated to localise genes that influence a quantitative 
trait. In linkage analyses LOD scores (logarithm of odds) are used to compare the 
likelihood of obtaining the test data if the two loci are indeed linked, to the likelihood of 
observing the same data purely by chance (Fulker & Cardon, 1994). Linkage studies can 
also be performed in affected sibling pairs, this de ign is optimal for detecting genetic 
variants with both a moderate effect and a moderate pen trance. Finally, common variants 
with possibly small effect sizes can be detected by performing association studies in a large 
group of unrelated cases and controls (Cardon & Bell, 2001). The aim of this approach is to 
find an ancestral risk allele that is shared among population cases with the disease, higher 
allele frequencies amongst cases versus controls. In the association analysis odds ratios or 
other measures of association are used to describe the strength of the association. 
 The genetic studies described above can further be distinguished into hypothesis based 
and hypothesis free approaches. In the hypothesis ba ed approach the involvement of 
candidate genes in a certain trait or disorder are inv stigated. Candidate genes are selected 
because of their specific function or their involvement in a certain biological pathway. 
Depending on the number of candidate genes tested, mo erate samples sizes are sufficient, 
and little genotyping resources have to be used. However, when the aetiology of a certain 
trait or disorder is largely unknown, applying a hypothesis free approach will enable the 
researchers to identify new genetic loci putatively involved in the trait. Due to 
technological advances the whole genome can now be scanned to investigate which area 
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may harbour susceptibility loci for the disorder of interest. Both genomewide linkage 
studies (in families or affected sibling pairs) and genomewide association studies belong to 
the hypothesis free approach. Genomewide linkage studies identify chromosomal regions 
that may harbour susceptibility loci for the trait under study. Genomewide association 
studies on the other hand identify actual genetic variants that may distinguish cases from 
controls.  
 
Candidate pathways or genes 
 
The serotonin pathway has mostly been indicated as relevant in the development of eating 
disorders, since it is involved in a broad range of relevant biological, physiological and 
behavioral functions, for example body weight regulation and eating behavior (Blundell, 
1992; Blundell et al., 1995; Brewerton & Jimerson, 1996; Halford & Blundell, 2000; Kaye, 
1997; Lucki, 1998; Monteleone et al., 2000; Simansky, 1996; Weltzin et al., 1994). In 
addition, serotonin might also contribute to the psychopathological features of eating 
disorders such as perfectionism, impulsivity and obsessionality (Carver & Miller, 2006; 
Hinney et al., 2000; Kaye, 1997; Kaye et al., 2000a). In both rodents and humans, drugs 
that either directly or indirectly increased postsynaptic serotonergic stimulation routinely 
decreased the consumption of food (Lucki, 1998; Simansky, 1996). In underweight and 
malnourished individuals with AN, levels of 5-hydroxyindolacetic acid (5-HIAA), a 
metabolite of serotonin, were reduced in cerebrospinal fluid compared to those of controls 
(Brewerton & Jimerson, 1996; Kaye et al., 2005b). Furthermore, the prolactin response to 
D-fen, which is an index of the functional activity of the central serotonin system, was 
reduced in underweight inidividuals with AN and in individuals with BN with high 
frequent binge episodes (two or more episodes a day) (Monteleone et al., 2000). In long-
term weight-recovered patients with AN or BN, on the other hand levels of 5-HIAA in the 
cerebrospinal fluid were elevated (Kaye et al., 1991; Kaye et al., 1998). Whether these 
changes are a consequence or precede the disease onset has to be elucidated, for example 
by investigating the serotonin system in relatives of eating disorder patients. These results  
suggest that hyperserotonergic activity is a trait marker in eating disorders that could 
predispose to the development of the disorder. 
 In addition to genes belonging to the serotonin pathw y, the involvement of many 
other candidate genes have been studied in eating disorders. Table 1.4 lists the candidate 
genes per pathway, the number of studies and the number of significant associations that 
have been evaluated. In addition, a large collaborative study investigated the association of 
182 candidate genes in AN (Pinheiro et al., 2010). After accounting for multiple testing, 
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there were no statistically significant associations. Thirty six of these genes are also 
presented in Table 1.4. Many of the conducted studies had small sample sizes and 
inadequate statistical power to detect an effect. The studies in Table 1.4 were divided into 
large and small using a boundary of 80% statistical power. An elaborate review on the 
candidate gene studies conducted until 2005 can be found in chapter 2. In addition, the 
results from the large candidate gene studies performed during the last five years (2006-
2010) are summarized in appendix B, references for the small studies from this same time-
frame are given in appendix C.  
 Most association studies performed in the eating dsor er field used a hypothesis based 
approach (listed in the top part of Table 1.4). So far the only association that has been 
observed in at least two large association studies was between brain-derived neurotrophic 
factor (BDNF) and AN. BDNF plays a key role in the survival, differentiation, and 
development of several central and peripheral neurons and is involved in synaptic plasticity 
(Huang & Reichardt, 2001; Lu, 2003). BDNF has been implicated in the pathophysiology 
of several psychiatric disorders, including mood disorders and schizophrenia (Angelucci et 
al., 2004; Duman, 2002; Nestler et al., 2002), and it is recognized as a regulator of satiety, 
appetite and weight regulation (Lebrun et al., 2006). Heterozygous BDNF knockout mice 
are obese and develop hyperphagia (Kernie et al., 2000). In addition, central administration 
of BDNF leads to severe, dose-dependent appetite suppression and weight loss 
(Pelleymounter et al., 1995). Thus increased functio  of BDNF may be a predisposing 
factor to develop AN. 
 In the bottom part of Table 1.4, the genes that were identified by a hypothesis free 
approach are listed. Genomewide linkage studies have demonstrated linkage peaks for AN 
on chromosomes 1p33-36 and 4q13 and for BN on chromos es 10p13, and 14q22-23 
(Bulik et al., 2003a; Devlin et al., 2002; Grice et al., 2002). Following up the genome-wide 
screen in AN (Grice et al., 2002), an association study was conducted focusing on candidate 
genes positioned under the linkage peak on chromosoe 1p33-36 (Bergen et al., 2003). 
Three candidate genes were tested, namely the serotonin receptor 1D (HTR1D), opioid 
receptor delta 1 (OPRD1) and hypocretin receptor 1 (HCRTR1). The case-control study 
yielded a positive association between HTR1D and OPRD1 polymorphisms in AN. These 
findings were confirmed in an independent association study (Brown et al., 2006). 
 Two genomewide association studies have been conduted in AN, results are listed in 
the bottom of Table 1.4. In a Japanese genomewide association study (Nakabayashi et al., 
2009), two loci, namely 1q41 and 11q22 were significantly associated with AN. Neither of 
these loci showed a positive evidence of association with BN. The most significant 
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association was observed at a SNP located near the gene encoding spermatogenesis-
associated protein 17.  
 
Table 1.4 Candidate genes investigated in eating disor ers, the number of studies and significant associati ns are 
divided into large (adequate statistical power) andsmall (statistically underpowered) studies.  
Hypothesis based approach  Large studies Small studie  
candidate pathways/genes Position N Sign ass N Sign ass 
Serotonin      
Serotonin receptor 1B (HTR1B) 6q13 1 0 1 0 
Serotonin receptor 2A (HTR2A) 13q14-21 2 0 16 7 
Serotonin receptor 2C (HTR2C) Xq24 1 0 4 1 
Serotonin receptor 3A (HTR3A) 11q23 2 1   
Serotonin receptor 3B (HTR3B) 11q23 2 1   
Serotonin receptor 7 (HTR7) 10q21-24 1 0 1 0 
Serotonin transporter (SLC6A4) 17q11-12 1 0 10 6 
Tryptophan hydroxylase (TPH1) 11p14-p15 1 0 2 0 
Catecholamine      
Beta-3-adrenergic receptor (ADRB3) 8p11-12 2 0 1 0 
Catechol-O-methyltransferase (COMT) 22q11 2 0 6 3 
Dopamine receptor D2 (DRD2) 11q23 2 1   
Dopamine receptor D3 (DRD3) 3q13 1 0 1 0 
Dopamine receptor D4 (DRD4) 11p15 2 1 2 0 
Dopamine transporter (SLC6A3) 5p15 1 0 2 1 
Mono amine oxidase A (MAOA) Xp11 1 0 2 0 
Norepineprhine transporter (SLC6A2) 16q12 2 1 1 1 
Neuropeptide, feeding & energy regulation      
Agouti related protein (AGRP) 16q22 1 0 2 2 
Cannabinoid receptor 1 (CNR1) 6q14-15 1 0 4 3 
Cannobinoid receptor 2 (CNR2) 1p36 2 1   
Cholecystokinine (CCK) 3pter-p21 2 1   
Fatty acid amide hydrolase (FAAH) 1p34-35   2 1 
Ghrelin (GHRL) 3p25-26 3 0 2 1 
Leptin (LEP) 7q31 1 0 1 0 
Leptin receptor (LEPR) 1q31 1 0 1 0 
Melanocortin receptor 4 (MCR4) 18q22 2 0 1 0 
Monogliceride lipase (MGLL) 3p21   1 0 
N-acylethanolamine-hydrolyzing acid  
amidase (NAAA) 4q21   1 0 
Neuropeptide Y receptor 1R (NPY1R) 4q31-32 1 0 1 0 
Neuropeptide Y receptor 5R (NPY5R) 4q31-32 1 0 1 0 
Proopiomelanocortine (POMC) 2q23 1 0 1 0 
Chapter 1 
17 
Hypothesis based approach  Large studies Small studie  
candidate pathways/genes Position N Sign ass N Sign ass 
Uncoupling protein 2/3 (UCP 2/3) 11q13 1 0 3 1 
Neurogenesis      
Brain-derived neuroptrophic factor (BDNF) 11p13 5 2 7 4 
Neurotrophic tyrosine kinase receptor 2 
(NTRK2) 9q22 1 0 1 1 
Other candidate genes      
Armadillo repeat gene deleted in VCSF  
(ARVCF) 22q11 1 0   
Estrogen receptor 1 (ESR1) 6q25 2 1 1 0 
Estrogen receptor 2 (ESR2) 14q 1 0 3 2 
ETS variant gene 5 (ETV5) 3q28 1 0   
Fat mass- and obesity associated gene (FTO) 16q12 1 0   
Glucosamine-6-phosphate deaminase 2  
(GNPDA2) 4p13 1 0   
Glutamate receptor (GRIN2B) 12p12 1 0 1 1 
G-protein coupled receptor 55 (GPR55) 2q37 1 1   
Major histocompatibilty complex (HLA) 6q21   3 1 
Mitochondrial carrier homolog 2(MTCH2) 11q12 1 0   
Neurol growth regulator 1 (NEGR1) 1p31 1 0   
Potassium channel (KCNN3) 1q21 1 0 3 3 
Potassium channel tetramerisation domain  
(KCTD15) 19q13 1 0   
SH2B adaptor protein 1 (SH2B1) 16p11 1 0   
Transmembrane protein 18 (TMEM18) 2p25 1 0   
Tumor necrosis factor (TNF) 6q21   2 2 
Hypothesis free approach  Large studies Small studies 
genes Position N Sign ass N Sign ass 
Serotonin receptor 1D (HTR1D) 1p34-36 3 2   
Hypocretin receptor (HCRTR1) 1p34-36 2 0   
Opioid receptor delta-1 (OPRD1) 1p34-36 3 2   
A-Kinase anchor protein 6 (AKAP6) 14q12 1 1   
Cadherin 9 (CDH9) 5p14 1 1   
Cysteine- & glycine-rich protein 2 binding  
protein (CSRP2BP) 20p11 1 1   
Netrin G1 (NTNG1) 1p13 1 1   
Spermatogenesis-associated protein 17 
 (SPATA17) 1q41 2 1   





This finding could not be confirmed in a second genomewide association study in 
individuals with AN and controls of European ancestry (Wang et al., 2010). In this study no 
SNP reached genome-wide significance, whereas top association signals were detected near 
genes encoding zinc protein 804B, cysteine- and glycine-rich protein 2 binding protein, 
netrin G1, a-kinase anchor protein and cadherin 9. I addition, the association between 
OPRD1 and AN was confirmed, while suggestive evidence was obtained for involvement 
of HTR1D in AN.  
 
Outline of this thesis 
 
This thesis aims to answer the following questions: 
1. Is disordered eating behaviour heritable and how much of this heritability is 
independent of BMI? 
2. Are the genes encoding serotonin receptor 1D, stathmin, brain-derived 
neurotrophic factor and tryptophan hydroxylase 2 involved in anorexia nervosa 
and/or eating disorders characterized by self-induce  vomiting?  
3. Can genetic predisposition to high perfectionism and impulsivity explain an 
association between the tryptophan hydroxylase 2 gene and eating disorders? 
 
Table 1.5 Study populations used in this thesis 
Population N Description Thesis question 
GenED study 389 Female participants with an eating 
disorder (DSM-IV): 182 with AN, 
149 with eating disorders 
characterized by self-induced 
vomiting 
2 and 3 
Netherlands Twin Registry 
 (NTR):  
   
Young twins (YNTR) 2702 Adolescent twins and siblings 
(956 male twins, 1219 female 
twins, 239 brothers and 
288 sisters) 
1, for 2 and 3  
(399 adolescent  
female twins) 
Adult twins (ANTR) 250 Adult female twins and family 
members 
2 and 3 
Healthy controls:    




To answer these questions data from three different populations were analyzed (see Table 
1.5):  
 The Genetics of Eating Disorder (GenED) study was designed and initiated for this 
thesis to collect DNA, DSM-IV eating disorder diagnoses and extensive phenotype 
information from a large group of participants with an eating disorder. Participants were 
recruited through ten specialist eating disorder units throughout the Netherlands. Eating 
disorder diagnoses were made by experienced clinicians based on a semi-structured 
interview at intake. The phenotype information was comprised of questionnaire data on 
eating disorder symptoms and characteristics, impulsivity and perfectionism for all eating 
disorder cases. Furthermore, additional interview and questionnaire data were collected on 
eating disorder features, comorbid psychiatric disor ers, personality and obsessionality, in a 
subgroup of participants who fulfilled DSM-IV criteria for anorexia (at least three years) or 
bulimia nervosa. First-degree family members from this group were also approached to 
participate in the GenED study.  
 In the late 1980s The Netherlands Twin Register (NTR) was established by recruiting 
young twins and multiples at birth and by approaching adolescent and young adult twins 
through city councils (Bartels et al., 2007; Boomsma et al., 2002; Boomsma et al., 2006). 
These twins, their parents and siblings participate in longitudinal survey studies concerning 
a wide variety of behavioral, psychological and lifestyle features, including disordered 
eating behavior (for items see Table 1.6), perfectionism and impulsivity. These phenotypic 
data were collected in a large sample of adolescent twi s and siblings from the Young 
Netherlands Twin Registry (YNTR). In addition, DNA was collected in a subsample of 
adolescent female twins. Phenotypic data and DNA samples were also available for adult 
female twins and family members from the Adult Netherlands Twin Registry (ANTR). 
 
Table 1.6 Disordered Eating Behavior (DEB) items 
Items Question 
Dieting Have you ever gone on a diet to lose weight or to stop  
gaining weight? 
Fear of weight gain How afraid are you to gain weight or become fat? 
Importance of body weight or  
shape on self-evaluation 
How important are body weight and/or shape in how 
you feel about yourself? 
Binge eating Have you ever had episodes of binge eating? 
 
 The third study population consists of a control gr up of adult women without eating 
disorders. This group was recruited through advertis ments in magazines and via internet 
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websites. Questionnaire data on eating disorder sympto s and characteristics, impulsivity 
and perfectionism were collected, identical to the eating disorder participants and family 
members from the GenED study. 
 
In chapter 2 an overview on the state of affairs of genetic research on family, twin and 
molecular genetic studies in the eating disorder field up till 2005 is given.  
 In chapter 3, we evaluated whether the Disordered Eating Behavior (DEB)-scale, used 
in the twin population of the NTR was comparable betwe n adolescent men and women. 
This study provides a comprehensive overview of the diff rent steps in multi-group discrete 
factor analyses accumulating into a model of complete measurement invariance with 
respect to sex, which were tested for the DEB-scale.  
 In chapter 4 it was investigated what proportion of heritability in DEB was attributable 
to genetic effects on body mass index (BMI), and what proportion was independent of these 
effects in a sample of twins and non-twin siblings from the YNTR. A bivariate genetic 
analysis of DEB and BMI was conducted to estimate the overlap between both traits and to 
disentangle the proportion of covariance due to shared nd specific genetic and 
environmental factors.  
 In chapter 5, the association between four candidate genes and two types of eating 
disorders (AN and eating disorders characterized by SV) were evaluated in participants 
from the GenED study as cases and random twin-based controls from the NTR. Two 
candidate genes, namely brain-derived neurotrophic factor (BDNF) and serotonin receptor 
1D (HTR1D) were selected because of previous promising associations in eating disorders. 
In addition, the genes encoding for tryptophan hydroxylase 2 (TPH2) and stathmin 
(STMN1) were selected. TPH2 is the rate-determining enzyme in the synthesis of serotonin 
in the brain (Walther & Bader, 2003). TPH2 was previously associated with depression and 
anxiety (Barnett & Smoller, 2009; Kim et al., 2009; Tsai et al., 2009; Zhang et al., 2006), 
which are both highly comorbid with eating disorders (Godart et al., 2000; Hudson et al., 
2007; Kaye et al., 2004a; Raney et al., 2008). STMN1 is located under the linkage peak for 
AN at 1p33-36. This gene is involved in the control of both learned and innate fear in mice 
(Shumyatsky et al., 2005), and fear and anxiety processing in humans (Brocke et al., 2010). 
Replication occurred in a meta-analysis with two additional independent eating disorder 
case-control samples from Germany and the Netherlands together providing 887 
participants with AN, 306 participants with an eating disorder characterized by SV and 
1914 controls.  
 In chapter 6 we explore the hypothesis that TPH2 affects perfectionism or impulsivity 
which predisposes to the AN and or SV phenotype. First a phenotypic analysis was 
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performed to confirm the association between perfectionism, impulsivity and eating 
disorders, in participants from the GenED study and  control group of women without an 
eating disorder. Then genotypic analyses were conducte . First, four TPH2 SNPs, that were 
previously associated to AN and/or SV, were tested for association with perfectionism 
and/or impulsivity in twin-based controls from the NTR. The SNPs that showed an 
association with perfectionism and/or impulsivity were subsequently tested for association 
with these features in the participants with an eating disorder.  
 In the final chapter of this thesis, a concise summary of the main findings is given 
followed by a discussion of the results in light of limitations, clinical implications and 
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Substantial effort has been put into the exploration of the biological background of eating 
disorders, through family, twin and molecular genetic s udies. Family studies have shown 
that anorexia (AN) and bulimia nervosa (BN) are strongly familial, and that familial 
aetiologic factors appear to be shared by both disor ers. Twin studies often focus on 
broader phenotypes or subthreshold eating disorders. These studies consistently yielded 
moderate to substantial heritabilities. In addition, there has been a proliferation of 
molecular genetic studies that focused on Diagnostic and Statistical Manual of Mental 
Disorders (DSM-IV, 1994) AN and BN. Seven linkage regions have been identified in 
genome-wide screens. Many genetic association studies have been performed, but no 
consistent association between a candidate gene and AN or BN has been reported. Larger 
genetic association studies and collaborations are needed to examine the involvement of 
several candidate genes and biological pathways in eati g disorders. In addition, twin 
studies should be designed to assist the molecular work by further exploring genetic 
determinants of endophenotypes, evaluating the magnitude of contribution to liability of 
measured genotypes as well as environmental risk factors related to eating disorders. In this 












Eating disorders are distinguished into anorexia nervosa (AN), bulimia nervosa (BN) and 
eating disorders not otherwise specified (EDNOS). The diagnostic features of AN include 
severe underweight and an intense fear of gaining wei ht or becoming fat. BN is 
characterized by recurrent episodes of binge eating nd compensatory behaviors. Binge 
eating disorder, the most studied form of EDNOS, is characterized by the occurrence of 
binge eating in the absence of compensatory behaviors. 
 AN and BN mainly affect young women (90 to 95%) and generally start during 
puberty or early adulthood. The prevalence among women between 15 and 24 years of age 
is estimated to be 0.3% for AN and 1% for BN in industrialized countries (Hoek, 1993; Van 
Hoeken et al., 1998). Chronicity and mortality of patients with eating disorders are among 
the highest of all psychiatric illnesses (Harris & Barraclough, 1998; Nielsen et al., 1998; 
Sullivan, 1995). Long-term follow-up studies show a mortality rate of 5% per decade. 
Mortality from AN is five times higher than in a comparable age group (Harris & 
Barraclough, 1998). Recent studies show that even aft r 10 years, 20% of the individuals 
continue to fulfil diagnostic criteria for an eating disorder, while another 30% show partial 
symptoms (Steinhausen, 1999; Steinhausen, 2002).  
 Despite substantial efforts to identify causal pathways for AN and BN, very little is 
known about the etiology of eating disorders. In logitudinal and cross-sectional studies, 
several risk factors have been identified, including gender, elevated weight and shape 
concerns, negative body image, negative self-evaluation nd dieting (Jacobi et al., 2004). 
For AN, high-level exercise and perfectionism have be n identified as additional risk 
factors.  
 To explore the role of biology in the etiology of eating disorders, numerous studies 
have been performed (for a review see Bulik & Tozzi, 2004; Tozzi & Bulik, 2003). Family 
studies have been conducted to examine if relatives of patients with AN or BN have an 
increased risk for developing an eating disorder. Family studies cannot distinguish between 
the genetic and environmental contribution to familial aggregation. In contrast, in twin 
studies, the similarities and differences between mo ozygotic (MZ) and dizygotic (DZ) 
twins allow us to delineate the nature and magnitude of genetic and environmental 
influences for a particular trait. In the first section, we will review family and twin studies 
of AN and BN.  
 Evidence of heritability justifies efforts to identify genetic loci that influence the risk 
for a trait or disorder. The last two decades have witnessed a proliferation of linkage and 
association studies of eating disorders. In the majority of studies candidate genes were 
examined based on their hypothesized function in the e iology of eating disorders. The 
second part of this paper focuses on the genetic studies of eating disorders.  
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Family and Twin studies 
 
All but one of the family studies of AN and BN (Logue et al., 1989) reported increased 
rates of eating disorders in relatives of patients (Biederman et al., 1985; Gershon et al., 
1983; Grigoroiu-Serbanescu et al., 2003; Halmi et al., 1991; Herpertz-Dahlmann, 1988; 
Hudson et al., 1987; Kassett et al., 1989; Lilenfeld et al., 1998; Stern et al., 1992; Strober et 
al., 1985; Strober et al., 2000; Strober et al., 2001; Strober et al., 1990). Strober et al. (2000) 
performed the most extensive family study in eating disorders, using phenotypes based on 
Diagnostic and Statistical Manual of Mental Disorders (4th ed.; DSM-IV; American 
Psychiatric Association, 1994) criteria. They compared the rate of eating and other 
psychiatric disorders in the relatives of 152 restrictive AN patients, 171 BN patients and 
181 healthy controls. The risk of developing AN was 11.4 times increased in relatives of 
AN patients compared to relatives of healthy controls, whereas the risk for BN in relatives 
of AN patients was 3.5 times increased. Relatives of BN patients had a 3.7 times increased 
risk for developing BN, and a 12.1 times increased risk for developing AN. Not only do 
these results suggest that AN and BN are familial, but also that familial etiological factors 
appear to be shared by AN and BN. 
 The first heritability studies in twins of AN and BN were clinical case reports and 
systematic studies of clinically ascertained twins (see the first section in Table 2.1; 
(Askevold & Heiberg, 1979; Fichter & Noegel, 1990; Holland et al., 1984; Holland et al., 
1988; Hsu et al., 1990; Nowlin, 1983; Treasure & Holland, 1990). The criteria applied to 
define AN and BN varied considerably between these studies, and none were based on 
DSM-IV. Nevertheless, for AN and BN, the concordance of MZ twins was greater than for 
DZ twins, which was more pronounced in AN. Bulik et al. (2000), reanalyzed the clinical 
twin studies of BN and fitted a full ACE model (including genetic, common environmental 
and unique environmental factors) to the data from these reports. In this analysis, 
concordance rates of 46% in MZ and 26% in DZ twins resulted in a heritability estimate of 
47% (95% confidence interval [CI] 0-66). It is important to note that clinical cases are 
likely to be more severely affected, and may differ rom community cases in other ways 
that might bias the results of genetic investigations (Kendler, 1993). The results obtained in 
clinical studies may therefore not be extrapolated to the total population of affected 
individuals. But they may be suitable in detecting a pathway which leads to the onset of AN 
or BN. 
 Three different population-based twin registries as essed AN and/or BN, namely the 
Danish Twin registry (DTR; Kortegaard et al., 2001), the Minnesota Twin Family Study 
(MTFS; Klump et al., 2001) and the Virginia Twin Registry (VTR; Bulik et al., 1998; 
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Kendler et al., 1991; Kendler et al., 1995; Wade et al., 2000b; Walters et al., 1992; Walters 
& Kendler, 1995). Due to the low prevalence of both AN and BN, all studies used broader 
phenotypes to boost statistical power. The criteria used to define these broader phenotypes 
varied considerably between registries. Partial DSM-IV and Diagnostic and Statistical 
Manual of Mental Disorders (3rd ed., rev.; DSM-III-R; American Psychiatric Association, 
1987) criteria were used in the MTFS and the VTR respectively, whereas the definitions 
used in the DTR were not based on DSM criteria at all. The reported prevalence for broad 
AN phenotypes ranged from 2.7% to 4.9% (Klump et al., 2001; Kortegaard et al., 2001; 
Wade et al., 2000b; Walters & Kendler, 1995), all exceeding the estimated population 
prevalence of 0.3% by far. For the broad BN phenotype the prevalences were around 4% 
(Bulik et al., 1998; Kendler et al., 1991; Kendler et al., 1995; Kortegaard et al., 2001), again 
considerably higher than the 1% population prevalence.  
 In the second section of Table 2.1, the best-fitting and full twin models of broad AN (if 
presented in the original study) are shown. In the best-fitting models, the heritability 
estimates in the DTR ranged from 48% to 52% (Kortegaard et al., 2001), and in the MTFS 
it was estimated at 76% (Klump et al., 2001). Moreover, Wade et al. (2000b) reported a 
heritability estimate of 58%, using bivariate analyses in the VTR. In all studies, the 
remaining variance was accounted for by unique enviro mental factors (Klump et al., 2001; 
Kortegaard et al., 2001; Wade et al., 2000b).  
 The best-fitting and full twin models of broad BN are listed in the final part of Table 
2.1. Both univariate and bivariate twin analyses of br ad BN (Bulik et al., 1998; Kendler et 
al., 1991; Kortegaard et al., 2001; Walters et al., 1992), consistently yielded high 
heritability estimates, ranging from 50% (Walters et al., 1992) to 70% (Bulik et al., 1998). 
In these studies, individual specific environmental components accounted for the remaining 
variance. In a multivariate analysis, examining BN in combination with five other 
psychiatric disorders (Kendler et al., 1995), a heritability estimate of 30% for broadly 
defined BN was obtained. Shared genetic factors were identified among BN, phobia and 
generalized anxiety disorder.  
 Statistical power can be enhanced by incorporating two occasions of measurement into 
a twin study. Bulik et al. (1998), applied this method using data from the first and third 
wave of data collection in the VTR to assess BN. The reliability between these two 
occasions of measurement was low (κ=.28), suggesting that single assessments of the 
lifetime history of broad BN are prone to error. When the error of measurement was 
incorporated into the structural equation twin model, a heritability of 83% was estimated 






























Table 2.1. Twin studies in eating disorders. Best-fitting and full twin models are shown including 95% confidence intervals, when reported in the original studies.  
Subject Sample size Concordance Model Reference Note 
 MZ DZ MZ DZ a2 c2 e2   
Clinical studies        
16 - 0.55 -    (Askevold et al., 1979)  
24 2 0.59 0    (Nowlin, 1983)  Review, criteria unclear 
16 14 0.72 0.13    (Holland et al., 1984)  Female-female pairs, Crisp & Russel  
(1970) 
25 20 0.71 0.10 98  
(se ±12) 
  (Holland et al., 1988)  Female-female pairs, ICD 9  
AN  
 
34 26 0.68 0.08 100 - - (Treasure et al, 1990)  Femal -female pairs, EDE 
14 17 0.35 0.29 10 60 30 (Treasure et al., 1990)  Female-female pairs, EDE 
6 2 0.50 0    (Hsu et al., 1990)  Female-female pairs, DSM-III-R 
BN  
 
6 15 0.91 0.42    (Fichter et al., 1990)  Female-femal  pairs, DSM-III-R 
Twin registries        
590 440 0.10 0.22    (Walters et al., 1995)  VTR, wave 1, clinical broad AN  






(Klump et al., 2001)  MTFS, DSM-IV, full model  
196 105 0.40 0 76  
(35-95) 
- 24  
(5-65) 
(Klump et al., 2001)  MTFS, DSM-IV, best-fitting model 






- 52 (Kortegaard et al., 2001)  DTR, definition based on 1 item,  
best-fitting model 






- 36 (Kortegaard et al., 2001) DTR, definition based on 2 items,  
best-fitting model 






(Wade et al., 2000)  VTR, DSM-III-R, bivariate analysis 





597 433   58  
(33-84) 
- 42  
(16-68) 
(Wade et al., 2000) VTR, DSM-III-R, bivariate analysis  











590 440 0.23 0.09 55 0 45 (Kendler et al., 1991)  VTR, wave 1, DSM-III-Rb, full model  
590 440 0.23 0.09 55 - 45 (Kendler et al., 1991)  VTR, wave 1, DSM-III-Rb,  
best-fitting model 
590 440 0.26 0.16 38 13 50 (Kendler et al., 1991)  VTR, wave 1, DSM-III-Rc, full model 
590 440 0.26 0.16 52 - 48 (Kendler et al., 1991)  VTR, wave 1, DSM-III-Rc,  
best-fitting model 
497 354   60 - 40 (Bulik et al., 1998)  VTR, wave 1, DSM-III-Rd,  
best-fitting model 
497 354   68 - 32 (Bulik et al., 1998)  VTR, wave 3, DSM-III-Rd,  
best-fitting model 






- 24 (Kortegaard et al., 2001) DTR, best-fitting model 
590 440   35 22 43 (Walters et al., 1992)  VTR, wave 1, DSM-III-Rc, bivariate  
analysis major depression, ra=0.26, 
 full model 
590 440   50 - 50 (Walters et al., 1992)  VTR, wave 1, DSM-III-Rc, bivariate  
analysis major depression, ra=0.46,  
best-fitting model 
590 440   30 41 29 (Kendler et al., 1995)  VTR, wave 1, DSM-III-Rc, multivariate 






497 354   83  
(64-100) 
- 17  
(0-36) 
(Bulik et al., 1998)  VTR, wave 1 & 3, DSM-III-Rd, 
 incorporation of 2 occasions of 
 measurement, best-fitting model 
Note: Best-fitting and full twin models are shown including 95% confidence intervals when reported in the original studies. 
Affected twin pairs: at least one twin endorsed oner more of the eating disorder questions. 
Definition broad BN: definite and probable cases BN based on DSM-III-R. 
Definition broad BN: definite, probable and possible cases BN based on DSM-III-R 
Definition broad BN: all DSM-III-R criteria minus criterion D (minimum frequency of binge eating). 
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 Due to the low prevalence of AN and BN, and subsequently the small numbers of 
affected twins in the VTR and MTFS samples, the statistical power, even when using 
broader phenotypes, was far from adequate in these studies as reflected in the broad 
confidence intervals around the heritability estimaes (Neale et al., 1994). Although, the 
sample sizes in the DTR were much larger, the statistical power in this study was still 
insufficient and the diagnostic criteria suboptimal.  
 In summary, family studies have consistently shown that AN and BN are strongly 
familial. The twin studies in AN and BN are indicative of a modest to considerable role of 
genetic factors in the etiology of broadly defined eating disorders, component behaviours, 
and related traits. Due to the relatively low preval nce of AN and BN, whether a threshold 
DSM-IV diagnosis represents a more heritable phenotype han the broad definition 
phenotypes used remains unknown.  
 
Molecular Genetic Studies 
 
Linkage studies 
In linkage analysis, the segregation of alleles in families together with the affected 
phenotypes is investigated to localize disease genes or, in general, genes that influence a 
quantitative trait (Slagboom & Meulenbelt, 2002). Relevant for the studies into AN and BN 
are the genome-wide marker data that are used to establish the extent of allele sharing in 
AN and BN affected sibling pairs by applying either a model-free or model-based linkage 
analysis method. To identify areas of the human genome that may harbour susceptibility 
loci for AN and BN, genome-wide screens have been conducted using polymorphic 
markers spanning all chromosomes, in a collaboration of the Price Foundation (Bulik et al., 
2003a; Devlin et al., 2002; Grice et al., 2002; Kaye et al., 2000b; Kaye et al., 2004b).  
 For AN, probands were included in the study if they ad a lifetime diagnosis of AN, 
based on DSM-IV criteria minus criterion D (amenorrhea) with a duration of at least 3 
years, whereas relatives of AN probands needed to fulfill DSM-IV criteria for an eating 
disorder (either AN, BN or EDNOS). Using these criteria, a total of 229 affected relative 
pairs were recruited. To provide better identity by descent (IBD) estimation, DNA was 
collected from biological parents where possible (Kaye et al., 2000b).  
 The BN probands were required to have a lifetime diagnosis of BN, according to 
DSM-IV criteria, purging had to include regular vomiting, and bingeing and vomiting must 
have occurred at least twice a week for a duration of 6 months. To be included in the study, 
relatives were required to have a DSM-IV diagnosis f an eating disorder (either AN, BN 
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or EDNOS). A total of 365 affected relative pairs were recruited. Again DNA was collected 





























































































































































































Figure 2.1. Linkage results of the genome-wide scan in eating disorders, with LOD-scores ≥ 1.97. 
I Anorexia nervosa restrictive subtype (chromosome 1 NPL = 3.03, chromosome 4 NPL = 2.44) 
II Anorexia nervosa, drive for thinness and obsessional ty combined (LOD = 3.46) 
III Anorexia nervosa and obsessionality (LOD = 2.22) 
IV Bulimia nervosa (chromosome 10 MLS = 2.92, chromosome 14 MLS = 1.97) 
V Anorexia nervosa and drive for thinness (LOD = 2.50) 
 
 Figure 2.1 shows the linkage regions that were obtained in genome-wide screens 
(linkage scores of 1.97 or greater) performed in these studies of AN and BN. In the total 
sample of AN affected relative pairs, none of the linkage peaks had a nonparametric linkage 
(NPL) score above 1.80. Linkage analysis performed in the restrictive subtype of AN (n = 
37 families), however, yielded a linkage peak at 1p33-36 (NPL score = 3.03), providing 
suggestive evidence and a peak at 4q12-14 (NPL score = 2.44; Bergen et al., 2003; Grice et 
al., 2002). Within the AN sample, a quantative trait locus (QTL) analysis was subsequently 
performed with drive for thinness and obsessionality (Devlin et al., 2002) that showed three 
suggestive linkages on chromosome 1q31 (Logarithm of the Odds [LOD] score = 3.46 for 
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Drive for Thinness and Obsessionality combined), 2p11 (LOD score = 2.22 for 
Obsessionality), and 13q13 (LOD score = 2.50 for Drive for Thinness), respectively. 
 For the entire BN sample, three regions of linkage were reported, significant linkage 
was achieved on chromosome 10p13 (nonparametric multipoint maximum LOD score 
[MLS] = 2.92), and suggestive evidence for linkage was reported for 10p14 (MLS = 2.70) 
and 14q22-23 (MLS = 1.97). In addition, linkage analysis was performed in a subset of 133 
families, in which at least two affected individuals reported regular vomiting behavior. This 
phenotype was chosen because vomiting is associated with a more reliable reporting of BN 
(Wade et al., 2000a), and because of its substantial heritability (Sullivan et al., 1998a). The 
analysis in this subset did not yield any different regions of linkage, but did increase the 
linkage peak on chromosome 10p13 (LOD score = 3.39).  
 
Genetic Association Studies 
In a genetic association study, candidate genes that are suggested to be involved in the 
pathophysiology of the disease can be investigated for their role in the onset of the trait. In 
such studies, the allele or genotype frequencies at markers, single nucleotide 
polymorphisms (SNP), are determined in affected indiv duals and compared to those of 
controls (either population- or family-based). Association studies are known as an effective 
approach to detect the effect of variants within cadidate genes with relatively small effects 
(Slagboom & Meulenbelt, 2002). 
 A variety of genes have been tested in association s udies in eating disorders. Most 
genes can be classified in three main biological pathw ys, namely the serotonin pathway, 
the catecholamine pathway, and the pathway involved in neuropeptide and feeding 
regulation. The serotonin pathway has been most intensively studied in eating disorders. It 
is involved in a broad range of biological, physiological and behavioral functions (Blundell, 
1992; Blundell et al., 1995; Halford & Blundell, 200 ; Lucki, 1998; Simansky, 1996). 
Serotonin is involved in body weight regulation and more specifically in eating behavior. In 
both rodents and humans, drugs that either directly or indirectly increased postsynaptic 
serotonergic stimulation routinely decreased the consumption of food (Lucki, 1998; 
Simansky, 1996). The serotonin pathway has also been implicated in the development of 
eating disorders (Brewerton & Jimerson, 1996; Kaye, 1997; Monteleone et al., 2000; 
Weltzin et al., 1994). In long-term weight-recovered patients with AN or BN, levels of 5-
hydroxyindolacetic acid (5-HIAA), a metabolite of serotonin, were elevated in 
cerebrospinal fluid compared to those of controls (Kaye et al., 1991; Kaye et al., 1998). 
These results suggest that hyperserotonergic activity is a trait marker in eating disorders. It 
is hypothesized that increased brain serotonin activity could predispose to the development 
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of eating disorders. In addition, serotonin might also contribute to the psychopathological 
features of eating disorders such as perfectionism, rigidity and obsessionality (Hinney et al., 
2000; Kaye, 1997; Kaye et al., 2000a). 
 Within the serotonin system, the serotonin 2A receptor gene (HTR2A) has received 
most attention in association studies. HTR2A is regulated by estrogen (Fink & Sumner, 
1996), which could render a possible explanation why 90 to 95% of those affected by AN 
are female and why the onset of the disorder is peripubertal. In addition, it has been 
reported that recovered patients with AN and BN have  reduced HTR2A receptor binding 
compared to healthy controls (Frank et al., 2002; Kaye et al., 2001). These findings suggest 
that alterations in the HTR2A gene might be involved in the etiology of eating disorders.  
 The eating disorder field is characterized by the performance of many genetic 
association studies in small samples that often present contradicting results (for references 
see Appendix D). In the majority of the studies, ANand BN were diagnosed according to 
DSM-IV criteria. The general problem of these studies is their lack of statistical power. 
When recalculating the power of these studies, assuming a dominant model with an allele 
frequency of .10 and a relative risk of 2, 93% of the studies (53 out of the 57) do not have 
adequate statistical power to detect an effect. To obtain a power of 80% under these 
assumptions, at least 178 cases and 178 controls are required. 
 An example of the inconsistency in smaller studies is the G-1438A polymorphism in 
the promoter region of the HTR2A gene. In Caucasians, six case-control association s udies 
reported a positive association of the G-1438A polym rphism and AN (Collier et al., 1997; 
Enoch et al., 1998; Nacmias et al., 1999; Ricca et al., 2002; Ricca et al., 2004; Sorbi et al., 
1998). In these studies, a higher frequency of the –1438A allele and/or –1438 A/A 
genotype in anorectics compared to controls, was report d. However, six other studies, also 
performed in Caucasian populations, did not confirm this finding (Campbell et al., 1998; 
Hinney et al., 1997; Karwautz et al., 2001; Kipman et al., 2002; Rybakowski et al., 2004; 
Ziegler & Gorg, 1999). Finally, two Japanese studies also did not detect association 
between the G-1438A polymorphism and AN (Ando et al., 2001; Nishiguchi et al., 2001).  
 Meta analyses provide a quantitative approach for combining results from different 
studies on the same topic. Systematic meta-analyses can be a useful tool in estimating 
population-wide effects of genetic risk factors in human disease (Ioannidis et al., 2001). So 
in response to the apparent discrepancies mentioned above, three meta-analyses have been 
performed (Collier et al., 1999; Gorwood et al., 2003; Ziegler et al., 1999). Collier et al. 
(1999) conducted a meta-analysis on four association s udies (Campbell et al., 1998; Collier 
et al., 1997; Enoch et al., 1998; Sorbi et al., 1998). In this analysis, a significant association 
between the -1438A/A genotype and AN, with an odds ratio of 2.29, was reported. Ziegler 
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et al. (1999) performed a meta-analysis based on six studies (Campbell et al., 1998; Collier 
et al., 1997; Enoch et al., 1998; Hinney et al., 1997; Sorbi et al., 1998; Ziegler & Gorg, 
1999) including the four studies used in the first meta-analysis (Collier et al., 1999), and the 
study by Hinney et al. (1997) which did not have a normal weight control group. This meta-
analysis did not reveal a significant association between the HTR2A promoter 
polymorphism and AN. The third meta-analysis (Gorwood et al., 2003) was based on nine 
studies (Campbell et al., 1998; Collier et al., 1997; Enoch et al., 1998; Hinney et al., 1997; 
Kipman et al., 2002; Nacmias et al., 1999; Nishiguchi et al., 2001; Sorbi et al., 1998; 
Ziegler & Gorg, 1999) including the studies used in the meta-analysis by Ziegler et al. 
(1999). One of the additional studies was a Japanese study (Nishiguchi et al., 2001). In this 
analysis, the frequency of the –1438A allele in patients with AN was significantly higher 
compared to controls.  
 An important issue concerning the meta-analyses is whether it is justified to combine 
the association studies. First, there is a difference i  the type of control group used. Hinney 
et al. (1997) used a group of obese and a group of nderweight participants as the control 
group, while all other studies used a normal weight control sample. Second, A-allele 
frequencies found in the Japanese controls (Nishiguc i et al., 2001), were higher (.54) than 
those reported in the Caucasian control samples (.30-.48). In addition, the frequencies of the 
-1438 A allele in the different Caucasian control samples shows substantial differences, 
ranging from .30 (Ziegler & Gorg, 1999) to .48 (Kipman et al., 2002). The difference of the 
-1438 A allele in AN patients is even greater, ranging from .29 (Ziegler & Gorg, 1999) to 
.57 (Sorbi et al., 1998). These fluctuating allele frequencies are almost inherent to small 
samples because none of the studies are able to give an accurate estimate of the allele 
frequencies in the population. 
 The performance of these meta-analyses does therefor  not appear to solve the problem 
of interpreting the excess of these small inconsistent association studies in AN and BN. 
There is still a discrepancy between the results, and the choice of study-inclusion criteria 
remains arbitrary. A solution to this problem is the performance of larger genetic 
association studies with adequate statistical power to detect an effect. Two large 
collaborative studies have tested several candidate gen s for association in both AN and BN 
(Table 2.2).  
 Following up their genome-wide screen in AN (Grice et al., 2002), the collaborative 
study mentioned previously performed an association study focusing on candidate genes 
positioned under the linkage peak on chromosome 1p33-36 (Bergen et al., 2003). For their 
association study, three candidate genes were tested namely the serotonin receptor 1D 
(HTR1D), opioid receptor delta 1 (OPRD1) and hypocretin receptor 1 (HCRTR1). The case-
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control study (based on 196 cases, 98 controls and DSM-IV criteria) yielded a positive 
association between one HTR1D (C1080T) and three OPRD1 (T8214C, G23340A, and 
A47821G) polymorphisms in AN. The subsequent Transmis ion Disequilibrium Test 
(TDT) analysis confirmed an association only for the OPRD1 A47821G SNP. However, 
after correction for multiple testing only the association with the HTR1D C1080T 
polymorphism remained statistically significant. 
 Another large European collaboration tested the HTR2A (G-1438A SNP), the catechol-
o-methyltransferase (COMT; Val-158-Met SNP), and the brain-derived neurotrophic factor 
(BDNF; C-270T and Val-66-Met SNPs) genes for association in eating disorders, defined 
according to DSM-IV criteria (Gabrovsek et al., 2004; Gorwood et al., 2002; Ribases et al., 
2004; Ribases et al., 2005). A significantly higher fr quency of the Met-66-Met genotype 
and the Met-66 allele was reported in both AN and BN cases compared to controls (Ribases 
et al., 2004; Ribases et al., 2005). None of the otr polymorphisms were associated with 
eating disorders, although the TDT analysis did reveal an excess of transmission of the -
270C/Met-66 haplotype in the BDNF gene in restrictive AN. 
 There is no overlap between the candidate genes studied in the two collaborations. 
Subsequently, the positive results reported for the candidate genes above are promising, but 
unless they are replicated in an independent sample, there is not enough evidence for a 
definite association. In addition, the only overlap between reported linkage regions and 
studied candidate genes is from the study by Bergen et al. (2003). Interestingly, the HTR2A 
gene is located near the linkage peak on chromosome 13q13.  
 In summary, the eating disorder field is characterized by an excess of small genetic 
association studies. In order to overcome the problems discussed above, association studies 
should be performed based on large sample sizes. Becaus  of the low prevalence of eating 
disorders, it is not an easy task to collect large numbers of patients. The establishment of 
more collaborations between centers could help to solve this problem. Another important 
issue is the choice of appropriate candidate genes or biological pathways. Selection of 
candidate genes can be based on their biological function and/or their location within the 
genome. The serotonergic system remains one of the most intriguing biological pathways 
given the role that serotonin plays in appetite and mood regulation and given the recent 
findings from neuroimaging studies (Frank et al., 200 ; Kaye et al., 1998; Kaye et al., 
2001). However, little is known about the biological underpinnings of eating disorders, and 































Table 2.2. Candidate gene studies performed by collab rations. 
Gene Polymorphism Phenotype N P-valuea Reference Note 







(Bergen et al., 
2003)  
OR 2.63, TDT NS 





NS (Bergen et al., 
2003)  
OR 1.37, TDT 0.04 





NS (Bergen et al., 
2003)  
OR 0.72, TDT 0.01 
USA, UK and Germany 







NS (Bergen et al., 
2003)  
OR 0.73, TDT 0.02 
USA, UK and Germany 




AN  316 
(trios) 
NS (Gorwood  
et al., 2002)  
TDT and HHRR, France, 
 Germany, UK, Italy and Spain  









NS (Gabrovsek  
et al., 2004)  
OR 0.98, TDT NS 
Austria, Germany, Italy,  
Slovenia, Spain and UK  







NS (Bergen  
et al., 2003)  
Germany, UK and USA 




NS (Bergen  
et al., 2003)  
Germany, UK and USA 




NS (Bergen  
et al., 2003)  
Germany, UK and USA 
Hypocretin Receptor 1 
Orexin 1 receptor, 
HCRTR1, 1p35 




NS (Bergen  
et al., 2003)  
Germany, UK and USA 









 et al., 2003)  
OR 0.98, TDT NS 

















0.045  (Bergen 
 et al., 2003)  
OR 1.46, TDT NS 







0.046  (Bergen  
et al., 2003)  
OR 0.68, TDT NS 










 et al., 2003)  
OR 0.61, TDT 0.06 








NS  (Bergen  
et al., 2003)  
OR 0.70, TDT 0.06 
Germany, UK and USA 
Other candidate genes       











 et al., 2004)  
France, Germany, Italy,  
Spain and UK 




NS (Ribases  
et al., 2005)  
HRR / TDT 
Austria, France, Germany, 
 Italy, Slovenia, Spain, UK  
Brain Derived  















0.0008 (AN vs C; geno) 
0.003 (ANr vs C; geno) 
0.012 (ANbp vs C;geno) 
<0.001 (BN vs C;geno) 
(Ribases  
et al., 2004)  
OR AN 1.37 (Met-allele) 
OR ANr 1.43 (Met-allele) 
OR ANbp 1.29 (Met-allele) 
OR BN 1.59 (Met-allele) 
France, Germany, Italy, 
 Spain, UK 





(ANr vs  C; HRR) 
(Ribases  
et al., 2005)  
HRR and TDT 
Austria, France, Germany ,  
Italy, Slovenia, Spain, UK  
a. P-values are reported for the allele-wise associati n of the polymorphism, unless stated otherwise. 
 




In the last decade, the number of studies focusing on the role of genetics in the etiology of 
eating disorders has increased enormously. This increase has been met by some successes 
in molecular genetic studies, although the majority of results remain inconclusive. Genome-
wide screens have demonstrated linkage peaks for AN and BN on chromosomes 1p33-36, 
4q13, 10p13, and 14q22-23. Furthermore, one collaborative study has incorporated 
behavioral covariates into their linkage analyses and identified three additional suggestive 
linkage peaks (chromosome 1q31, 2p11 and 13q13). To confirm the linkage findings, 
further replication studies are needed. Lander and Kruglyak (1995) propose that the 
significant linkage from one or a combination of initial studies should be confirmed in a 
further sample, preferably by an independent group of investigators. Since all of the linkage 
studies in eating disorders have been performed by the same international multicenter 
collaboration, replication in an independent sample is warranted. 
 Many genetic association studies have been conducte  in eating disorders without any 
definite conclusion. Typical of the association studies in this field are the excess of small, 
discrepant studies. In the future, more SNPs should be measured per candidate gene to truly 
test a gene for association. For example in the HTR2A gene, the G-1438A polymorphism 
has been tested for association in 15 studies. Onlytwo of these studies tested four other 
SNPs within this gene for association (Hinney et al., 1997; Nacmias et al., 1999), and none 
of the studies examined haplotypes. The only conclusion that can be drawn from these 
studies is that the G-1438A polymorphism is not associated with eating disorders however 
the HTR2A gene could still be involved. In addition to more SNPs per candidate gene, more 
candidate genes per pathway should also be examined. Th  linkage results in eating 
disorders should be used more extensively to identify ew candidate genes and pathways. 
Because of the rarity of eating disorders, it is nearly impossible to identify biological 
pathways involved in the etiology by utilizing prospective study designs. The majority of 
the current candidate genes and biological pathways in eating disorders are adopted from 
research in other psychiatric disorders (e.g., the serotonin system in depression and anxiety 
disorders). The comorbidity between depression, anxiety disorders and eating disorders 
appears to have a substantial genetic component (Kedler et al., 1995; Rowe et al., 2002; 
Wade et al., 2000b; Walters et al., 1992), but this does not necessarily mean that the genes 
involved in these disorders will also play a role in AN and BN. Another method of 
identifying biological pathways possibly involved in the etiology of eating disorders is 
based on studies of individuals who have recovered from AN and BN. 
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 One of the most striking features of the family, twin and molecular genetic research in 
eating disorders is the difference in phenotypes usd in the various study designs. 
Practically all linkage and genetic association studies used DSM-IV criteria to define AN 
and BN. The strong familiality of the DSM-IV eating disorders has been demonstrated in 
family studies (Strober et al., 2000; Strober et al., 2001). However, twin studies, both 
clinical and population-based, have not been able to ob ain an adequate number of affected 
twins to determine the heritability of eating disorde s according to DSM-IV criteria. Twin 
studies did yield moderate to substantial heritability estimates for the broader eating 
disorder phenotypes. However, even when using broader, more prevalent phenotypes, the 
studies were still characterized by low statistical power. 
 One critical question is how best to integrate twin and molecular genetic studies when 
focusing on a relatively rare phenotype. On one hand there is interest in determining the 
contribution of genetic and environmental factors t liability to threshold DSM-IV 
diagnostic categories. This approach could tell us whether the threshold diagnoses in some 
way represent more genetically homogeneous entities han broader or subthreshold entities. 
Alternatively, greater genetic homogeneity may best  determined by focusing more on 
component behaviors rather than syndromes. There is no a priori reason to believe that the 
DSM diagnostic schema represent more ‘genetic’ syndromes than underlying core 
behaviors or traits. Indeed, Reichborn-Kjennerud et al (2004b; 2004a) have suggested that 
familial resemblance for different symptoms of bulimia nervosa, as codified by DSM-IV 
criteria, may have distinct sources. Binge-eating ad vomiting represent more genetically 
mediated symptoms and undue importance of weight as an indicator of self-evaluation 
representing a more environmentally mediated sympto. Thus, our clinically determined 
diagnostic criteria may actually represent frequently co-occurring mixtures of genetically 
and environmentally influenced symptoms which could potentially obscure searches for 
susceptibility loci. 
 Moreover, several studies have demonstrated the presence of an underlying continuum 
of liability for eating disorders (Fairburn & Harrison, 2003; Hay & Fairburn, 1998; Kendler 
et al., 1991; Sullivan et al., 1998b; Walters & Kendler, 1995), and have indicated that the 
diagnostic entities and thresholds of the DSM-IV do not adequately capture the eating 
disordered behavior. Thus, both twin and molecular genetic studies should pay careful 
attention to the definition of phenotypes especially when dealing with a relatively rare set 
of disorders for which the underlying neurobiology is not yet fully understood. 
 Moving forward, what additional value might twin studies have in the field of eating 
disorders in the age of molecular genetics? Twin studies can be used to identify 
heritabilities and genetic determinants (loci) of eating disorder-related phenotypes 
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(endophenotypes) and risk factors or intermediate phenotypes for AN and BN. Loci for 
eating disorder-related traits can next provide newcandidate gene loci to be tested for 
association in strict AN and BN phenotypes, applying a case-control design in collaborative 
studies.  
 The twin study design also enables exploration of gene-environment interactions. Most 
traditional genetic analyses assume that the effects of genes and environment are additive 
and that the impact of genetic factors is equal across diverse environments (Kendler, 2001). 
However two other forms of the joint effect of genes and environment in the etiology of 
psychiatric illness are also possible: genes may control sensitivity to the environment and 
genes may alter the probability of exposure to enviro ments (Kendler & Eaves, 1986). 
Because of the complex nature of the etiology of eating disorders, gene-environmental 
interactions are expected. Due to the low prevalence of eating disorders, gene-environment 
interactions should be explored in endophenotypes and intermediate phenotypes of AN and 
BN. 
 In conclusion, how can we conduct future studies that maximize our chances of 
identifying genes and environmental factors that ply a role in the development of AN and 
BN? First, sample size is of critical importance: large (collaborative) genetic studies should 
be conducted. Second, twin studies to identify heritabilities and genetic determinants of 
endophenotypes, risk factors and intermediate phenotypes associated with eating disorders 
should be applied. A combination of twin and genetic designs may lead to enhanced 
understanding of the complex manner in which genes a d environment interact to increase 
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In most assessment instruments, distinct items are designed to measure a trait, and the sum 
score of these items serves as an approximation of a individual’s trait score. In interpreting 
group differences with respect to sum scores, the instrument should measure the same 
underlying trait across groups (e.g., male/female, young/old). Differences with respect to 
the sum score should accurately reflect differences in the latent trait of interest. A necessary 
condition for this is that the instrument is measurement invariant. In the current study we 
illustrated a stepwise approach for testing measurement invariance with respect to sex in a 
4-item instrument designed to assess disordered eating behavior (DEB-scale) in a large 
epidemiological sample (1195 men and 1507 women). Our approach can be applied to 
other phenotypes for which group differences are expected. Any analysis of such variables 
may be subject to measurement bias if a lack of measur ment invariance between grouping 
variables goes undetected. 
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Questionnaires are often used to assess psychological and behavioral traits on a quantitative 
scale. Well-known examples are the Beck Depression Inventory (Beck et al., 1961), 
Eysenck EPQ scales (Eysenck & Eysenck, 1975) and, the Temperament and Character 
Inventory (Cloninger et al., 1993). In these assessm nt instruments, items are designed to 
measure an underlying trait or latent (i.e., unobserved) variable and scores on the items are 
summed to derive a total score on the trait of interest. The Diagnostic and Statistical 
Manual of Mental Disorders (4th ed., American Psychiatric Association, 1994) also employs 
a weighted sum score in diagnosing psychiatric disor ers.  
 When comparing groups, it is vital that an instrument measures the same underlying 
trait across groups (e.g., male/female, young/old). Observed group differences in the sum 
scores should accurately reflect group differences with respect to the latent variable. A 
necessary condition for this is that the instrument displays measurement invariance with 
respect to the groups under consideration (Mellenbergh, 1989; Meredith, 1993). If there is a 
sex difference with respect to the latent trait, men should for example score lower on all the 
items of the instrument measuring this trait. If however, men score lower on all the items 
but one, this one item displays differential item functioning, and the scale is not 
measurement invariant with respect to sex (Dolan, 2000; Mellenbergh, 1989; Meredith, 
1993; Millsap & Yun-Tein, 2004). In that case, group differences in sum scores reflect, at 
least in part, measurement bias. The interpretation of differences between groups with 
respect to the sum scores thus hinges on the establishment of measurement invariance, or at 
least on the understanding of the violations, if any, of measurement invariance. Ideally, 
differences in sum scores should reflect true differences in the latent variable that the 
psychometric instrument purports to measure. 
 Measurement invariance can be investigated by fitting a measurement model that 
relates item scores to the underlying trait(s) across groups. Several methods have been 
suggested for both continuous and categorical variables (Dolan, 2000; Mellenbergh, 1989; 
Meredith, 1993; Millsap & Yun-Tein, 2004; Muthen & Asparouhov, 2002; Muthén & 
Muthén, 2005). In the current study we described a stepwise approach that was derived 
from previous studies to investigate measurement invar ance for ordered categorical items. 
Our goal was to provide a comprehensive overview of the different steps accumulating into 
a model of complete measurement invariance. To illustrate this approach, we investigated 
whether a four item instrument, designed to measure disordered eating behavior is 
measurement invariant with respect to sex. As eating d sorders mainly affect young women 
(90 – 95% of cases) (Fairburn & Harrison, 2003; Hoek, 1993; Van Hoeken et al., 1998), 
one might expect sex differences in the endorsement of the four eating disorder items. 
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Multi-group discrete factor analyses were applied to test whether the disordered eating 





All participants were registered with the Netherlands Twin Registry, which is maintained at 
the Department of Biological Psychology at the VU University in Amsterdam (Bartels et 
al., 2007; Boomsma et al., 2006). In this study, we us d data from the 1986-1992 birth 
cohorts. In January 2005, questionnaires were sent to adolescent twins (mean age 15.2, 
SD=1.3) and their non-twin siblings (mean age 16.7, SD=2.8). The twins and siblings were 
asked to complete a survey containing items relevant for eating disorders. Questionnaires 
were sent to 2000 families. A total of 2175 twins (twin response rate 54.4%) and 527 
siblings from 1144 families returned the questionnaire (family response rate 57.2 %). The 
total sample consisted of 1195 men and 1507 women (956 male twins, 1219 female twins, 
239 brothers and 288 sisters, respectively), mean age w s 15.5 (SD=1.8).  
 
Measures 
Participants filled out a self-report questionnaire containing measures of health and 
behavior (Bartels et al., 2007; Boomsma et al., 2006). The eating disorder section included 
four items: 1) dieting (Q: Have you ever gone on a diet to lose weight or to stop gaining 
weight?); 2) fear of weight gain (Q: How afraid are you to gain weight or become fat?); 3) 
importance of body weight or shape on self-evaluation (Q: How important are body weight 
and/or shape in how you feel about yourself?); 4) binge eating (Q: Have you ever had 
episodes of binge eating?). Responses were given on five point Likert-scales, ranging from 
‘never’ to ‘always’ for dieting (DIET), from ‘not afraid’ to ‘extremely afraid’ for fear of 
weight gain (FEAR), from ‘not important’ to ‘most important’ for importance of body 
weight and shape on self-evaluation (ISE), and from ‘never’ to ‘more than once a week’ for 
binge eating (BE). For the multi-group confirmatory factor analyses it was essential that, 
for every item, each category was endorsed by both groups. Because none of the men 
reported that they were always on a diet, the fourth and fifth categories of the dieting item 
were merged. As a consequence, three items with five categories and one item with four 







We performed multi-group confirmatory factor analyses to establish whether the four eating 
disorder items formed a uni-dimensional scale, and whether the scale was measurement 
invariant with respect to sex. To conduct a confirmatory factor analysis, a minimum of 
three items is required. Measurement invariance with respect to sex held if the probability 
of a certain response on a given item was the same for all participants with the same value 
on the underlying trait (disordered eating behavior [DEB]) regardless of the sex of the 
participant. This definition gave rise to a highly constrained multi-group factor model 
(Chen et al., 2005; Meredith, 1993; Millsap & Yun-Tein, 2004). To establish measurement 
invariance, we fitted several increasingly restrictive models derived from approaches 
described in previous studies (Dolan, 2000; Mellenbergh, 1989; Meredith, 1993; Millsap & 
Yun-Tein, 2004; Muthen & Asparouhov, 2002; Muthén & Muthén, 2005), cumulating in 
this highly constrained model.  
 In the first step, a saturated model was fitted to the data simply to obtain estimates of 
the item thresholds and the polychoric correlation among items. To this end, we assumed 
that a latent continuous variable, called the liabity, was underlying the responses to each 
discrete item. Assuming the liability underlying each item was standard normally 
distributed, the discrete responses were modeled to items by estimating thresholds on the 
standard normal distributions of the liability (3 thresholds for the DIET item, and 4 
thresholds for the other three items). The positions f these thresholds determined the 
marginal response probabilities of each item. In addition, the (polychoric) correlations 
among the liability underlying the four items were stimated. Thresholds and correlations 
were estimated separately in men and women.  
 In the second model it was tested whether the four items were uni-dimensional in men 
and women. The four continuous latent liabilities were regressed on a single common 
factor, without imposing any equality constraints over sex. Thresholds in men were 
constrained to equal those in the women. By imposing this constraint, the thresholds were 
estimated on a common metric. The distribution of the liability for each item was standard 
normal in the women as in model 1. In the men the means and variances of the liability 
underlying the four items were estimated freely. Thus, in this step we fitted a single factor 
model to the correlation matrix of the liabilities in the women, and a single factor model to 
the covariance matrix of the liabilities in the men. In both sexes, the common factor was 
scaled to have a mean of zero and a variance of one (i.e., standard scaling constraints in the 
common factor model). By estimating all the factor loadings freely, the item reliability in 
the women and the men were obtained separately. Note tha  these reliability estimates need 
not be equal over sex.  
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 In model 3, the factor loadings were constrained to be equal over sex. This constraint 
allowed estimation of the variance of the common factor in one group (men), while 
retaining the scaling constraint (variance of factor equal to one) in the other group 
(women). We thus allowed for a difference in common factor variance between men and 
women. This model included sex differences in the residual variances of the items, in the 
liability means and in the common factor variance.  
 In model 4 mean liabilities (intercepts) in the male sample were constrained at zero, 
and the common factor mean was estimated. As before, the mean liabilities and common 
factor mean were fixed to zero in women. In the preceding model the estimated mean in 
liabilities in men gave an indication of the sex differences per item. By fixing these 
intercepts at zero in men, while freely estimating he mean of the common factor, any sex 
difference in means of the liabilities was explained by a difference in the mean of the 
common factor, i.e. a difference with respect to the latent variable of interest.  
 In model 5, we added the final constraint of ‘invariance of residual variances over sex’. 
As a consequence, the amount of the variance in the separate items that was not explained 
by the common factor was constrained to be equal in the women and men. This model 
represented full measurement invariance. Note that in this model any observed sex 
difference in the observed test scores was attributable to a difference with respect to the 
latent variable that we purported to measure. With respect to the interpretation of sex 
differences in test scores, model 5 represented the ideal. Model 4 represented a weaker 
form of invariance in which sex differences in the residuals were permitted. Model 4 was 
still useful as it allowed us to interpret sex differences in the mean scale score as a 
manifestation of a mean difference with respect to the latent variable. Weaker forms of 
measurement invariance are entertained in the literature (e.g., model 3: equality of factor 
loadings), but we did not consider these to be sufficient for the interpretation of sex 
differences with respect to the test scores (Meredith, 1993).  
 All analyses were performed in Mplus 4.0 (Muthen & Asparouhov, 2002; Muthén & 
Muthén, 2005). Because our sample consisted of families, the individual cases were not 
independent. To correct for the effect of this dependence on the standard errors and overall 
goodness of fit indices, we used the Weighted Least Square with mean adjusted Chi-square 
test statistics (WLSM) in combination with the ‘Complex’ option in Mplus. The latter 
corrects the statistical effect of clustering on the results. Rebollo et al. (2006) found this 
method to be satisfactory to correct for dependency due to family grouping. 
 As suggested by Schermelleh-Engel, Moosbrugger and Müller (2003), several fit 
statistics were used to evaluate the fit of the models; hierarchical Chi-square tests, the 
comparative fit index (CFI), and the root mean square error of approximation (RMSEA). 
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For the hierarchical Chi-square test, the difference between the Chi-square test statistics 
obtained for each model yielded a new Chi-square value with degrees of freedom equal to 
the difference in the number of parameters in the two models. In the WLSM approach in 
Mplus, the reported Chi-squares were mean adjusted and a scaling correction factor was 
applied for each model. As a consequence, in calculating the Chi-square difference test, 
scaling correction factors had to be entered into the equation (Asparouhov & Muthen, 
2006). According to the principle of parsimony, models with fewer parameters are 
preferred, if they do not give a significant deterioration of the fit. Significance can be 
determined on statistical grounds, but in structural equation modeling, rules of thumb are 
usually used (Schermelleh-Engel et al., 2003). The CFI ranges from zero to one with higher 
values indicating better fit; for a good model fit the CFI should be above 0.97, and values 
greater than 0.95 indicate an acceptable fit (Schermelleh-Engel et al., 2003). The RMSEA 
is a measure of closeness of fit, and provides a measur  of discrepancy per degree of 
freedom. A value of 0.05 or smaller indicates a close fit, and values between 0.05 and 0.08 
indicate an acceptable fit (Jöreskog, 1993; Schermelleh-Engel et al., 2003). 
 There were 257 persons (n=127 men and n=130 women) who completed the survey 
twice with an interval of six months. Retest data obtained in this group will serve to 
estimate stability of the test scores. The reliabilty of the eating disorder items was 
estimated separately in men and women. Polychoric crelations between the two occasions 




To evaluate how often the different eating disorder attitudes and behaviors were endorsed, 
we calculated the frequencies of the item scores grate  than three in the adolescent twins 
and their non-twin siblings for the four items. These frequencies showed significant sex 
differences for three features (p<0.001). For the DIET item, 0.4% of the men compared to 
3.4% of the women had been on a diet often or always. Few men (1.3%) reported being 
very or extremely afraid to gain weight or become fat (FEAR). In women this item was 
endorsed more often with 8.7%. A large proportion of both men and women reported that 
“their body weight and or shape played an important role in how they felt about 
themselves” (ISE). The frequency of this feature was 40.9% in the women compared to 
26.8% in the men. No sex differences were found for the BE item, 5.1% of the women and 
5.5% of the men reported having binge eating episode  at least once a week. 
 In model 1 polychoric correlations among items, and the thresholds for each item were 
estimated per sex. These are reported in Table 3.1. Small to moderate correlations between 
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the items were found in both sexes. Although the magnitude of the correlations differed 
between groups, similar patterns were observed with the highest correlation between DIET 
and FEAR and the lowest between ISE and BE. The thresholds of the liabilities represent 
the cut-points of the response categories in the corresponding ordinal items on a sex-
specific z-scale. The mainly positive thresholds indicate that the majority of women and 
men did not engage in eating disordered behaviors and/or attitudes.  
 
Table 3.1 Correlations and thresholds for women and men (saturated model). 
 DIETb FEARc ISEd BEe 
Correlationsa     
DIETb 1.00 0.59 (0.52,0.66) 0.39 (0.30,0.48) 0.41 (0.31,0.5 ) 
FEARc 0.53 (0.38,0.67) 1.00 0.59 (0.54,0.64) 0.33 (0.24,0.41) 
ISEd 0.27 (0.13,0.40) 0.39 (0.29,0.48) 1.00 0.27 (0.19,0.36) 
BEe 0.22 (0.03,0.41) 0.20 (0.06,0.34) 0.16 (0.06,0.27) 1.00 
Women     
Threshold 1 0.68 (0.57,0.78) -0.43 (-0.52,-0.33) -1.54 (-1.68,-1.40) 0.64 (0.54,0.74) 
Threshold 2 1.36 (1.24,1.49) 0.67 (0.57,0.77) -0.56 (-0.66,-0.46) 1.12 (1.00,1.23) 
Threshold 3 1.83 (1.66,1.99) 1.36 (1.24,1.49) 0.23 (0.14,0.32) 1.63 (1.48,1.78) 
Threshold 4 - 2.13 (1.93,2.33) 1.88 (1.70,2.06) 2.08 (1.87,2.29) 
Men     
Threshold 1 1.62 (1.44,1.80) 0.72 (0.60,0.83) -0.94 (-1.06,-0.83) 0.95 (0.83,1.07) 
Threshold 2 2.29 (2.02,2.56) 1.71 (1.52,1.89) -0.10 (-0.20,0.001) 1.27 (1.13,1.40) 
Threshold 3 2.64 (2.25,3.02) 2.24 (1.97,2.51) 0.58 (0.48,0.69) 1.60 (1.44,1.76) 
Threshold 4 - 2.71 (2.28,3.14) 1.94 (1.73,2.15) 1.87 (1.68,2.06) 
a The correlations in the women are listed above the diagonal, the correlations in the men are listed below the 
diagonal. Numbers in parentheses represent 95% confidence intervals. 
The thresholds are estimated on a sex-specific z-scale. 
b DIET: Dieting 
c FEAR: Fear of weight gain 
d ISE: Importance of body weight or shape in self-evaluation 
e BE: Binge eating 
 
 In Table 3.2, fit statistics of the nested models are given. Model 2, which tested 
whether one factor could account for the correlations among the four eating disorder 
variables, fitted significantly worse compared to mdel 1 according to the chi-square. 
However, both the RMSEA and the CFI indicated a good fit of this model. The parameter 
estimates of model 2 are presented in Table 3.3. The factor loadings of DIET and BE were 
comparable between men and women. On the other hand, the factor loading in the men for 
FEAR was higher and for ISE was lower compared to the women. The least reliable item 
was BE, while the FEAR item had the highest reliabity.  
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Table 3.2 Model fit statistics  
Model χ2 df CFI a RMSEA b CM c ∆χ2 d ∆df e p 
Model 1 (saturated)  0.00 0 1.00 0.00 - - - - 
Model 2 (one factor model) 37.98 11 0.99 0.04 1 37.98 11 0.0001 
Model 3 35.62 14 0.99 0.03 2 2.32 3 0.51 
Model 4 101.07 17 0.96 0.06 3 50.99 3 0.0001 
Model 5  
(full measurement invariance) 
246.53 21 0.90 0.09 4 99.57 4 0.0001 
a CFI: Comparative Fit Index  
b RMSEA: Root Mean Square of Error of Approximation  
c CM: Compared to model  
d ∆χ2: Chi-square test statistic between two models adjusted for scaling correction factor  
e ∆df: degrees of freedom for the Chi-square difference test 
 
 The estimates of the mean liability in men were all significantly lower than zero. As 
these means were fixed to zero in the women, we establi hed, as expected, that the men 
scored lower than the women on all eating disorder items. The estimated variances of the 
liability of FEAR, ISE, and BE were significantly smaller than one in the men. The 
variances were fixed at one in the women.  
 
Table 3.3 Parameter estimates for model 2 in the femal  reference group and the male group.  
 DIETa FEARb ISEc BEd 
Women     
Factor loading 0.68 (0.60, 0.75) 0.88 (0.81, 0.94) 0.66 (0.59, 0.72) 0.44 (0.35, 0.52) 
Mean 0 0 0 0 
Variance 1 1 1 1 
Reliability 0.46 0.77 0.43 0.19 
     
Men     
Factor loading 0.69 (0.35, 1.03) 0.97 (0.71, 1.24) 0.55 (0.41, 0.70) 0.45 (0.19, 0.71) 
Mean -1.11 (-1.83, -0.39) -1.30 (-1.56, -1.05) -0.44 (-0.57, -0.31) -0.84 (-1.28, -0.40) 
Variance 0.91 (0.59, 1.24) 0.84 (0.70, 0.98) 0.85 (0.77, 0.93) 0.65 (0.50, 0.79) 
Reliability 0.48 0.94 0.30 0.20 
Numbers in parentheses represent 95% confidence intervals for the factor loadings and residual variances 
a DIET: Dieting 
b FEAR: Fear of weight gain 
c ISE: Importance of body weight or shape in self-evaluation 
d BE: Binge eating 
 
 The Chi-square test statistic suggested some violation of uni-dimensionality (model 2). 
But because both the RMSEA and the CFI indicated a good fit, the invariance of factor 
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loadings across sexes was tested next. For this model, all three fit statistics indicated a good 
fit. The estimate of variance of the common factor (disordered eating behavior (DEB)) in 
the male group was 0.96. Given the 95% confidence iterval (CI) of 0.62 and 1.30, we 
concluded that the variance was not significantly different between the men and women in 
model 3.  
 In model 4, the mean of the liabilities were constrained to be zero in men (as they were 
in women). The mean of the common factor was fixed to zero in the women, as before, and 
estimated freely in the men. This model did not fit very well in comparison to model 3. The 
Chi-square test statistic indicated a significantly worse fit for this model. However, the fit 
was acceptable according to the RMSEA and the CFI. The estimated common factor mean 
in the men was -0.99, which differed significantly from zero (95% CI -1.18 - -0.80). In 
other words, the mean of DEB was lower in men than in women (factor mean fixed at 
zero). 
 Because the fit of model 4 was acceptable based on the RMSEA and the CFI, the final 
model of complete measurement invariance was tested. In this fifth model, the residual 
variances were also constrained to be equal across the groups. The Chi-square statistic 
indicated deterioration in fit compared to model 4. In addition, the CFI and the RMSEA 
indicated a bad fit. This implied that the eating disorder items were not fully measurement 
invariant with respect to sex. The variances present d i  Table 3.3, give an indication of 
which item might be underlying this bad fit. The variance of BE showed the largest 
deviation from 1, suggesting that the greatest difference between both groups in residual 
variance was observed for this item.  
 Finally the stability of the item responses and the DEB total score were considered. 
The four eating disorder items were moderately to highly correlated over a period of six 
months. The polychoric correlation was 0.59 (95% CI 0.28-0.89) for DIET, 0.75 (95% CI 
0.59-0.90) for FEAR, 0.56 (95% CI 0.41-0.71) for ISE, and 0.74 (95% CI 0.55-0.93) for 
BE in men. In women, the polychoric correlation was 0.75 (95% CI 0.60-0.89) for DIET, 
0.67 (95% CI 0.55-0.79) for FEAR, 0.43 (95% CI 0.27-0.59) for ISE, and 0.58 (95% CI 




In most assessment instruments, distinct items are designed to measure a trait, and the sum 
score of these items serves as an approximation of a individual’s trait score. The 
interpretation of differences between groups with respect to these sum scores hinges on the 
establishment of measurement invariance. Ideally, differences in sum scores should reflect 
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true differences in the latent variable that the psychometric instrument purports to measure. 
If there is a lack of measurement invariance, group differences in sum scores reflect, at least 
in part, measurement bias. 
 We described a stepwise multi-group confirmatory factor analysis to investigate 
measurement invariance for categorical items with respect to a grouping variable. 
Previously, several methods have been reported to tes  for measurement invariance both for 
continuous and categorical items (Dolan, 2000; Mellenbergh, 1989; Meredith, 1993; 
Millsap & Yun-Tein, 2004; Muthen & Asparouhov, 2002; Muthén & Muthén, 2005). All 
these methods cumulated in an identical highly constrained model in which strict factorial 
invariance, or complete measurement invariance, was tested. However, the number and 
order of the constraints in the intermediate models iffered between the reported methods. 
In contrast to previous studies, our analysis began by fitting a saturated model to the data, 
to obtain estimates of the polychoric correlation among items and the thresholds for each 
item. The second model, which tested for uni-dimensionality of the items, was more 
comparable to the baseline models described by other groups (Millsap & Yun-Tein, 2004; 
Muthen & Asparouhov, 2002; Muthén & Muthén, 2005), although there was a difference in 
the constraints. In our model, thresholds were constrained across groups, while factor 
loadings were estimated freely. This enabled us to calculate the reliability of the separate 
item scores. Means and variances of the liabilities provided insight in the between-group 
differences. In the third model, both item thresholds and factor loadings were constrained to 
be equal across groups. The between-group differencs i  this model were represented by 
the residual variances of the items, the liability means and by the common factor variance. 
In addition to the previous constraints, the liability means were constrained at zero in all 
groups in model 4. Within this model, any group difference in the means of the latent 
indicators would be explained by a difference in the mean of the common factor. This 
model represented a weaker form of invariance in which group differences were permitted 
in the residuals, and was similar to the third model described by Millsap et al. (2004). The 
final model of strict factorial invariance, added the constraint of invariance of residual 
variances over groups; i.e. the amount of the variance in each item that was not explained 
by the common factor was constrained to be equal in the groups. 
 The method was illustrated by investigating whether a scale comprised of four eating 
disorder items was measurement invariant with respect to sex. The model of full 
measurement invariance with respect to sex (model 5), did not fit the data well. If this 
model had fitted, the probability of a certain response on a given item would have been the 
same for all participants with the same value on the underlying trait (DEB) regardless of the 
sex of the participant. However, this was not the case. The underlying common factor might 
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not be the only source of difference between the sex s with respect to the four items. The 
sum score based on the four eating disorder items therefore cannot be taken to represent 
exactly the same underlying trait in men and women. This means that sex differences in this 
sum score might be due to measurement bias instead of a true difference in the underlying 
trait.  
 What implication does this finding have for existing eating disorder measurement 
instruments? We acknowledge that a scale consisting of four items might not be ideal to 
measure the underlying latent trait in eating disorders. However, in large epidemiological 
studies such as becoming common for gene finding, short cales might be a requirement to 
obtain phenotyping in sufficiently large samples. With the selection of the items we have 
tried to capture a variety of eating disorder symptoms. Three of the items (FEAR, ISE and 
BE) used in this study are based on eating disorder crit ria from the Diagnostic and 
Statistical Manual of Mental Disorders (4th ed., American Psychiatric Association, 1994). 
The fourth item (DIET) has been identified as a potent risk factor (Jacobi et al., 2004). 
However, one eating disorder symptom, compensatory behavior, is missing in our 
assessment instrument. 
 There has been a lot of debate about whether eating disorders are dimensional like 
proposed in the “continuum of eating disorders” (Fairburn & Harrison, 2003; Hay & 
Fairburn, 1998), or whether they are discrete syndromes (Williamson et al., 2005). Some 
studies suggest that eating disorders can be conceptualized as having at least two latent 
features (Williamson et al., 2002; Williamson et al., 2005); binge eating, and general 
psychopathology. Accordingly, the FEAR, DIET, and ISE items would load on one factor, 
and the BE item would load on a second factor. The correlations presented in Table 3.1, 
however, show substantial correlations between DIET and BE, especially in women (0.41). 
Bulimic behavior has been correlated with dieting ad body concerns in several other 
studies (Williamson et al., 2005), although this correlation appears to exist exclusively in 
nonclinical samples. Since our sample is also nonclinical, this may be the cause of the high 
correlation between DIET and BE. Hence, the factor s ructure discussed above might not be 
suitable in nonclinical groups. On the other hand, the low reliability of the BE item and the 
fact that the variance of this item showed the largest deviation from one in model 2, might 
be supportive of the two factor structure underlying eating disorders. However, 
investigating partial measurement invariance by omitting the final constraints on the BE 
item did not lead to a model of strict factorial invariance for the remaining three items. 
 The finding of a lack of strict factorial invariance in the 4-item DEB scale might not 
generalize to existing eating disorder scales. However, this form of measurement invariance 
has never been tested in the eating disorder field.Many studies have used both exploratory 
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and confirmatory factor analysis to test whether existing measurement instruments have the 
same factor structure across, for example, different types of patients, and different ethnic 
groups, and to establish different factors within eating disorders (Calugi et al., 2006; 
Fernandez et al., 2006; Hrabosky et al., 2008; Lee et al., 2007; Peterson et al., 2007; 
Varnado et al., 1995; Wade et al., 2008a; Williamson et al., 2002; Williamson et al., 2005). 
Until now, only one study has investigated measurement equivalence (Warren et al., 2008). 
Warren et al. tested for the equivalence of factor loadings for the Body Shape Questionnaire 
in American and Spanish women with and without an eting disorder diagnosis. For a 
subscale of 10 items, the constraint of invariant fc or loadings fitted the data well. 
However, because the intercepts were not constrained to quivalence in this study, the 
scores in the different groups may not have the same origin (Chen et al., 2005). Thus, 
differences on factor means between groups could still be caused by measurement bias.  
 The responses to the four eating disorder items were fairly stable over a six month 
period, with correlations ranging from 0.43 for ISE in the women to 0.75 for FEAR in the 
men and DIET in the women. The prevalence for the DIET, FEAR, and BE item were low 
to moderate. The prevalence of ISE was substantially higher. Comparable rates were found 
in other population-based studies in adolescents with the exception of the DIET item, which 
had a lower prevalence (Kjelsas et al., 2004; Neumark-Sztainer et al., 2007; Rowe et al., 
2002; Silberg & Bulik, 2005). Because of the low endorsement rates of dieting in the men, 
we had to merge the fourth and fifth category for the DIET item. As a consequence, the 
number of response frequencies differed between the four items. This difference in 
response categories does not appear to impact the results. When all items are merged into 
four or even three categories, the same results were found throughout the different steps of 
the confirmatory factor analyses. Comparable correlations, thresholds and factor loadings 
for the four items were found. In addition, the model of weak measurement invariance 
(model 4) remained the best-fitting model.   
 The framework we presented in this paper can serve as a valuable tool for examining 
the psychometric qualities of other interviews and questionnaires with respect to sex. In 
addition, other kinds of grouping variables (e.g. ae, level of education) can also be studied 
using this method. An advantage of our approach is t at it provides a better understanding 
of the consequences of the different constraints per model. As a consequence, it gives a 
better insight into the violations of measurement invariance, and the underlying causes of 
this measurement bias. It is essential to test for measurement invariance before sum scores 
or scale scores are used to compare groups. This is not only the case in the eating disorder 
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Introduction: Prior studies suggest eating disorders and related characteristics are 
moderately to substantially heritable. We are interested in identifying genes underlying 
disordered eating behavior (DEB), and want to know h  much of the genetic influence 
underlying DEB is attributable to genetic influences on BMI.  
Method: Bivariate analyses were performed, in adolescent twi s and siblings from the 
Netherlands Twin Registry, to estimate the genetic and environmental contributions for 
DEB, BMI and their overlap.  
Results: Shared genetic risk factors explained the overlap between BMI and DEB (genetic 
correlation was 0.43 in women, 0.51 in men). DEB was highly heritable in women 
(a2=0.65; a2 independent of BMI=0.53) and moderately heritable in men (a2=0.39; a2 
independent of BMI=0.29). BMI was highly heritable in both men (a2=0.76) and women 
(a2=0.80).  
Conclusion: The entire correlation between DEB and BMI was explained by shared genetic 
risk, but the majority of genetic influences on DEB were due to genetic effects independent 















Despite substantial efforts to identify causal pathways for anorexia and bulimia nervosa, 
very little is known about the aetiology of eating disorders. In longitudinal and cross-
sectional studies, several risk factors have been id tified, including gender, elevated 
weight and shape concerns, negative body image, negativ  self-evaluation, dieting and 
childhood obesity (Jacobi et al., 2004).  
 Various family and twin studies have been performed to explore causes of individual 
differences in the development and stability of eating disorders, a variety of eating disorder 
symptoms, and related characteristics. In population-based twin studies, the heritability 
estimates for these different phenotypes in women ranged from zero to 0.82, but on average 
a moderate heritability of around 0.40 was estimated (Bulik et al., 1998; Bulik et al., 2003b; 
Bulik et al., 2006; Holland et al., 1988; Keski-Rahkonen et al., 2005; Klump et al., 2000; 
Klump et al., 2003; Neale et al., 2003a; Reichborn-Kjennerud et al., 2003; Reichborn-
Kjennerud et al., 2004b; Reichborn-Kjennerud et al., 2004a; Rowe et al., 2002; Rutherford 
et al., 1993; Slof-Op 't Landt et al., 2005; Sullivan et al., 1998a; Wade et al., 1998). In men, 
heritability estimates ranged from 0 to 0.51, with an average heritability estimate of 0.20 
(Keski-Rahkonen et al., 2005; Reichborn-Kjennerud et al., 2003; Reichborn-Kjennerud et 
al., 2004b; Reichborn-Kjennerud et al., 2004a; Rowe et al., 2002). Only one study focussed 
on the overlap between eating attitudes, behavior and body weight in adolescent female 
twins (Klump et al., 2000). This is an interesting overlap to investigate, since body weight 
might be a risk factor for the development of eating disorders (Jacobi et al., 2004).  
 We herein report the results of a bivariate twin study on disordered eating behavior 
(DEB) and body mass index (BMI) in a Dutch population sample of adolescent male and 
female twins. To overcome the drawbacks and limitations of the previous studies (such as 
small sample sizes, inadequate power, and the use of categorical data; e.g. see (Slof-Op 't 
Landt et al., 2005, review)), we used a large sample of twins and siblings aged 11-18 years. 
DEB was measured in a more continuous fashion. Fouritems on different eating disorder 
features were used to calculate a sum score. Three items used in this study are based on 
eating disorder criteria from the DSM-IV (1994). The fourth item, dieting, was added to 
assess an important risk factor for the development of eating disorders (Jacobi et al., 2004). 
Prior work has shown that these four items could be accounted for by one underlying latent 
factor in a confirmatory factor analysis (Slof-Op 't Landt et al., 2009). However, the DEB 
items were not measurement invariant with respect to sex, indicating that this scale might 
not measure the same trait in men and women (Slof-Op 't Landt et al., 2009). Therefore the 
genetic analyses were performed separately in men and women.  
 The aim of the current study is to investigate how much of the heritability in DEB is 
attributable to genetic effects on body mass index (BMI), and how much of it is 
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independent of these effects. Because we would like to identify genes that influence DEB in 
the future, investigating the overlap between DEB and BMI may shed some light on 
possible biological pathways involved in DEB. We performed a bivariate analysis using 
both traits, to estimate the overlap between DEB and BMI and to disentangle the proportion 
of variance due to shared and specific genetic and environmental factors.  
 
Materials and methods 
 
Sample 
All participants were registered with the Netherlands Twin Registry (NTR), kept by the 
Department of Biological Psychology at the VU University in Amsterdam. Young twins 
(YNTR) are registered at birth by their parents, who are approached through 'birth 
felicitation' services. During the first years of their lives the parents are the primary sources 
of information on their development. Twins are categorized by birth cohort and data 
collection is cohort driven. Nationwide data collection of all families is by mailed surveys. 
Parents of twins receive questionnaires when their wins are aged 1, 2, 3, 5, 7, 10, and 12 
years of age. At ages 7, 10, and 12, teacher data are lso collected, after written permission 
is given by the parents. When the twins are 14, 16, and 18 they receive a self report 
questionnaire, used in the current study (Bartels et al., 2007; Boomsma et al., 2006). For 
this study data from the 1986-1992 birth cohorts were used. In January 2005, questionnaires 
were sent to 14-, 16- and 18-year old twins and their non-twin siblings. The twins and 
siblings were asked to complete a survey containing items relevant for eating disorders. 
Questionnaires were sent to 2000 families. A total f 2131 twins and 517 siblings from 
1121 families returned the questionnaire (family response rate 56.1 %).  
 Zygosity was determined for 461 same-sex twin pairs by DNA analysis or blood group 
polymorphisms. For all other same-sex twin pairs, zygosity was determined by discriminant 
analysis, using longitudinal questionnaire items. Agreement between zygosity assignment 
by the replies to the longitudinal questionnaire and zygosity determined by DNA 
markers/blood typing was around 93% (Rietveld et al., 2000). 
 The final sample consisted of 474 monozygotic twin pairs (194 male (MZM) and 280 
female (MZF) pairs), 310 dizygotic twin pairs (140 male (DZM) and 170 female (DZF) 
pairs), and 45 incomplete twin pairs (22 men and 23 women). The sibling group was 







The Dutch Health Behaviour Questionnaire is a self-report instrument containing direct 
measures of several health and behavior features, including a number of eating disorder 
characteristics and self report of height and weight. Based on the self-reported height and 
weight, the body mass index (BMI = weight [kg] / height2 [m]) was used as a measure of 
relative body weight in this study.  
 The eating disorder section included four items: 1) dieting (have you ever gone on a 
diet to loose weight or to stop gaining weight?); 2) fear of weight gain (how afraid are you 
to gain weight or become fat?); 3) importance of body weight or shape on self-evaluation 
(how important are body weight and/or shape in how y u feel about yourself?); 4) eating 
binges (have you ever had eating binges?). Responses wer  given on a five point scale. The 
scores on the four items were summed to calculate disordered eating behavior (DEB). If 
one of the four eating disorder items was missing, the sum score was also missing.  
 Prior work has shown that these four items could be accounted for by one underlying 
latent factor in a confirmatory factor analysis (Slof-Op 't Landt et al., 2009). In comparing 
groups or parallel use of data from different groups, such as men and women, it is 
important that an instrument measures the same underlying latent (unobserved) trait in 
these groups. Observed group differences in the sum scores should accurately reflect group 
differences with respect to the latent variable. A necessary condition for this is that the 
instrument displays measurement invariance with respect to the groups under consideration 
(Mellenbergh, 1989; Meredith, 1993). Formally, measurement invariance requires that the 
distribution of the item scores, conditional on only the trait score equals the distribution of 
the item scores, conditional on both the trait score and group membership. If for example 
men score lower on average on one item than women without actually scoring lower on the 
total scale (underlying trait), this item is said to lack measurement invariance. In that case, 
observed group differences in sum scores might not be caused by true differences in the 
underlying trait, but by measurement bias. Prior analyses have shown that the four eating 
disorder items were not measurement invariant with respect to sex. This implies that the 
sum score based on these items cannot be taken to present exactly the same trait in men and 
women. Therefore all analyses were performed separately in men and women.  
 
Statistical Analyses 
Age-effects for both DEB and BMI were expected (Klump et al., 2000; Schousboe et al., 
2003), therefore we first calculated the correlations between both traits and age in the two 
sex groups. For the descriptive statistics, we tested whether the means and variances for 
DEB and BMI were equal between the twins and siblings in men and women.All analyses 
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were performed using the software package Mx (Neale t al., 2003b). The means were 
corrected for age in all genetic analyses. 
 In the next step, the phenotypic correlation betwen DEB and BMI was calculated. 
Subsequently we calculated twin correlations, twin-sibling, and cross-twin/sib cross- trait 
correlations. The correlations provide an initial indication of genetic and environmental 
effects on DEB, BMI, and their overlap. By constraining the DZ twin correlations and the 
twin-sib correlation to be equal the presence of a specific twin environment is tested. 
Monozygotic (MZ) twin pairs are genetically (nearly) identical, whereas dizygotic twin and 
sibling pairs share on average 50% of their segregating genes. Therefore, if the MZ twin 
correlation is substantially larger than the DZ twin and twin-sib correlations genetic 
influence is implied. Shared family environmental factors (for example religion, 
socioeconomic level and parenting style) will make family members relatively more similar 
and will create differences between families. If the MZ and DZ twin correlation are similar 
and both statistically significant, shared environme tal influence is suggested. Finally, the 
importance of non-shared environmental influences can be seen from the extent to which 
the MZ twin correlations differ from one. This influence stands for the impact of all 
environmental factors influencing only one of the twin pair (for example illness, trauma or 
relationships with peers). In addition, the pattern of cross-twin cross-trait correlations for 
MZ twins and DZ twins and siblings indicates to what extent the covariance between the 
traits is influenced by genetic or environmental comp nents. Finally, if a twin specific 
environment is implied if DZ twin correlations are significantly higher than twin-sib 
correlations. 
 The Cholesky Decomposition or triangular decomposition, is used for the bivariate 
genetic model fitting. The Cholesky decomposition decomposes the phenotypic statistics 
into genetic, shared environmental, and nonshared environmental contributions. In other 
words the pattern of the factor loadings on the latnt genetic and environmental factors 
reveals a first insight into the etiology of covariances between DEB and BMI. Since the 
saturated model is fully parameterized, it yields the best possible fit to the input matrices. 
 The bivariate Cholesky decomposition model contained two latent factors for A, C and 
E respectively (per individual), of which the variances were constrained to be one. In 
Figure 4.1 the path diagram of this model is shown. Correlation coefficients are represented 
by curved lines with an arrow at each end. Within a twin- or sibling pair the C component 
for a trait is identical for each member (correlation coefficient of one), the E component is 
uncorrelated. A on the other hand, is identical for MZ twins but the correlation is 0.5 for 





Figure 4.1. The bivariate Cholesky model for BMI and DEB, represented for a twin or sibling pair. Correlation 
coefficients are represented by curved lines with an arrow at each end. Variance in each phenotype is assumed to 
be determined by the additive combination of three lat nt factors: additive genetic effects (A), shared 
environmental effects (C) and nonshared environmental ffects (E). BMI loaded on the first latent factors A, C and 
E. The additive genetic, shared environmental and nonshared environmental variance in DEB scores are 
partitioned into those components attributable to the genetic and environmental effects on BMI (a21, c21, e21) and 
residual components that are independent of the gentic and environmental effects of BMI (a22, c22, e22). 
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 When multiplying the factor loadings on the first latent factors (i.e., (a11 x a21) + (c11 x 
c21) + (e11 x e21)), the covariance between BMI and DEB is derived. Based on the 
covariance, genetic and environmental correlations between the two traits can be calculated 
(see below). 
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 Based on the estimated heritability for DEB and the genetic correlation, the heritability 
estimates for DEB dependent on BMI (a21
2) and independent on BMI (a22
2) can be 
determined by:  
a21 = rg x (a21 + a22) = rg x aDEB 
a22 = aDEB – (rg x aDEB) 
 
 We fitted models by the method of maximum likelihood to data from all twins and 
siblings, separately in women and men, beginning with a full bivariate ACE model. 
Subsequently, parameters (a21, c21, e21,) were dropped from the model to test if the 
covariance between traits can be attributed to shared genes (a21,) or overlapping C or E 
influences. Twice the difference in log-likelihood between two models yields a statistic that 
is asymptotically distributed as a Chi-square statitic with degrees of freedom equal to the 
difference in the number of estimated parameters in the two models. This statistic can be 
used to test the tenability of the constraints associated with the more constrained model. 
According to the principle of parsimony, models with fewer estimated parameters are 
preferred if they do not give a significant deterioration of the fit (p>0.05)..  
 Based on the twin and twin-sibling correlations estimated in this study, we performed 
power analyses in Mx. We calculated the power to test for the significance of the different 
paths of A (a11,a21,a22) and/or C (c11,c21,c22) in a bivariate model with a significance level α 
of .05 for the phenotypes (DEB and BMI). In addition, we calculated the statistical power 
to test whether the genetic correlation between the two phenotypes was statistically 
different from one or zero in the bivariate model. A genetic correlation of one indicates that 
identical genes are underlying the genetic influence on the traits. A genetic correlation of 
zero, means that genetic influences on the traits are totally independent from each other. 









Table 4.1 Descriptive statistics for DEB and BMI in women (upper part) and men (lower part) per zygosity 
 DEB BMI 
 N Meana Var Min Max N Meana Var Min Max 
Women           
MZF firstborn 280 8.0 6.1 4.0 18.0 266 20.1 8.4 14.2 34.6 
MZF second born 278 7.7 6.2 4.0 17.0 268 19.7 7.7 14.7 36.4 
MZF sister 64 8.2 5.5 4.0 16.0 61 20.9 8.8 14.0 30.8 
DZF firstborn 172 7.9 5.7 4.0 16.0 169 20.3 8.3 14.5 32.7 
DZF second born 173 7.9 6.1 4.0 19.0 169 20.2 7.9 15.5 33.2 
DZF sister 49 8.1 7.8 4.0 15.0 47 20.5 8.3 13.7 29.9 
Men           
MZM firstborn 194 6.3 3.4 4.0 13.0 183 20.0 8.4 13.0 34.0 
MZM second born 190 6.3 3.4 4.0 12.0 190 19.7 6.5 14.1 34.0 
MZM brother 41 6.6 4.6 4.0 14.0 40 20.9 8.2 16.2 34.6 
DZM firstborn 145 6.5 3.0 4.0 13.0 140 19.7 5.6 15.1 30.3 
DZM second born 141 6.3 2.5 4.0 12.0 139 19.3 3.9 13.8 26.2 
DZM brother 26 5.7b 2.0 4.0 10.0 26 21.2b 5.9 15.7 28.4 
MZF = monozygotic females, DZF = dizygotic females  
MZM= monozygotic males, DZM= dizygotic males 
a Unadjusted means, in the analyses means were adjusted for age 
b The mean for both DEB and BMI of the DZM brothers was not equal to the means in the remaining males. 
 
Women 
In the women both BMI and DEB showed a significant correlation with age, r=0.27 (95% 
CI 0.19-0.34) and r=0.14 (95% CI 0.06-0.21) respectiv ly. BMI and DEB scores increased 
with increasing age. The descriptive statistics for the female sample are presented in the 
upper part of Table 4.1. Means (adjusted for age), and variances of DEB and BMI were 
equal in the female twins and siblings (χ28 = 5.54; p= 0.70). The phenotypic correlation 
between BMI and DEB was 0.32 (95% CI 0.25-0.38) in women. Table 4.2 displays the 
correlations and cross-correlations for BMI and DEB in MZ twins, and same-sex DZ 
twins/twin-sibling pairs in the women. All the MZ correlations, both cross-twin and cross-
twin cross-trait, were substantially higher than the DZ/twin-sibling correlations. In other 
words, genetic influence is implied in DEB, BMI, and the overlap between these traits. DZ 
twin correlations and twin-sibling correlations could be constrained to be equal (χ218 = 
26.72; p= 0.08). 
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Table 4.2 Correlations and cross-correlations for DEB and BMI in monozygotic twins, and in same-sex dizygotic 
twins or twin-sibling pairs. Women are presented in the upper part of the table, men in the lower part. 
  MZ  DZ / same-sex siblings 
  DEB BMI DEB BMI 
DEB 0.67 (0.60, 0.72)  0.21 (0.10, 0.32)  Women 
 BMI 0.29 (0.20, 0.37) 0.80 (0.76, 0.84) 0.15 (0.07, 0.24) 0.30 (0.19, 0.40) 
      
DEB 0.38 (0.26, 0.49)  0.25 (0.12, 0.37)  Men 
BMI 0.24 (0.15, 0.33) 0.76 (0.70, 0.81) 0.23 (0.13, 0.32) 0.34 (0.21, 0.45) 
95% confidence intervals are shown in parentheses 
 
 In Table 4.3, the parameter estimates and fit statistics for the full model and the best-
fitting model, from the bivariate twin analyses, are presented. The AE model, with genetic 
influences explaining the overlap between BMI and DEB (a21) gave the best fit to the data. 
Both BMI and DEB were highly heritable in women. The total phenotypic correlation 
between BMI and DEB was due to shared genetic influe ces with an rg of 0.43 (95% CI 
0.34- 0.52) in women. 
 
Table 4.3 Fit statistics and parameter estimates of the ull and best-fitting model of bivariate Cholesky analysis of 
BMI and DEB in female same-sex twins and siblings.  
 Fit statistics   
 -2lla df ∆χ2 b ∆df c   
ACE; 
 a12, c12, e12 
9034.13 1983 - -   
AE; a12 9035.54 1987 1.42 4  
 
 a2 c2 e2 
 BMI DEB BMI DEB BMI DEB 
ACE;  





















95% confidence intervals shown in parentheses 
a -2ll: -2 log likelihood 
b ∆χ2: Chi-square test statistic between two models 
c ∆df: degrees of freedom for the Chi-square difference test 
 
 For the women, the statistical power to test for the significance of the different paths of 
A (a11,a21,a22) was 1.00 in the bivariate analyses. In addition, the power to test whether rg 
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was significantly different from zero or one, was al o 1.00. This means that we had 
sufficient power to decompose the variance and covariance in BMI and DEB. 
 
Men 
The correlation between age and BMI was 0.35 (95% CI 0.26-0.42) in men, between age 
and DEB a non significant correlation of 0.08 (95% CI -0.01-0.16) was obtained. In the 
lower part of Table 4.1, the descriptive statistics for the male sample are listed. Not all 
means of DEB and BMI were equal between twins and siblings. The mean of DEB was 
lower, while the mean of BMI was higher in the DZM brothers compared to the other male 
twins and siblings (χ26 = 8.33; p= 0.22). In the subsequent analyses, we therefore used
different means for the DZM brothers. 
 The phenotypic correlation between BMI and DEB was0.28 (95% CI 0.21-0.36). The 
lower part of Table 4.2 displays the correlations ad cross-correlations for BMI and DEB in 
MZ twins, and same-sex DZ twins or twin-sibling pairs estimated in the male sample. The 
correlations for BMI and DEB were substantially higher in the MZ than in the DZ/twin-
sibling pairs in men. The cross-twin cross-trait correlation, however, was quite similar in 
the MZ and DZ/twin-sibling pairs. DZ twin correlations and twin-sibling correlations could 
be constrained to be equal (χ218 = 26.52; p= 0.09).  
  
Table 4.4. Parameter estimates and fit statistics of the full and best-fitting model of bivariate Cholesky analysis of 
BMI and DEB in male same-sex twins and siblings.  
 Fit statistics   
 -2lla df ∆χ2 b ∆df c   
ACE;  
a12, c12, e12 
6023.62 1440 - -   
AE; a12 6026.35 1444 2.72 4  
 
 a2 c2 e2 
 BMI DEB BMI DEB BMI DEB 
ACE;  





















95% confidence intervals shown in parentheses 
a -2ll: -2 log likelihood 
b ∆χ2: Chi-square test statistic between two models 
c ∆df: degrees of freedom for the Chi-square difference test 
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 For the bivariate Cholesky decomposition analyses, the AE model with genetic 
components explaining the overlap (a21), gave the best fit to the data. In Table 4.4, the 
parameter estimates as well as the fit statistics are mentioned for the full and best-fitting 
models in the male sample. DEB was moderately heritable in men, whereas BMI was a 
highly heritable trait. The total phenotypic correlation between BMI and DEB was due to 
shared genetic influences with an rg of 0.51 (95% CI 0.37-0.64) in men.  
 The statistical power to test for the significance of the different paths of A (a11,a21,a22) 
was 1.00 in the male sample. However, the power to test whether rg between BMI and DEB 
was statistically different from one was only 0.58, while the power to test if rg was 
significantly different from zero was 0.99 in the AE model. This means, that we had limited 
power to estimate the size of rg accurately.  
 
How much of the genetic influence on DEB is independent of BMI? 
In both women and men the estimated genetic correlations indicated that about half of the 
genetic factors that influence BMI also influence DEB. But what does this mean for the 
heritability? How much of the heritability estimate in DEB is attributable to genetic 
influences on BMI, and how much is independent of i? Based on the genetic correlation we 
can calculate the heritability of DEB independent of genetic influences on BMI. For women 
this leads to a heritability estimate of 0.53, in the men an independent heritability of 0.29 
was obtained. These results show that the majority f genetic influence on DEB is 




Twin-, cross-twin, and twin-sibling correlations ind cated that a large part of the variance in 
both DEB and BMI was explained by genetic factors, and that genetic components were 
underlying the overlap between DEB and BMI in women. The bivariate analysis showed 
that DEB is a highly heritable trait in women (a2=0.65) and moderately heritable in men 
(a2=0.39), whereas BMI is highly heritable in both women (a2=0.80) and men (a2=0.76). In 
addition, additive genetic factors were responsible for the total overlap between the two 
characteristics, yielding a genetic correlation of 0.43 in women and 0.51 in men. Despite 
the overlap between BMI and DEB, the majority of the genetic influences on DEB were 
due to genetic effects that are independent of BMI in women as well as men. 
 Klump et al. (2000) used a bivariate Cholesky decomp sition analysis to examine the 
genetic and environmental contributions to BMI and several scales from the Eating 
Disorder Inventory (EDI) in adolescent female twins. In this study heritability estimates 
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ranged from 0.02 to 0.45 in 11-year old twins, and 0.52 to 0.63 in 17-year old twins for the 
EDI scales, and from 0.78 to 0.84 for BMI in both 11-year and 17-year old twins. Genetic 
correlations between 0.38 and 0.97 in 11-year old twins and between 0.33 and 0.60 in 17-
year old twins were estimated for BMI and the different scales of the EDI. Despite the 
difference in age and the use of different assessment instruments, our results in the women 
were comparable to the estimates in the 17-year old twins from this study. In addition, 
results from the current study are comparable to adult population-based univariate twin 
studies that have investigated genetic and environmental contributions to BMI (Schousboe 
et al., 2003), and eating disorder related characteristics (Bulik et al., 1998; Bulik et al., 
2003b; Bulik et al., 2006; Holland et al., 1988; Keski-Rahkonen et al., 2005; Klump et al., 
2000; Klump et al., 2003; Neale et al., 2003a; Reichborn-Kjennerud et al., 2003; 
Reichborn-Kjennerud et al., 2004b; Reichborn-Kjennerud et al., 2004a; Rowe et al., 2002; 
Rutherford et al., 1993; Sullivan et al., 1998a; Wade et al., 1998).  
 The majority of the variance in DEB was explained by genetic factors in women, while 
unique environmental factors had the largest influece in men. Since eating disorders are 
more common in women, items used to asses symptoms and features related to these 
disorders are also mainly developed for women. The scale we used might not be measuring 
the same underlying trait in men and women (Slof-Op 't Landt et al., 2009), the differences 
in heritability estimates between the sexes in the current study can therefore be indicative of 
a true difference in disordered eating behavior, but might also be due to measurement bias. 
None of the previously performed twin studies examining eating disorder related 
characteristics (Keski-Rahkonen et al., 2005; Reichborn-Kjennerud et al., 2003; Reichborn-
Kjennerud et al., 2004b; Reichborn-Kjennerud et al., 2004a; Rowe et al., 2002) in both men 
and women, have tested whether the items used to asses the phenotype measured the same 
trait in both sexes. As a consequence it is not clear if the reported differences and 
similarities between male and female heritability estimates are due to measurement bias or 
true sex differences in disordered eating behavior.   
 The genetic correlation of 0.43 in women and 0.51 in men obtained in this study, 
indicates that approximately 50% of the genetic factors that influence BMI also influence 
DEB. Because DEB and BMI are related with each other, it would be interesting to 
disentangle the direction of causation of the overlap between these characteristics. Genetic 
influences on for example metabolism may be causal to weight gain that eventually leads to 
disturbed eating behavior. Genetic influences on DEB may alternatively be causal to a 
disturbed eating profile, leading to fluctuations i weight. Eventually we would like to 
identify genes that are underlying DEB. Therefore, w  are planning to test the causal 
hypothesis in future studies, to further clarify the underlying aetiology of the overlap 
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between BMI and DEB. Several approaches can be taken to disentangle the direction of 
causation, for example phenotypic causation models (Duffy & Martin, 1994; Heath et al., 
1993) and the co-twin control design (Cederlof et al., 1977; Kendler et al., 1993). The first 
method is a nested model of the bivariate Cholesky decomposition, in this approach the 
correlated traits need to have different modes of inheritance. In the co-twin control design 
relative risks for DEB would be compared between unrelated individuals discordant for 
BMI, DZ twins discordant for BMI, and MZ twins discordant for BMI.  
 The power analysis revealed that our sample size was sufficient to detect genetic and 
shared environmental effects on BMI and DEB (both dependent and independent from 
BMI) in men and women. Our female sample size also was sufficient to estimate the 
genetic correlation between BMI and DEB correctly. In the men, we had limited statistical 
power to estimate this correlation. The small difference between the cross-twin cross-trait 
correlations in the male MZ and DZ/twin-sib pairs gave a first indication for this lack of 
power. As a consequence, there is a possibility that the overlap between BMI and DEB is 
not solely due to genetic factors in men, but that common environmental factors also play a 
role.  
 A concern with regard to our study is the selection of the eating disorder features, and 
the comparability of this phenotype with other studies. Three items used in this study are 
based on DSM-IV (1994) criteria for eating disorders. The fourth item, dieting, was added 
to assess an important risk factor for the development of eating disorders (Jacobi et al., 
2004). Within the eating disorder field a broad variety of assessment instruments is used to 
assess eating disorders and eating disorder-related phenotypes. A majority of these 
assessment instruments is based on DSM-IV criteria, indicating that our broad phenotype is 
probably fairly comparable to these phenotypes. However, one eating disorder symptom is 
missing in our phenotype, namely compensatory behavior. Heritabilities of 0.50 for 
compensatory behavior in 17-year old female twins (Klump et al., 2000) and 0.70 for self-
induced vomiting in adult female twins (Sullivan et al., 1998a) have been found. Based on 
these findings, the inclusion of compensatory behaviors in our phenotype might not 
influence the results found for the women in the current study. However, we do not know 
what the consequences for the heritability estimates in the men would be, especially since 
significant gender differences have been reported for a variety of compensatory behaviors 
like self-induced vomiting, laxative use and fasting (Anderson & Bulik, 2004). 
 The current study provides further evidence that genetic components are underlying 
disordered eating behavior in both men and women. Part of these genetic components are 
influencing both BMI and disordered eating behavior, while the majority of genetic effects 
influencing disordered eating behavior is independent of the genetic effects that influence 
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BMI. In future studies, we hope to identify genes that are involved in this eating disorder 
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Twin studies suggest that genetic factors play a substantial role in anorexia nervosa (AN) 
and self-induced vomiting (SV), a key symptom that is shared among different types of 
eating disorders. We investigated the association of 25 single nucleotide polymorphisms 
(SNPs), capturing 71 to 91% of the common variance i  candidate genes stathmin (STMN1) 
, serotonin receptor 1D (HTR1D), tryptophan hydroxylase 2 (TPH2) and brain-derived 
neurotrophic factor (BDNF), with AN and eating disorders characterized by SV.  
First, allele frequencies of all SNPs were compared b tween a Dutch case group (182 AN, 
149 eating disorders characterized by SV) and 607 controls. Associations rendering p-
values <0.05 from this initial study were then tested for replication in a meta-analysis with 
two additional independent eating disorder case-control samples, together providing 887 
AN participants, 306 participants with an eating disorder characterized SV, and 1914 
controls. A significant effect for the minor C-allele of TPH2 rs1473473 was observed for 
both AN (OR=1.30, 95% CI 1.08-1.57, p<0.003) and eating disorders characterized by SV 
(OR=1.52, 95% CI 1.28-2.04, p<0.006). In the combined case group a dominant effect was 
observed for rs1473473 (OR=1.38, 95% CI 1.16-1.64, p<0.0003). The meta-analysis 
revealed that the TPH2 polymorphism rs1473473 was associated with a higher risk for AN, 




Eating disorders (ED) are debilitating diseases with h gh chronicity and mortality rates 
(Crow et al., 2009; Steinhausen, 2002; Steinhausen & Weber, 2009). Genetic influences 
appear to be considerable for ED, with heritability estimates ranging from 28 to 83% in 
women (Bulik et al., 2006; Slof-Op 't Landt et al., 2005). A common and frequently 
occurring symptom in individuals with ED is self-induced vomiting (SV). This symptom 
was associated with greater clinical severity (Dalle Grave et al., 2009; Reba et al., 2005), 
and also appears to be heritable (8-72%) (Sullivan et al., 1998a; Wade et al., 2008b).  
 Despite the multitude of performed molecular genetic studies in ED, no specific genes 
have been definitively implicated as causal, although several promising candidate genes 
exist (Scherag et al., 2010; Slof-Op 't Landt et al., 2005). To retain adequate statistical 
power we selected four of these candidate genes to test for association in a case-control 
design. The selected genes were serotonin receptor 1D (HTR1D), tryptophan hydroxylase 2 
(TPH2), stathmin (STMN1) and brain-derived neurotrophic factor (BDNF).  
 HTR1D and TPH2 belong to the serotonin pathway. Serotonin is involved in a broad 
range of functions, including body weight regulation, eating behavior and mood (Lucki, 
1998). Furthermore, the functional activity of the serotonin system appears to be altered in 
both current as well as recovered ED patients (Ehrlich et al., 2010; Kaye, 2008; Kaye et al., 
2005a). HTR1D is located under the linkage peak for anorexia nervosa (AN) at 1p33-36 
(Grice et al., 2002), and was significantly associated to AN in two independent studies 
(Bergen et al., 2003; Brown et al., 2006). TPH2 encodes the rate-determining enzyme in the 
synthesis of serotonin tryptophan hydroxylase in the brain (Walther & Bader, 2003), and 
was previously associated with depression and anxiety (Barnett & Smoller, 2009; Kim et 
al., 2009; Tsai et al., 2009; Zhang et al., 2006).  
 STMN1 is also located under the linkage peak for restrictive AN (Grice et al., 2002), 
and was associated to fear processing and anxiety in both mice and humans (Brocke et al., 
2010; Shumyatsky et al., 2005).  
 Finally, the involvement of BDNF in ED was reported by two large collaborative 
studies, that showed an association between AN and the functional Val-66-Met 
polymorphism (Ribases et al., 2004; Ribases et al., 2005). This finding was replicated by 
some but not all subsequent studies (Scherag et al., 2010).  
 In general, consistent associations in the ED field are lacking, possibly due to small 
sample sizes and the limited number of polymorphisms assessed (Scherag et al., 2010; Slof-
Op 't Landt et al., 2005). In the current study we selected 25 tagging SNPs across the four 
genes and tested them for association with AN (N=182) and participants (N=149) with an 
ED characterized by self-induced vomiting (SV). Replication occurred in a meta-analysis 
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with two additional independent ED case-control samples from Germany and the 
Netherlands together providing 887 AN cases, 306 SV cases and 1914 controls.  
 
Methods and Materials 
 
Participants 
This study was approved by each national ethics committee. All participants (and if 
underage, their parents) gave written informed consent. 
 Three hundred and eighty nine female ED patients were recruited through ten specialist 
ED units throughout the Netherlands (the GenED study). All participants fulfilled DSM-IV 
(Diagnostic and Statistical Manual of Mental Disorders 4th edition) criteria for an ED, made 
by experienced clinicians based on a semi-structured int rview at intake, and via the self-
report eating disorder examination questionnaire (EDEQ; Fairburn & Beglin, 1994). For 
AN, criterion D - amenorrhea for three consecutive months- was discarded because some of 
the participants despite having AN continue to menstruate (for example, due to treatment 
with oral contraceptives). Of the 389 cases, 182 fulfilled the DSM-IV criteria (excluding 
criterion D) for AN. Based on the EDEQ (q14: Over the past 28 days, how many times 
have you made yourself sick (vomit) as a means of controlling your shape and weight?) and 
assessment interviews (current and past slef-induced vomiting), we defined a subgroup of 
ED cases (N=149) who reported regular self-induced vomiting (SV). Frequencies of mean 
rates of self-induced vomiting were 30% 2 to 8 times p r month, 40% 8 to 20 times per 
month, and 30% more than 20 times per month. Participants with SV fulfilled the following 
DSM-IV diagnoses AN (N=64), boulimia nervosa (N=74) and ED not otherwise specified 
(N=11) (see Table 5.1). Thus the two groups were patly overlapping, with 64 participants 
belonging to both groups. 
 Random controls come from the population-based Netherlands Twin Registry (NTR), 
which was established in the late 1980s at the VU University in Amsterdam, the 
Netherlands. Data on the multiples (twins or triplets) and their families have been collected 
every two to three years in longitudinal survey studies (Boomsma et al., 2002). Subsamples 
of the multiples were invited to participate in exprimental and laboratory studies and 
donate their DNA (Boomsma et al., 2006). For the current study, one woman per family 
served as control, yielding a control group of 607 unrelated women (Middeldorp et al., 
2010). 
 For the meta-analysis additional sample collections were used from Essen (The 
EDNET and Essen study, Germany) and Utrecht (The Netherlands) (see Table 5.1). The 
EDNET and Essen sample consisted of 420 female partici nts with AN according to 
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DSM-IV criteria and 189 normal weight controls (75 men and 114 women; females with 
ED were excluded) (Muller et al., 2008). The Utrecht sample consisted of 481 female 
participants diagnosed with an eating disorder, 285 participants fulfilled DSM-IV criteria 
for AN and 157 participants reported regular self-induced vomiting. These two groups were 
partly overlapping, with 56 participants belonging to both groups. As a control population 
measured and imputed genotype data from the female control group of the GAIN GWA 
study were used (Boomsma et al., 2008). This group c mprised 1118 unrelated female 
participants from the NTR who were at low liability for major depressive disorder. The 
GAIN control group was independent of the initial NTR control group.  
 
Table 5.1 Cases and controls 
    DSM-IV Eating disorder diagnosis 







AN-R AN-BP AN-P BN EDNOS 
GenED         
NTR Controls 607 25.4 
(13.6) 
      
GenED AN 182 28.7 
(9.9) 
64 108 35 39 - - 
GenED SV 149 28.9 
(9.9) 
64 - 29 35 74 11 
EDNET-Essen         
EDNET-Essen Controls 189 24.6 
(2.5) 
      
EDNET-Essen AN 420 21.4 
(9.1) 
- 152 N.A. N.A. - - 
Utrecht         
Gain GWA NTR Controls 1118 44.0 
(13.7) 
      
Utrecht AN 285 22.9 
(4.8) 
56 213 N.A. N.A. - - 
Utrecht SV 157 23.8 
(5.7) 
56 - N.A. N.A. 37 63 
AN= anorexia nervosa, AN-R= anorexia nervosa restriciting type, AN-BP= anorexia nervosa binge purging type, 
AN-P= anorexia nervosa purging type (without binge eating), SV= eating disorders characterized by self-induced 
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SNP selection and genotype measurements 
Genomic DNA was isolated from buccal swabs for the case group from the GenED study 
and for part of the NTR control group (39%). For the EDNET-Essen, and the Utrecht 
samples, genomic DNA was isolated from blood samples.  
 
Table 5.2 Selected SNPs per candidate gene 
Gene SNP  Remarks 
STMN1 rs12037513 The 3 SNPs genotyped capture  
 rs807055 11 out of 12 (91%) alleles of  
 rs807062 STMN1 at r2 >=0.8 
HTR1D rs605367 The 2 tagging SNPs (rs676643  
 rs6300 and rs674386) genotyped  
 rs676643 capture 9 out of 10 (90%)  
 rs674386 alleles of HTR1D at r2 >=0.8 
TPH2 rs10748185 The 10 SNPs genotyped  
 rs2129575 capture 108 out of 148 (72%)  
 rs17110489 alleles of TPH2 at r2 >=0.8 
 rs7305115  
 rs1007023  
 rs4760820  
 rs1473473  
 rs3903502  
 rs12231356  
  rs4474484  
BDNF rs7124442 The 8 SNPs genotyped capture  
 rs6265 38 out of 53 (71%) alleles of  
 rs11030107 BDNF at r2 >=0.8 
 rs7103873  
 rs11030123  
 rs17309930  
 rs2049048  
 rs1491851  
 
 HTR1D SNPs were selected based on previous association studies in AN (Bergen et 
al., 2003; Brown et al., 2006). For BDNF, STMN1, and TPH2 tagging SNPs were selected 
from HapMap Public Release #19 applying the efficient multimarker method with r2>0.8 
and minor allele frequency (MAF)>0.05 as implemented in the HapMap web browsers 
(http://www.hapmap.org; de Bakker et al., 2005). Two of the selected HTR1D SNPs 
Chapter 5 
79 
(rs676643 and rs674386) were also present as tagging SNPs in the HapMap database. In 
Table 5.2 the selected SNPs and coverage rate per candidate gene are listed.  
 Multiplex genotyping assays were designed using Assay Designer software 
(Sequenom, San Diego, CA). SNPs were genotyped by mass spectrometry (the 
homogeneous MassARRAY system; Sequenom, San Diego, CA) using standard conditions. 
PCR reactions were carried out in a final volume of 5 µl and contained standard reagents 
and 2.5 ng of genomic DNA. Genotypes were assigned by using Genotyper version 3 
software (Sequenom, San Diego, CA).  
 Genotype call rates for each multiplex were checked within the cohorts. Samples with 
call rate <75% were excluded from further analyses in the datasets. Success rates of the 
SNPs ranged from 97.9 to 100% for the GenED case group, and from 87.3 to 100% for the 
NTR control group. Between 6 and 10% of the samples w re genotyped in duplicate and 
checked for concordance. Duplicate genotyping error rates were 0.07% in the case group, 
0.2% for the control sample. 
 For the GAIN GWA controls, genomic DNA was isolated from blood samples. 
Individual genotyping was conducted by Perlegen Sciences (Mountain View, CA, USA) 
using a set of four proprietary, high-density oligonucleotide arrays (Sullivan et al., 2009). 
SNPs were imputed by Abecasis’ MACH (v1). For the imputed SNPs the average 
maximum posterior probability was calculated. This measure represents how much 




The χ 2 test for Hardy-Weinberg equilibrium (HWE) was calculated in the NTR controls 
using the HWE program of LINKUTIL (http://linkage.rockefeller.edu/ott/linkutil.htm). 
To investigate the association of the 25 SNPs from four candidate genes we applied a two-
stepped approach. First, allele frequencies for all SNPs were compared between cases from 
the GenED study and controls from the NTR. SNPs that s owed nominal significant 
association (p<0.05) with either AN or SV in the first step, were tested for replication in a 
meta-analysis with the two additional independent case-control samples (EDNET and 
Essen, and Utrecht).  
 Differences in allele frequencies were compared and tested for significance by 
Pearson’s chi-square test with SPSS version 15 software (SPSS, Chicago, IL). For the 
meta-analysis, the fixed- and random-effects model f DerSimonian and Laird 
(DerSimonian & Laird, 1986) was used to estimate summary odds ratio’s (ORs), as 
implemented in R (http://www.r-project.org/, package meta). The heterogeneity was 
Association study in eating disorders 
80 
quantified using the I2 statistic for inconsistency (Higgins & Thompson, 2002) and its 
statistical significance was tested with the χ2 distributed Cochran Q statistic (Lau et al., 
1997). I2 describes the proportion of variation that is unlikely to be due to chance and is 
considered large for values over 50% (Higgins & Thompson, 2002). Two tailed p-values 
are reported for all analyses.  
 Power calculations were performed in Quanto version 1.2.4 (2009). Instead of 
adjusting p-values a priori for multiple testing, nominal p-values are provided in order to 
allow the reader to interpret the level of significan e. The results from the final analyses 
were corrected for multiple testing by using an interface developed by Nyholt (2004), 
available at http://genepi.qimr.edu.au/general/daleN/SNPSpD/. Given the fact that the 
linkage disequilibrium (LD) structure among the SNPs was not independent, adjusting the 
p-value for the actual number of tests would be overly st ingent and result in a loss of 
power. With this method the p-values were therefore adjusted for the estimated number of 
independent SNPs tested. Calculation of the number of independent SNPs (also called the 
effective number of SNPs; Meff) was based on the number of eigenvalues of the n x n




SNP association analysis 
In the NTR control group none of the SNPs revealed  departure from HWE (p>0.01). 
Depending on the MAF of the SNP, this initial study had adequate power (85% power at an 
alpha level of 0.05, log-additive or allelic model) to detect effects sizes ranging between 
1.45 and 1.8 for AN and ranging between 1.48 and 1.85 for SV. 
 The results of the association analysis in the initial study (GenED cases and NTR 
controls) are presented in Table 5.3. A nominal significant association (p<0.05) was 
observed for TPH2 rs1473473 in AN as well as SV. This SNP was followed-up in the 
meta-analysis. 
 Exploratory association analyses were performed in the restricting type AN subgroup 
(N=108) of the GenED study and the NTR controls. The results of these analyses are 
presented in supplementary Table S5.1. No significat association was observed for any of 







Table 5.3 Minor allele frequencies (MAF) for each SNP in cases of the GenED study and NTR controls  
Control AN   SV       
DNA (n=607) (n=182)   (n=149)   
Gene Position SNP change MAF MAF Χ2 p MAF Χ2 p 
STMN1 1.p36.11 rs12037513 A>G 0.35 0.32   0.33   
  rs807055 C>T 0.43 0.39   0.37 3.14 0.08 
  rs807062 G>C 0.25 0.26   0.24   
HTR1D 1.p36.12 rs605367 T>C 0.31 0.33   0.33   
  rs6300 A>G 0.10 0.10   0.07   
  rs676643 G>A 0.16 0.15   0.16   
  rs674386 G>A 0.29 0.30   0.30   
TPH2 12.q21.1 rs10748185 G>A 0.49 0.45   0.46   
  rs2129575 G>T 0.26 0.25   0.24   
  rs17110489 T>C 0.26 0.27   0.24   
  rs7305115 G>A 0.41 0.41   0.41   
  rs1007023 T>G 0.12 0.15   0.16 3.38 0.07 
  rs4760820 C>G 0.43 0.40   0.38 2.84 0.09 
  rs1473473 T>C 0.14 0.18 4.26 0.04 0.19 4.82 0.03 
  rs3903502 C>T 0.39 0.42   0.41   
  rs12231356 C>T 0.08 0.05 3.41 0.07 0.07   
  rs4474484 G>A 0.35 0.36   0.37   
BDNF 11p14.1 rs7124442 T>C 0.33 0.29   0.28   
  rs6265 C>T 0.19 0.19   0.20   
  rs11030107 A>G 0.27 0.23   0.24   
  rs7103873 G>C 0.46 0.49   0.48   
  rs11030123 G>A 0.11 0.10   0.10   
  rs17309930 C>A 0.20 0.20   0.18   
  rs2049048 G>A 0.16 0.13   0.17   
  rs1491851 C>T 0.46 0.45   0.46   
AN=anorexia nervosa, SV=eating disorders characterized by self-induced vomiting 
Reported results are comparisons between allele frequencies (1df), p-values <0.1 are shown only. 
 
Meta-analysis 
The TPH2 SNP rs1473473 was genotyped in the EDNET and Essen and the Utrecht case-
control samples. In the GAIN GWA control group this SNP was imputed. The average 
maximum posterior probability, which represents how much uncertainty there is for the 
imputation of a SNP, was 0.99 for TPH2 rs1437473. For the meta-analysis, genotype data 
was available for a total of 2,987 individuals (887 AN cases, 306 SV cases, 1914 controls) 
which provides adequate power (85% power at an alpha level of 0.05, log-additive or allelic 
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model, MAF of 0.16) to detect effect sizes higher than 1.25 for AN and higher than 1.4 for 
SV. 
 
Table 5.4 Meta-analysis of TPH2 SNP rs1473473 in anorexia nervosa and eating disorders characterized by self-
induced vomiting 
 SNP rs1473473  SNP rs1473473 
 AN  SV 
Study OR CIL CIR p  OR CIL CIR p 
GenED 1.39 1.02 1.92 0.040  1.46 1.04 2.04 0.029 
Utrecht 1.25 0.98 1.60 0.067  1.24 0.91 1.70 0.176 
Ednet-Essen 1.11 0.81 1.51 0.53  - - - - 
Meta-analysis 1.25 1.06 1.47 0.009  1.34 1.06 1.69 0.013 
AN=anorexia nervosa, SV=eating disorders characterized by self-induced vomiting , CIL=lower 95% confidence 
interval, CIR=upper 95% confidence interval. Number of AN and SV cases per study: GenED AN N=182, SV 
N=149; Utrecht AN N=285, SV N=157; EDNET-Essen AN N=420, SV N=0. 
 
 Table 5.4 shows ORs, their 95% CI and p-values within the individual case-control 
samples and the subsequent meta-analyses. For the minor C-allele (frequency 0.16) of 
TPH2 SNP rs1473473 a significant association was observed in the meta-analyses with 
both AN and SV. We observed an OR of 1.25 (95% CI 1.06-1.47, p<0.009) for AN, and an 
OR of 1.34 (95% CI 1.06-1.69, p<0.013) for SV. There was no significant evidence for 
heterogeneity of the effect in the AN or SV analyses (p=0.58, I2= 0% and p=0.50, I2=0%).  
 
Table 5.5 Genotype counts TPH2 rs1473473 for the three case-control samples 
 AN  SV  Control 
 Genotype (n)  Genotype (n)  Genotype (n) 
Case-control sample 11 12 22  11 12 22  11 12 22 
GenED 123 52 7  95 52 2  447 125 18 
Utrecht 187 90 8  95 49 3  789 300 29 
EDNET-Essen 266 128 16  - - -  130 50 9 
 
 The OR for the combined group of AN and/or SV cases (n=1073) was 1.24 (95% CI 
1.06-1.44, p<0.006). We could not observe significant evidence for heterogeneity of the 
effect (p=0.38, I2= 0%) between the different case-control samples. Ba ed on the genotype 
frequencies of the TPH2 SNP rs1473473 (presented in Table 5.5) we expected a dominant 
effect to be underlying the association. Therefore, we evaluated the association with this 
SNP in the combined case-group under a dominant genotypic model.  
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Figure 5.1 Random effect plot of the association betwe n TPH2 rs1473473 and the 
combined AN/SV cases under a dominant genotypic model. 
Results: GenED: OR=1.62 (95% CI 1.18-2.23); EDNET-Essen: OR=1.19 (95% CI 0.83-1.72); Utrecht OR=1.33 
(95% CI 1.04-1.72); Random effect model total: OR=1.38 (95% CI 1.16-1.64, p<0.0003)  
 
Figure 5.1 represents the results of this associatin. Homo- and/or heterozygous carriers of 
the minor allele of rs1473473 had an increased probability of either AN or SV (OR=1.38, 
95% CI 1.16-1.64, p<0.0003). Again, no evidence for heterogeneity was observed (p=0.44, 
I2= 0%). As there is a general tendency for initial studies to overestimate effect sizes, we 
tested sensitivity of the association by excluding the discovery sample (GenED cases and 
NTR controls). Under the dominant genotypic model, carriers of the minor allele of 
rs1473473 had an OR of 1.29 (95%CI 1.05-1.59, p<0.018) among the two replication case-
control samples. In supplementary Figure S5.1, the LD-plot between TPH2 rs1473473 and 
the nine other selected TPH2 tagging SNPs is depicted.  
Association study in eating disorders 
84 
 Because the LD structure among the SNPs was not completely independent, adjusting 
the p-value for the actual number of tests would be overly st ingent and result in a loss of 
power. By using the interface developed by Nyholt (2004), the number of independent 
SNPs in our study was estimated to be 23.5. This led to an experiment-wide significance 
threshold of p<0.002. Thus the observed dominant effect of rs1473473 in the final analysis 
in the combined AN-SV group remained significant after adjustment for multiple testing. 
However, the observed effects in the separate AN and SV analyses did not remain 
significant. In this case, the method by Nyholt (2004) was still conservative since not all 25 





This is the first study to report that TPH2 SNP rs1473473 is significantly associated to AN 
and ED characterized by SV. When the two ED case groups are combined, a dominant 
genotypic model for rs1473473 shows that carriers of the minor allele of rs1473473 had a 
higher risk of AN or SV (OR=1.38, 95% CI 1.16-1.64, p<0.0003). This SNP tags an LD 
block that spans across part of the TPH2 gene, and is ended by a recombination hotspot on 
one side. Therefore it is highly likely that this SNP is in LD with a functionally relevant 
variant(s) in the TPH2 gene. The TPH2 gene encodes the main rate-limiting enzyme in the 
synthesis of serotonin in the brain (Zill et al., 2007). Serotonin is involved in satiety, 
anxious and obsessional behavior, mood, and impulse control, features all linked to ED 
(Kaye, 2008; Lucki, 1998). In long-term recovered ED participants elevated 5-
hydroxyindoleacetic acid levels in cerebrospinal fluid were detected (Kaye, 2008; Kaye et 
al., 2005c). This is the major metabolite of serotonin in the brain and body and is thought to 
reflect extracellular serotonin concentrations. This finding thus could be indicative of an 
‘overactive’ serotonin system in ED, which in turn could be caused by an increased 
function of the TPH2 gene. TPH2 was also one of 182 candidate genes that were tested for 
association by comparing in total 5151 SNPs between 1085 AN cases and 677 controls 
(Pinheiro et al., 2010). After accounting for multiple testing, there were no statistically 
significant associations for any individual SNP (including TPH2). Rs1473473 is not in LD 
with known TPH2 mutations (Haavik et al., 2008). TPH2 SNPs in LD with rs1473473 
however, have been associated with a suicidal mental condition in Finnish men (Zhou et al., 
2005), with antidepressant response in depressive pati nts (Peters et al., 2004), and with 
allelic mRNA expression imbalance in sections of the human pons (Lim et al., 2007), 
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indicating that genetic variation at this locus may contribute to mental conditions and could 
influence gene function.  
 To retain adequate statistical power, the current study only covered a selection of 
candidate genes for ED. To replicate previous results in ED, we selected genes for which 
association was observed and confirmed in studies with an adequate sample size. Both 
HTR1D and BDNF fulfilled these criteria, although we acknowledge that inclusion of the 
gene encoding the opioid delta receptor (OPRD1) would also have been appropriate 
(Bergen et al., 2003; Brown et al., 2006; Ribases et al., 2004; Ribases et al., 2005). Because 
of previous inconsistent results the Serotonin Receptor 2A and the Serotonin Transporter 
genes were not included in our selection (for a review see Bulik et al., 2007b; Slof-Op 't 
Landt et al., 2005). Besides replication of previous results, the current study also aimed to 
evaluate the involvement of two unexplored candidate genes for ED. Like HTR1D and 
OPRD1, STMN1 was located under the linkage peak of restrictive AN (1p33-36) (Grice et 
al., 2002). Because the associations with HTR1D and OPRD1 only explained part of the 
linkage, it was expected that additional candidate genes could underlie the linkage peak 
(Bergen et al., 2003). TPH2 was selected because of the link between serotonin and ED. 
The role of TPH2 in the synthesis of serotonin (Zill et al., 2007), makes it a plausible 
candidate gene for ED. Thus far no other genes havebeen analysed in the GenED study.  
 A note concerning our study populations is the fact that the EDNET and Essen control 
population was limited in size and consisted of both men and women. However, no 
difference in the allele frequency of rs1473473 betwe n sexes was observed, in either the 
German controls or the GAIN GWA control group (Boomsma et al., 2008). So it is unlikely 
that this has interfered with our results. Another remark with regard to the German sample 
is the lack of information regarding self-induced vomiting. Finally, the NTR control group 
were random controls, not selected based on for example liability to psychiatric disorders or 
social economic status. Due to the low prevalence of ED in the general population we do 
not think that this has affected our results. 
 Another concern is the issue of multiple testing. We acknowledge that if we correct for 
multiple testing in the GenED study, the association with rs1473473 does not remain 
significant. However, if we perform permutation analysis in this study the global p-value 
for the association between the TPH2 gene and SV and AN is still trend significant 
(p<0.10). Therefore we do think that the decision to follow-up the association of TPH2 
SNP rs1473473 in the additional cohorts was justified. 
 The reported association between the functional BDNF Val-66-Met polymorphism 
(rs6265) and AN was not replicated in this study (Ribases et al., 2004; Ribases et al., 2005). 
However, this result is in line with several other studies which also could not confirm this 
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association (Dardennes et al., 2006; de Krom et al., 2006; Dmitrzak-Weglarz et al., 2007; 
Friedel et al., 2005; Koizumi et al., 2004; Mercader et al., 2007).  
 Previously two studies have reported significant association between HTR1D SNPs 
(including rs6300 and rs674386) and AN (Bergen et al., 2003; Brown et al., 2006). We did 
not detect any allele frequency differences between controls and AN cases in the four SNPs 
that were examined. Considering the strength of the previous association and the allele 
frequency, we should have had sufficient power to detect an effect of rs6300. For rs674386 
on the other hand, statistical power was lower (60%), and the association may have been 
missed due to this reason. 
 No consistent associations were observed for the ot r positional candidate gene, 
STMN1. Despite its position under the linkage peak for AN, it might not be involved in ED. 
However, since linkage was observed in the restrictive subtype of AN, it is also possible 
that an effect of this gene is only apparent in this specific eating disorder subgroup. The 
exploratory analyses in restrictive AN (N=108) of the GenED study and the NTR controls 
(supplementary Table S5.1), also did not reveal an association with STMN1. This 
exploratory study had adequate power (85% power at an lpha level of 0.05, log-additive or 
allelic model) to detect effects sizes around 1.6 for restricting AN. Thus, the association 
may have been missed due to limited statistical power.  
 For the first time candidate genes in ED characterized by self-induced vomiting were 
evaluated. We selected this phenotype because there is no a priori reason to believe that the 
DSM diagnostic schema represent more ‘genetic’ syndromes than underlying core 
behaviors or traits. A distinctive eating disorder symptom that is shared among different 
types of ED is self-induced vomiting. Prevalences of vomiting within clinical samples 
ranged between 31 and 39% for AN (Ben-Tovim et al., 1989; Garner et al., 1993), and even 
over 90% in BN (Ben-Tovim et al., 1989). The reliability of the measurement of this 
behavior and the heritability of self-induced vomiting has also been demonstrated (Sullivan 
et al., 1998a; Wade et al., 2008b). Other symptoms that are shared among ED are binge 
eating and the undue influence of weight and shape on self-evaluation. Binge eating has a 
substantial heritability but is less reliably measured (Bulik et al., 1998; Reichborn-
Kjennerud et al., 2003; Sullivan et al., 1998a; Wade et al., 2000a; Wade et al., 2008b). The 
undue influence of body weight appears to be more environmentally mediated (Reichborn-
Kjennerud et al., 2004a; Wade & Bulik, 2007). 
 Many genetic studies in AN have been performed, mainly in small populations 
measuring only one or a few SNPs (Bulik et al., 2007b). In the current study we used a 
large population of AN cases. We selected 25 SNPs to capture the majority of the common 
variation within four candidate genes (STMN1, HTR1D, TPH2 and BDNF). Our two-step 
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approach gave us the opportunity to explore associati n with all 25 SNPs in the first step, 
and to evaluate the initial findings in two additional independent case-control samples. This 
approach has led to a robust association of the TPH2 SNP rs1473473. The minor allele of 
this SNP was associated with a higher risk for AN, SV and for the combined group. It is 
interesting that the same SNP was associated with both types of ED. Although there was 
overlap between the two types of ED, 13% of the 887 AN cases also belonged to the SV 
group, the effect of rs1473473 is also present in the independent AN and SV groups. It has 
been hypothesized that AN, BN, and also subthreshold forms of ED share at least some risk 
and liability factors (Kaye, 2008; Strober et al., 2000). In a Swedish twin study, 
approximately half of the genetic factors contributed o liability to both AN and BN (Bulik 
et al., 2010). Our current finding is consistent with this hypothesis. For future studies we 
aim to establish the effect of genetic variation at the TPH2 gene on behaviors underlying 
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Supplementary table S5.1 Minor allele frequencies (MAF) for each SNP in restricting AN cases of the 
GenED study and NTR controls  
Control Restricting AN   
   
DNA (n=607) (n=108)   
Gene Position SNP change MAF MAF Χ2 p 
STMN1 1.p36.11 rs12037513 A>G 0.35 0.31   
  rs807055 C>T 0.43 0.42   
  rs807062 G>C 0.25 0.29   
HTR1D 1.p36.12 rs605367 T>C 0.31 0.33   
  rs6300 A>G 0.10 0.11   
  rs676643 G>A 0.16 0.17   
  rs674386 G>A 0.29 0.29   
TPH2 12.q21.1 rs10748185 G>A 0.49 0.44   
  rs2129575 G>T 0.26 0.27   
  rs17110489 T>C 0.26 0.27   
  rs7305115 G>A 0.41 0.41   
  rs1007023 T>G 0.12 0.14   
  rs4760820 C>G 0.43 0.42   
  rs1473473 T>C 0.14 0.18 2.77 0.09 
  rs3903502 C>T 0.39 0.42   
  rs12231356 C>T 0.08 0.06   
  rs4474484 G>A 0.35 0.37   
BDNF 11p14.1 rs7124442 T>C 0.33 0.29   
  rs6265 C>T 0.19 0.22   
  rs11030107 A>G 0.27 0.24   
  rs7103873 G>C 0.46 0.45   
  rs11030123 G>A 0.11 0.11   
  rs17309930 C>A 0.20 0.19   
  rs2049048 G>A 0.16 0.12   
  rs1491851 C>T 0.46 0.44   
AN=anorexia nervosa. 




Supplementary figure S5.1 Linkage disequilibrium (LD) plot for the ten TPH2 tagging 
SNPs, based on HapMap. D’ values are presented (if absent D’=1), color scheme dark grey: strong evidence of LD 
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Objective: Genes are involved in anorexia nervosa (AN) and a key symptom of different 
types of eating disorders (ED), self-induced vomiting (SV). Perfectionism and impulsivity 
are possible predisposing personality features for ED. Could genetic variation in the 
Tryptophan Hydroxylase 2 (TPH2) gene, previously associated with AN and SV (Slof-Op 't 
Landt et al., 2011), explain the overlap between ED, perfectionism and impulsivity?  
Method: Perfectionism and impulsivity scores were compared b tween 324 participants 
with ED and 240 controls. Subsequently, the genetic association between four TPH2 SNPs 
and perfectionism/impulsivity was evaluated. First in a random twin-based control group 
(N=512), and secondly within ED participants.  
Results: ED participants report higher levels of perfectionism and impulsivity than controls. 
The minor alleles of TPH2 rs1473473 (OR=1.49, p=0.04) and rs1007023 (OR=1.60, 
p=0.02) were more frequent in impulsive controls, but also in impulsive participants with 
ED (OR=1.79, p=0.05 and OR=1.83, p=0.02, respectively).  
Discussion: Genetic variation at the TPH2 gene appeared to affect impulsivity which in turn 
might predispose to the ED phenotype.
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Eating disorders have chronicity and mortality rates which are among the highest in the 
field of psychiatry (Nielsen et al., 1998). The most familiar types of eating disorders are 
anorexia nervosa (AN) and bulimia nervosa (BN). However, the majority of eating disorder 
patients (about 60%) do not meet strict DSM-IV diagnostic criteria for either of these types, 
and therefore belong to the eating disorder not otherwise specified (EDNOS) category 
(Fairburn & Bohn, 2005). An important symptom that is shared among the different types 
of eating disorders (AN purging type, BN, and EDNOS) is self-induced vomiting (SV), 
which has been associated with greater clinical severity and higher novelty seeking (Dalle 
Grave et al., 2009; Reba et al., 2005).  
 Despite substantial efforts to identify causal pathways for AN and BN, very little is 
known about the aetiology of eating disorders. In longitudinal and cross-sectional studies, 
several risk factors have been proposed, including being a woman, elevated weight and 
shape concerns, negative self-evaluation, dieting, perfectionism and possibly impulsivity 
(Fairburn et al., 1997; Fairburn et al., 1998; Jacobi et al., 2004; Stice, 2002). Population-
based twin studies have yielded moderate to substantial heritability estimates (8%-83%) for 
eating disorders and self-induced vomiting in women (Bulik et al., 2006; Slof-Op 't Landt et 
al., 2005; Sullivan et al., 1998a; Wade et al., 2008b).  
 In this paper we explore the hypothesis that part of the heritability of eating disorders 
may be explained by heritable aspects of perfectionism and impulsivity, which are 
consistently associated to AN and /or BN (Cassin & von Ranson, 2005). Both 
perfectionism and impulsivity remained present after recovering from an eating disorder 
(Bastiani et al., 1995; Kaye et al., 1998; Lilenfeld t al., 2000; Srinivasagam et al., 1995; 
Wagner et al., 2006). In addition, elevated levels of perfectionism were observed in 
relatives of individuals with AN and BN (Lilenfeld et al., 2000; Woodside et al., 2002). 
These findings suggest that perfectionism and impulsivity may be of potential aetiological 
relevance for eating disorders.  
 The Multidimensional Perfectionism Scale (MPS) developed by Frost et al. (Frost et 
al., 1990) is one of the most widely used instruments to measure perfectionism. This scale 
distinguishes six dimensions of perfectionism, the core three dimensions were moderate to 
substantially heritable (0.29 to 0.42) (Tozzi et al., 2004). The Dickman Impulsivity 
Inventory (DII; (Dickman, 1990) distinguishes two forms of impulsivity (dysfunctional and 
functional). This same distinction was observed in a factor analysis based on the DII, the 
Eysenck Impulsiveness Questionnaire, and the Barrat Impulsiveness Scale in a Flemish 
population (Bastiaens et al., 2003). For the DII scale the highest factor loadings and highest 
internal consistency was observed. A substantial heritability of approximately 45% has 
been estimated for different impulsivity measures (Hur & Bouchard, Jr., 1997; Pedersen et 
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al., 1988; Seroczynski et al., 1999). To obtain perfectionism and impulsivity scores in a 
large random control group, we have selected two items from the Youth Self Report (YSR) 
(Levinson, 2005; Verhulst et al., 1997) questionnaire, to represent these behaviours in the 
current study. 
 Recently we observed an association between tryptophan hydroxylase 2 (TPH2) SNP 
rs1473473 and AN (p=0.04) as well as ED characterized by SV (p=0.03) (Slof-Op 't Landt 
et al., 2011). Trend significant associations were observed for TPH2 rs12231356, 
rs1007023 and rs4760820 (p<0.09). In a subsequent meta-analysis with two additional 
independent case-control populations the association between rs1473473 and both disorders 
(AN p=0.009, SV p=0.01) was replicated. The TPH2 gene encodes tryptophan hydroxylase 
in the brain (Zill et al., 2007). This enzyme catalyses the formation of 5-
hydroxytrypthophan, which is the first and rate-determining step in the biosynthesis of the 
neurotransmitter serotonin. In individuals with long-term recovered AN and BN elevated 5-
hydroxyindoleacetic acid levels in cerebrospinal fluid were detected (Kaye et al., 1991; 
Kaye et al., 1998). This is the major metabolite of serotonin in the brain and body and is 
thought to reflect extracellular serotonin concentrations. This finding thus could be 
indicative of an ‘overactive’ serotonin system in eating disorders, which in turn could be 
caused by an increased function of the TPH2 gene. It has been hypothesized that a 
disturbance of serotonin activity may create a vulnerability for a cluster of symptoms that 
are common to both AN and BN, for example perfectionism and impulsivity/control (Bruce 
et al., 2005; Kaye et al., 1998; Racine et al., 2009; Steiger et al., 2001; Steiger et al., 2004; 
Steiger et al., 2005).  
 In the current study, we investigated whether genetic variation at the TPH2 gene 
explains the overlap between eating disorders, perfectionism and impulsivity, by 
performing three analyses. Firstly, extensive phenotypic analyses were conducted to 
evaluate the association between the perfectionism and impulsivity phenotypes, as 
measured by the MPS and DII, and AN and SV in 324 participants with eating disorders 
from the GenED study and 240 controls without an eating disorder. DNA was not collected 
for this control group. Secondly, to study the involvement of the TPH2 gene in 
perfectionism and impulsivity items (YSR) in the absence of disease, four TPH2 SNPs 
were evaluated in a second control group consisting of random twin-based controls 
(N=512) from the Netherlands Twin Registry (NTR). Thirdly, for the SNPs that showed an 
association with impulsivity or perfectionism in the NTR controls, we tested if this 
association was also present within the participants with eating disorders from the GenED 







This study was approved by the ethics committee of the VU University and by the ethics 
committee for mental health instutions in the Netherlands (METiGG). All participants (and 
if underage, their parents) gave written informed consent. In this study we distinguish three 
groups (Table 6.1): 1. participants with eating disorders from the GenED study, for whom 
extensive perfectionism and impulsivity phenotypes (MPS, DII, and YSR) and DNA was 
available; 2. controls without an eating disorder, fo  whom extensive perfectionism and 
impulsivity phenotypes (MPS and DII) but no DNA was available; 3. random twin-based 
controls from the NTR, for whom less extensive perfectionism and impulsivity phenotypes 
(YSR) and DNA was available. 
 
 The GenED study. 
Female eating disorder patients (N=322) were recruited through 10 specialist eating 
disorder units throughout the Netherlands (the GenED study). DSM-IV eating disorder 
diagnoses were made by experienced clinicians based on a semi-structured interview at 
intake, and by the self-report eating disorder examin tion questionnaire (Fairburn & Beglin, 
1994). Of the 322 participants, 218 fulfilled modified DSM-IV criteria for AN (excluding 
criterion D, amenorrhea). Based on the eating disorer examination questionnaire and 
assessment interviews, we defined a subgroup of partici nts (n=189) who reported regular 
self-induced vomiting (SV). These two groups were partly overlapping, 85 participants 
belonged to both groups, thus the eating disorder group was comprised of 133 independent 
participants with AN, and 104 independent participants with SV.  
 DNA was collected for all the participants of the G nED study. However, TPH2 SNPs 
were only genotyped in part of the participants with eating disorders (as can be seen in 
Table 6.1). For the genetic analyses in the eating disorder group, TPH2 genotype data was 
available for 267 participants with either AN or SV.  
 
 Controls  
A healthy control group was recruited through advertis ments in magazines and via internet 
websites. The questionnaires collected in the GenED study were send to 276 women, 252 
women returned the questionnaire (response rate 91.3%). Twelve women were excluded 
because they reported that they had a current or past eating disorder. A total of 240 women 
without an eating disorder were used in the current study for phenotypic comparison to 
participants with AN and SV. No DNA was collected from these participants.  
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 Netherlands Twin Registry (NTR) controls 
The NTR was established in the late 1980s at the VU University in Amsterdam, the 
Netherlands. Data on the multiples (twins or triplets) and their family members have been 
collected every two to three years in longitudinal survey studies (Bartels et al., 2007; 
Boomsma et al., 2002). Subsamples of the multiples were invited to participate in 
experimental and laboratory studies and provide their DNA (Boomsma et al., 2006). 
Genotype and phenotype data for a total of 512 random unrelated women from the NTR 
were analyzed. 
 












GenED study      
Participants with  
eating disorders  
(AN and/or SV) 322 315 89 89 267 
Controls      
Controls without an 
 eating disorder 240 233 - - - 
Netherlands Twin Registry (NTR)     
Twin-based controls - - 512 484 512 





An overview of measurement instruments available in the participating groups in this study 
is presented in Table 6.1. The Multidimensional Perfectionism Scale (MPS) by Frost (1990) 
is a 36-item questionnaire which distinguishes six dimensions of perfectionism: Concern 
over Mistakes (the negative reaction to mistakes and the tendency to interpret mistakes as 
equivalent to failure), Personal Standards (the settings of high standards and the importance 
placed on these standards for self-evaluation), Parent l Expectations (the believe that one’s 
parents set very high goals), Parental Criticism (the believe that one’s parents are overly 
critical), Doubt about Actions (the tendency to doubt about the ability to accomplish tasks), 
and Organization (the importance and preference for order and organization). Responses 
were given on five point Likert-scales, ranging from ‘strongly disagree’ to ‘strongly agree’. 
The coefficients of internal consistency for the factor scales ranged from 0.77 to 0.93 (Frost 
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et al., 1990). In our control group without eating disorders the internal consistency 
coefficients were comparable and ranged from 0.79 to 0.91. 
 The Dickman Impulsivity Inventory (DII, Dickman, 1990) is a 23-item questionnaire 
with responses in a true/false answer format. This instrument distinguishes two forms of 
impulsivity: Dysfunctional Impulsivity (the tendency to engage in rapid, error-prone 
information processing in situations where this is nonoptimal) and Functional Impulsivity 
(the tendency to engage in rapid, error-prone information processing when such a strategy 
is rendered optimal). The coefficient of internal consistency was 0.85 for the DI subscale 
and 0.74 for the FI subscale (Dickman, 1990). In our controls without eating disorders the 
internal consistency coefficients were 0.75 for the DI subscale and 0.77 for the FI subscale. 
 The Young Adult Self Report (YASR; Achenbach, 1990) and the Youth Self Report 
(YSR; Levinson, 2005; Verhulst et al., 1997) questionnaires belong to the Achenbach 
System of Empirically Based Assessment (ASEBA, www.aseba.org), which provides age 
adjusted instruments to assess similar facets of maladaptive functioning from 1.5 to 90 
years. Responses were given on three point scale, with the code 0 if the item was not true, 1 
for sometimes true, and 2 for often true. For the current study two items (item 32: I feel that 
I have to be perfect, and item 41: I act without stopping to think) from the YSR/YASR 
questionnaire were used to measure perfectionism and impulsivity. 
 For the genetic analyses in the eating disorder group, data from the YSR perfectionism, 
YSR impulsivity, MPS perfectionism and DII impulsivity measures were available to test 
for association with the TPH2 SNPs. 
 
 Genotype measurements 
Genomic DNA was isolated from buccal swabs for the participants with eating disorders 
from the GenED study and for part of the controls from the Netherlands Twin Registry 
(39%), for the remaining 61% of the genotype controls genomic DNA was isolated from 
blood samples. Multiplex genotyping assays were design d using Assay Designer software 
(Sequenom, San Diego, CA). SNPs were genotyped by mass spectrometry (the 
homogeneous MassARRAY system; Sequenom, San Diego, CA) using standard conditions. 
PCR reactions were carried out in a final volume of 5 µl and contained standard reagents 
and 2.5 ng of genomic DNA. Genotypes were assigned by using Genotyper version 3 
software (Sequenom, San Diego, CA).  
 In a previous study (Slof-Op 't Landt et al., 2011), ten TPH2 tagging SNPs were 
selected from HapMap Public Release #19. We observed and replicated an association 
between the minor allele of TPH2 SNP rs1473473 and a higher risk for both AN (OR=1.30, 
95% CI 1.08-1.57, p<0.003) and SV (OR=1.52, 95% CI 1.28-2.04, p<0.006). Furthermore, 
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trend significant associations were observed for three additional TPH2 SNPs in participants 
from the GenED study, rs12231356 was associated with AN (OR=0.59, 95% CI 0.35-1.01, 
p<0.05), rs1007023 (OR=1.40, 95% CI 0.98-2.01, p<0.06) and rs4760820 (OR=0.80, 95% 
CI 0.62-1.04, p<0.09) with SV. In the current study, genotypes for these four SNPs were 
available for 267 participants with eating disorders and 512 controls from the NTR. 
 
Study design 
In the current study we investigated whether genetic variation at the TPH2 gene explains 
the overlap between eating disorders, perfectionism and impulsivity, by performing three 
analyses. In the phenotypic analyses, we tested whether perfectionism and impulsivity, as 
measured by the MPS and DII scales, are different in participants with an eating disorder 
(AN or SV) from the GenED study compared to controls without an eating disorder (see 
Table 6.1). In addition to the MPS and DII scales, the YSR perfectionism and impulsivity 
items were obtained in a subset of the participants with eating disorders (N=89). In these 
participants, we tested the overlap between the diff rent MPS and DII scales and the YSR 
items.  
 In the genetic analyses, we tested whether the four TPH2 SNPs that we found 
previously to be associated to eating disorders (rs1007023, rs4760820, rs1473473, and 
rs12231356; Slof-Op 't Landt et al., 2011) were associated to perfectionism or impulsivity, 
as measured by the YSR items, in the random twin-based control group from the NTR 
(N=512).  
 In the final analyses, we tested whether the TPH2 SNPs, that were associated with 
perfectionism or impulsivity in the NTR controls, also showed such associations in the 
participants with eating disorders from the GenED study. These analyses were performed 
for the YSR items, and the MPS and DII measures that were substantially correlated to 
these items.  
 
Statistical Analyses 
Data from the MPS and DII scales were tested for normality. Natural logarithm 
transformations were calculated for nonnormally distributed data. ANOVA’s were 
performed to calculate the differences between the participants without eating disorders and 
the participants with eating disorders (AN, SV, and the combined group), and to compare 
the two independent eating disorder groups (AN and SV) with each other.  
 The overlap between the YSR perfectionism and impulsivity items and the subscales of 
the MPS and DII in a subset of the participants with eating disorders (N=89) was evaluated 
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by calculating Pearson correlations. The MPS and/or DII scales that were correlated (above 
0.5) to the YSR perfectionism or impulsivity item were used in the final genetic analyses.  
 In the two genetic analyses, Pearson’s Chi-Square st tistics were calculated to compare 
response frequencies of perfectionism and impulsivity between carriers and non-carriers of 
the minor allele of the TPH2 SNPs, and between the different TPH2 genotypes. In the NTR 
controls these analyses were performed for the YSR items, whereas the YSR items, the 
MPS and the DII subscales were tested in the participants from the GenED study. All 





The controls without eating disorders (N=240) were on average four years older (mean 
age=31.7, SD=11.3) than the participants with AN (mean age=27.1, SD=9.4), and with SV 
(mean age=27.8, SD=9.8). As expected, the BMI was significantly different between the 
controls (mean BMI=22.4, SD=3.4) and the participants with AN (mean BMI=16.6, 
SD=2.9). Within the control group a significant effect for age on the perfectionism scales 
Personal Standards and Parental Criticism was observed, therefore the subsequent case-
control analyses were adjusted for age.  
 As can be seen in Table 6.2, the participants witheating disorders scored significantly 
higher on all perfectionism scales and the Dysfunctio al Impulsivity scale (except for 
participants with AN), whereas the score on Functioal Impulsivity was significantly lower 
in participants with eating disorders (p-values ranging from 0.003 to 5.8 x 10-50). Within the 
eating disorder group, the participants with AN scored significantly higher than the 
participants with SV on the perfectionism scales Personal Standards (t(232)=3.063, p<0.01) 
and Organization (t(234)=3.882, p<0.01). Dysfunctional Impulsivity scores, on the other 
hand, were significantly higher in the participants with SV (t(232)=-3.923, p<0.01). When 
performing nonparametric tests instead of applying natural log-transformations identical 
results were observed (data not shown). 
 As expected the participants with eating disorders scored extremely different on the 
perfectionism and impulsivity scales compared to the controls without an eating disorder. 
Because the differences between participants with AN and with SV were minimal, and the 
scores in comparison to the controls went in the same direction, the combined AN/SV 
group was used in the subsequent genetic analyses. 
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Table 6.2. Comparison of MPS and DII scales between Co trols and independent AN, independent SV, AN and/or 
SV combined 
 Controls AN p SV p AN / SV p 
 (N=240) (N=133)  (N=104)  (N=322)  
 Mean (SD) Mean (SD)  Mean (SD)  Mean (SD)  
MPS:        
CM  15.7 (6.2) 30.9 (9.0) ** 28.6 (9.5) ** 30.4 (9.1) ** 
PS1  17.2 (6.0) 26.8 (5.7) ** 24.6 (7.2) ** 26.0 (6.5) ** 
PE  7.3 (3.4) 9.5 (5.1) * 9.3 (4.7) * 9.5 (4.9) ** 
PC1  5.4 (2.7) 8.1 (4.2) ** 8.4 (4.4) ** 8.4 (4.4) ** 
DA  7.2 (3.1) 13.0 (4.0) ** 12.5 (4.6) ** 13.1 (4.1) ** 
O  19.5 (5.2) 24.4 (5.3) ** 21.6 (5.6) * 23.4 (5.6) ** 
DII:        
FI  6.6 (2.7) 3.7 (2.8) ** 4.2 (2.8) ** 3.8 (2.8) ** 
DI  1.8 (2.2) 2.3 (2.8) N.S. 3.7 (3.5) * 3.0 (3.2) * 
MPS=Multidimensional Perfectionism Scale: CM=Concer over Mistakes; PS=Personal Standards; PE=Parental 
Expectations; PC=Parental Criticism; DA=Doubt about Actions; O=Organization. DII=Dickman Impulsivity 
Inventory: FI=Functional Impulsivity; DI=Dysfunctional Impulsivity. 
1 Analyses in PC and PS corrected for age 
* p < 5 x 10-4 
** p < 5 x 10-10 
 
 The two YSR items measuring perfectionism and impulsivity were also present in a 
subset of the eating disorder group (N=89). Table 6.3 presents the Pearson’s correlations 
between the different MPS and DII scales and the YSR items. For the YSR perfectionism 
item the highest correlation was observed with the MPS scales Concern over Mistakes 
(r=0.53) and Personal Standards (r=0.51). The correlation between the YSR impulsivity 
item and the Dysfunctional Impulsivity scale of theDII was 0.61. 
 
Table 6.3 Pearson correlations between YSR items and MPS and DII scales in participants with eating disorders 
(N=89) 
 MPS  DII 
YSR-item CM PS PE PC DA O  FI DI 
Perfectionism 0.53** 0.51** 0.01 0.05 0.38** 0.21*    
Impulsivity        0.01 0.61** 
MPS=Multidimensional Perfectionism Scale: CM=Concer over Mistakes; PS=Personal Standards; PE=Parental 
Expectations; PC=Parental Criticism; DA=Doubt about Actions; O=Organization. DII=Dickman Impulsivity 
Inventory: FI=Functional Impulsivity; DI=Dysfunctional Impulsivity. 
** Correlation is significant at the 0.01 level (2-tailed) 
* Correlation is significant at the 0.05 level (2-tailed) 
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Genetic analyses in twin-based controls 
The NTR control group had a mean age of 29.3 (SD=14.3) and a mean BMI of 22.9 
(SD=4.1). For the YSR perfectionism response frequencies were 47.7% score 0, 41.6% 
score 1, and 9.3% score 2. The response frequencies for the YSR impulsivity item were 
45.9% score 0, 49.6% score 1, and 4.5% score 2. Becaus  less than five percent of the 
controls reported an impulsivity-score of 2, the responses were merged into two answer 
categories (absent/present, Impulsivity 1 / 2). 
 In Table 6.4 the genotype counts and minor allele fr quencies of the four TPH2 SNPs 
are shown per perfectionism category. As a comparison the MAF in participants with AN 
and/or SV are also listed in this table.  
 
Table 6.4 Genotype counts and minor allele frequencies (MAF) for the four TPH2 SNPs per perfectionism 
category within a control sample (as reference MAF in combined AN/SV group are included) 
  Rs1007023 Rs476820 Rs1473473 Rs12213156 
Perfectionism 0 Genotype 11 (n) 200 77 187 203 
(N=244) Genotype 12 (n) 34 126 43 39 
 Genotype 22 (n) 10 37 10 1 
 MAF 0.11 0.42 0.13 0.08 
Perfectionism 1 Genotype 11 (n) 154 72 150 178 
(N=213) Genotype 12 (n) 54 101 55 33 
 Genotype 22 (n) 4 38 5 2 
 MAF 0.15 0.42 0.16 0.09 
Perfectionism 2 Genotype 11 (n) 10 14 43 50 
(N=55) Genotype 12 (n) 4 28 11 5 
 Genotype 22 (n) 1 13 1 0 
 MAF 0.12 0.49 0.12 0.05 
Association Geno p 0.02 0.51 0.21 0.61 
 Allele p 0.26 0.34 0.47 0.35 
AN/SV (N=267) MAF 0.15 0.39 0.19 0.06 
 
 For rs1007023 a significant difference in genotype frequency was observed between 
the three perfectionism categories. However, no allelic association was observed and the 
genotypic effect appeared to be due to a higher frequency of heterozygotes in the ‘middle 
perfectionism’ category compared to lower frequencis of heterozygotes in both the ‘no 
perfectionism’ and ‘high perfectionism’ group, and is not considered robust.  
 For impulsivity (Table 6.5) two SNPs showed a signif cant association. Both genotypic 
and allelic associations were observed for rs1007023. The minor allele of this SNP was 
more frequent in impulsive controls compared to nonimpulsive controls (OR=1.60, 95% CI 
1.08-2.36, p=0.02). Furthermore, the minor allele of rs1473473 was also more frequent in 
the impulsive controls (OR=1.49, 95% CI 1.02-2.17, p=0.04) compared to the non-
impulsive controls. The linkage disequilibrium (LD) between the two TPH2 SNPs was high 
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(D’= 0.95, r2=0.74), therefore haplotype analyses with these SNPs were performed in New 
Thesias (http://ecgene.net/genecanvas/uploads/THESIAS3.1). The combined haplotype of 
the minor alleles was significantly more frequent in he impulsive controls compared to the 
non-impulsive controls (OR=1.58, 95% CI 1.05-2.37, p=0.03).  
 
Table 6.5 Genotype counts and minor allele frequencies (MAF) for the four TPH2 SNPs per impulsivity category 
within a control sample (as reference MAF in combined AN/SV group are included) 
  Rs1007023 Rs476820 Rs1473473 Rs12213156 
Impulsivity 0 Genotype 11 (n) 179 66 172 188 
(N=222) Genotype 12 (n) 41 117 42 33 
 Genotype 22 (n) 2 37 4 1 
 MAF 0.10 0.43 0.12 0.08 
Impulsivity 1 / 2 Genotype 11 (n) 195 90 187 221 
(N=262) Genotype 12 (n) 54 125 62 39 
 Genotype 22 (n) 13 43 11 2 
 MAF 0.15 0.41 0.16 0.08 
Association Geno p 0.03 0.50 0.13 0.91 
 Allele p 0.02 0.43 0.04 0.85 
AN/SV (N=267) MAF 0.15 0.39 0.19 0.06 
 
Genetic analysis in participants with an eating disorder 
The YSR impulsivity item and TPH2 genotypes were available for 79 participants with AN 
and/or SV. The reported frequencies for YSR impulsivity were 34.2% score 0, 50.6% score 
1, and 15.2% score 2. In accordance with the NTR controls, the responses on the YSR 
impulsivity item were merged into two answer categories (absent/present, Impulsivity 1 / 
2). In the eating disorder group the minor alleles of both rs1007023 and rs1473473 
appeared to be more frequent in the impulsive participants compared to the non-impulsive 
participants (14.8% vs 25.0%), although this effect did not reach significance (OR=1.97, 
95% CI 0.80-4.59, p=0.14).  
 In the final analyses, it was evaluated whether th TPH2 SNPs rs1007023 and 
rs1473473 were also associated to the Dysfunctional Impulsivity scale in the eating 
disorder group. The responses on this impulsivity scale were also merged into two answer 
categories, 31% of the participants reported that impulsivity was absent whereas 69% 
reported that impulsivity was present. The minor alleles of both rs1007023 and rs1473473 
were more frequent in the impulsive participants compared to the non-impulsive 
participants (rs1007023: 10.6% vs 17.5%, OR=1.79 95% CI 1.01-3.17, p=0.05; rs1473473: 
13.1% vs 21.6%, OR=1.83, 95% CI 1.08-3.08, p=0.02). The combined haplotype of the 
minor alleles was significantly more frequent in the impulsive participants with eating 




Because the LD structure among the TPH2 SNPs was not independent, adjusting the p-
value for the actual number of tests would be overly stringent. An interface developed by 
Nyholt (2004; http://genepi.qimr.edu.au/general/daleN/SNPSpD/); was used to determine 
experiment-wide significant p-values for the analyses in the control women (p<0.017), and 
the ED patients (p<0.041). Thus, the association between impulsivity and rs1007023 in the 
control women (p=0.018) came close to significance, while the associati n between 





In the current study it was shown that perfectionism and impulsivity are related to AN and 
SV. Because the hypothesis of the study was based upon the assumed relation between 
these features and eating disorders (Cassin & von Ranson, 2005), we first confirmed this 
association in a sample consisting of 324 participants with eating disorders and 240 controls 
without an eating disorder. To study the involvement of TPH2 in perfectionism or 
impulsivity in the absence of disease, the relation between the TPH2 SNPs and a 
perfectionism and impulsivity item was subsequently evaluated in a random twin-based 
control group. It was shown that the TPH2 SNP rs1473473 that was associated with a 
higher risk of both AN as well as SV previously (Slof-Op 't Landt et al., 2011), was 
associated with higher impulsivity in the controls (OR =1.49, 95% CI 1.02-2.17, p=0.04). 
In addition, the nearby located rs1007023 showed an eve  stronger association with higher 
impulsivity (OR=1.60, 95% CI 1.08-2.36, p=0.02). In our previous study, a trend 
association was observed between this SNP and a higher risk of SV, although this 
association could not be replicated in two additional case-control samples. Finally, in the 
combined AN/SV group an association between Dysfunctio al Impulsivity (DII) and TPH2 
rs1007023 (OR=1.79, 95% CI 1.01-3.17, p=0.05) and rs1473473 (OR=1.83, 95% CI 1.08-
3.08, p=0.02) was observed.  
 The observed significant difference between participants with AN and participants with 
SV in the perfectionism scales Personal Standards an  Organization, and in the 
Dysfunctional Impulsivity scale was in accordance with the study by Reba et al. (2005). 
They also reported that individuals with eating disorders who endorse vomiting scored 
lower on the Personal Standards and Organization scales of the MPS compared to 
participants who do not vomit. Furthermore, both Reba t al. (2005) and Dalle Grave et al. 
(2009) have shown significantly higher scores on the Temperament and Character 
Inventory scale Novelty Seeking in individuals who endorse vomiting compared to those 
TPH2 gene influences impulsivity 
104 
without vomiting or purging. Impulsivity is also measured as a subscale of the Novelty 
Seeking scale (Cloninger et al., 1993). Whiteside et al. (2001) showed that this Impulsivity 
subscale of the Temperament and Character Inventory loads on the same underlying factor 
as the Dysfunctional Impulsivity scale, suggesting hat these scales measure the same 
underlying construct.  
 The haplotype analyses revealed that the association between impulsivity and the 
combined haplotype of rs1007023 and rs1437473 was not tronger than the effect observed 
for rs1007023 alone in the controls. In the participants with eating disorders however, the 
association between the combined haplotype was stronge  than the effect observed for both 
SNPs separately. It appears that the presence of an eating disorder influences the 
association between TPH2 and impulsivity. However, the difference could also be caused 
by the difference in measurement instrument used. Dspite the considerable correlation 
between the YSR impulsivity item and the Dysfunctional Impulsivity scale, these scales 
might not measure the same underlying construct. Another possibility is that both 
rs1007023 and rs1437473 are in LD with a third genetic variant that underlies the 
associations with eating disorders and impulsivity.  
 It is interesting that rs1473473, a TPH2 SNP associated to both AN and SV (Slof-Op 't 
Landt et al., 2011), was linked to impulsivity in healthy controls and individuals with eating 
disorders, while the results in Table 6.2 indicate that Dysfunctional Impulsivity scores in 
AN did not differ from healthy controls. This might be explained by the relatively small 
sample sizes. The association between AN and Dysfunctional Impulsivity may have been 
small, hence there was insufficient power to detect this effect.  
 Impulsivity has been linked to alterations in serotonin activity in both non-clinical 
populations and in eating disordered groups (Bruce et al., 2005; Racine et al., 2009; Steiger 
et al., 2001; Steiger et al., 2004; Steiger et al., 2005). In addition, trend significant (p<0.07) 
associations were observed between three other TPH2 SNPs (rs1352250, rs10879352, and 
rs1487275) and cognitive impulsivity in children with ADHD (Oades et al., 2008). There is 
substantial LD between these SNPs and rs1007023 and rs1473473, D’ ranges from 0.9 to 
1.0 and r2 is between 0.21 and 0.46. Furthermore, genetic varation at the TPH2 gene have 
been associated with suicide attempts (Yoon & Kim, 2009; Zhou et al., 2005; Zill et al., 
2004), response inhibition (Stoltenberg et al., 2006), behaviors that are linked to 
impulsivity (Congdon & Canli, 2008). Indicating that genetic variation at this locus may 
contribute to mental conditions characterized by impulsivity like SV.  
  The current study has several limitations. First, with the present study design we could 
not test whether the association between impulsivity and TPH2 was underlying the 
previously reported association between eating disor ers and TPH2. Because YSR 
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impulsivity was only measured in a small subset of the participants with eating disorders, 
we did not have sufficient power to adjust the previous case-control association analyses 
with impulsivity scores. Another approach to determine a causal relation is to evaluate, in a 
longitudinal prospective design, whether carriers of the minor alleles of rs1007023 and 
rs1473473 who are impulsive will also develop an eating disorder more frequently than 
non-carriers or non-impulsive carriers. As mentioned above, there was a difference in 
measurement instruments used in the twin-based controls from the NTR and the 
participants with eating disorders from the GenED study. Because we were not able to 
collect DNA from the healthy control group used in the phenotypic analyses, we could not 
evaluate whether an association with Dysfunctional Impulsivity was also present in controls 
without an eating disorder, which is subject for further research. Finally, sample sizes of the 
eating disorder groups were modest. Hence, we might have missed associations due to 
suboptimal statistical power. 
 In the present study we have reported that two of the previously identified 
susceptibility SNPs for eating disorders in TPH2 showed an association with impulsivity in 
a twin-based control group. Carriers of the minor alleles of rs1473473 and rs1007023 did 
not only have a higher risk for SV and/or AN, but were also more prone to higher 
impulsivity. Interestingly, these same two SNPs were also associated with high impulsivity 
in individuals with eating disorders. Genetic variation at the TPH2 gene thus appears to 
affect impulsivity which in turn might predispose to the AN and or SV phenotype. In future 











Eating disorders have a debilitating effect on the liv s of people who suffer from these 
disorders, and the people surrounding them. The mortality rate is considerable and the 
prognosis is poor. Relapse rates are high, and after four to ten years of follow-up a 
substantial part of the patients has not recovered (Crow et al., 2009; Harris & Barraclough, 
1998; Nielsen et al., 1998; Papadopoulos et al., 2009; Steinhausen, 2002; Steinhausen & 
Weber, 2009; Sullivan, 1995). Eating disorders have a large heritable component, and 
identification of susceptibility genes underlying these disorders will clarify which 
pathophysiologic mechanisms and pathways contribute to their aetiology. In the future, 
knowledge regarding the genetic aetiologies may open pathways for novel drug targets, 
enhance treatment and improve prevention. Also, an increase in knowledge regarding the 
extent to which disorders are influenced by genetic vulnerability may help to decrease the 
stigma associated with such disorders (Klump et al., 2009).  
 However, it is clear that the genetics of eating disorders is still in an early phase. 
Despite the fact that since the publication of our review (chapter 2) several twin (Bulik et 
al., 2006; Bulik et al., 2010) and a multitude of molecular genetic studies have been 
performed (see Appendix B and C), the conclusions regarding those studies remain the 
same. Studies have mainly been characterized by small ample sizes, inadequate statistical 
power and the use of diagnostic categories for phenotype assessment.  
 In the series of genetic studies described in this the is, I tried to improve issues such as 
study design, use of phenotypes, phenotype measurements, choice of candidate genes, and 





Figure 7.1 summarizes the design of the novel study described in this thesis. There were 
three groups of participants who took part in different phases of the study: 
 
1. participants from the Genetics of Eating Disorder (GenED) study, this study was initiated 
as part of this thesis to collect DSM-IV eating disorder diagnoses, DNA and extensive 
phenotype information from a large group of participants with an eating disorder 
throughout the Netherlands;  
2. population-based sample of twins and family membrs from the Netherlands Twin 
Registry (NTR); and  





Figure 7.1 Study design used in this thesis 
 
 This design can be used for heritability studies (in group 2) and genetic association 
studies (in groups 1 and 2). Elaborate phenotype data were collected for the different 
groups by administering questionnaires and interviews. Therefore, it was not only possible 
to examine the genetics of DSM-IV eating disorder diagnoses, but also of related traits and 
possible endophenotypes like perfectionism and impulsivity (Bulik et al., 2007a).  
 
Heritability of disordered eating behaviour  
 
In the adolescent twins from the NTR, the Disordere Eating Behavior (DEB) scale was 
devised and used instead of categorical DSM-IV (1994) eating disorder diagnoses. To 
enhance the statistical power, an extended twin design including an additional sibling per 
family was applied. In addition, the psychometric quality of the DEB-scale was evaluated 
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by testing for measurement invariance with respect to sex (chapter 3), before performing 
the bivariate genetic analysis. In both adolescent men and women the different disordered 
eating behaviors and attitudes measured by the DEB-scale were explained by one 
underlying factor. This is in line with the overlap nd the hypothesized shared liability 
between the different eating disorders. The requirements of complete measurement 
invariance with respect to sex could not be met for he DEB-scale. Thus scores on the DEB-
scale cannot be taken to represent exactly the sameunderlying trait in men and women. As 
a consequence the genetic analysis described in chapter 4 were performed separately in men 
and women. We were the first to evaluate complete measurement invariance in the eating 
disorder field. Thus, despite the fact that sum scores n eating disorder scales are used 
widely to compare for example men and women, eating d sorder cases and controls, or 
different age and ethnic groups, measurement invariance was never established for any of 
these grouping variables. In other words, reported similarities and differences between 
these groups could be a consequence of measurement bias instead of a genuine resemblance 
or difference in the underlying trait.  
 Genetic bivariate analyses as presented in chapter 4 showed that genetic factors 
explained a considerable part of the variance in disor ered eating behavior (DEB). 
Heritability estimates for DEB were 0.65 in women and 0.39 in men. BMI was highly 
heritable in women (heritability =0.80) and men (heritability =0.76). In addition, additive 
genetic factors were responsible for the total overlap between the two characteristics, 
yielding a genetic correlation of 0.43 in women and 0.51 in men. Despite the overlap 
between BMI and DEB, a large part of the genetic influences on DEB was due to genetic 
effects that are independent of BMI in women as well as men. The heritability estimates for 
DEB are in line with the heritability estimates previously reported for eating disorders and 
eating disorder symptoms (ranging from 7 to 83%, see chapter 1). 
 The four DEB items are related to body weight, andin general body weight appears to 
be a risk factor for the development of eating disorders, especially bulimia nervosa (Jacobi 
et al., 2004). Therefore it is noteworthy that the genetic influence on DEB was largely 
independent of BMI, indicating that there are genes i volved in DEB that do not seem to 
have an effect on body weight. On the other hand, part of the genetic factors that influence 
BMI also influence DEB. It would be interesting to disentangle the direction of causation of 
the overlap between these characteristics. Genetic i fluences on for example metabolism 
may be causal to weight gain that eventually leads to disturbed eating behavior. Genetic 
influences on DEB may alternatively be causal to a disturbed eating profile, leading to 
fluctuations in weight. Several approaches can be tak n to disentangle the direction of 
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causation, for example phenotypic causation models (Duffy & Martin, 1994; Heath et al., 
1993) and the co-twin control design (Cederlof et al., 1977; Kendler et al., 1993).  
 A concern with regard to the four item DEB-scale is that it might not be ideal to 
measure the underlying latent trait in eating disorders. However, in large epidemiological 
studies such as becoming common for gene finding, short cales might be a requirement to 
obtain phenotyping in sufficiently large samples. With the selection of the items we have 
tried to capture a variety of eating disorder symptoms. Three of the items (fear of weight 
gain, importance of body weight and shape for self-evaluation and binge eating) used in this 
study are based on eating disorder criteria from the DSM-IV. The fourth item (dieting) has 
been identified as a potent risk factor (Jacobi et al., 2004). One eating disorder symptom, 
compensatory behavior, is missing in our assessment instrument. Since heritability 
estimates for compensatory behavior and self-induce vomiting in female twins (0.50-0.70) 
were comparable to the estimate for DEB (Klump et al., 2000; Sullivan et al., 1998a), the 
inclusion of compensatory behaviors in our phenotype might not influence the results found 
for the women in the current study. However, we do not know what the consequences for 
the heritability estimates in the men would be, especially since significant gender 
differences have been reported for a variety of compensatory behaviors like self-induced 
vomiting, laxative use and fasting (Anderson & Bulik, 2004). 
 
Genetic association study 
 
In a two step design, the association between four candidate genes and eating disorders was 
investigated in chapter 5. Eating disorders included anorexia nervosa (AN) as well as eating 
disorders characterized by self-induced vomiting (SV). The four candidate genes were 
serotonin receptor 1D (HTR1D), stathmin (STMN1), brain-derived neurotrophic factor 
(BDNF) and tryptophan hydroxylase 2 (TPH2). To replicate previous results in ED, genes 
were selected for which association was observed and co firmed in studies with an 
adequate sample size (as discussed in Chapter 2). Both HTR1D and BDNF fulfilled these 
criteria (Bergen et al., 2003; Brown et al., 2006; Ribases et al., 2004; Ribases et al., 2005). 
Besides replication of previous results, we also aimed to evaluate the involvement of two 
unexplored candidate genes for ED. STMN1 was located under the linkage peak of 
restrictive AN (1p33-36) (Grice et al., 2002). Because the associations with HTR1D and 
Opioid Receptor Delta-1 (genes located under the same peak) only explained part of the 
linkage, it was expected that additional candidate genes could underlie the linkage peak 
(Bergen et al., 2003). TPH2 was selected because of the link between serotonin and eating 
disorders (Kaye, 2008; Lucki, 1998). To overcome the drawbacks of previous association 
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studies in which candidate genes were tested by single SNPs , 25 tagging SNPs were 
selected based on HapMap to capture the majority of the common variation within the four 
candidate genes. Between 71 and 91% of common variation within the four genes was 
captured by the tagging SNPs. In addition, replication of association was performed in two 
additional independent case-control samples from the Netherlands and Germany, making 
this one of the largest association studies performed thus far with 887 AN cases, 306 SV 
cases and 1914 controls. 
 In the first step allele frequencies of the 25 SNPs were compared between the GenED 
case groups (AN and SV cases) and random controls from the NTR. No association was 
observed for any of the BDNF, HTR1D and STMN1 SNPs. A nominal significant 
association (p<0.05) was observed for TPH2 rs1473473 in AN as well as SV. Subsequently 
this association was replicated in a meta-analysis with two additional independent eating 
disorder case-control samples. In the meta-analysis, the minor allele of TPH2 SNP 
rs1473473 was significantly more frequent in AN cases (OR=1.25, 95% CI 1.06-1.47, 
p<0.009) and SV cases (OR=1.34, 95% CI 1.06-1.69, p=0.013) compared to controls. We 
are the first to observe an association with a genetic variant in the TPH2 gene and eating 
disorders.  
 The TPH2 gene encodes the main rate-determining enzyme in the synthesis of 
serotonin in the brain (Zill et al., 2007). Serotonin is involved in satiety, anxious and 
obsessional behavior, mood, and impulse control, featur s all linked to eating disorders 
(Kaye, 2008; Lucki, 1998). In long-term recovered AN and bulimia nervosa (BN) patients 
elevated 5-hydroxyindoleacetic acid levels in cerebrospinal fluid were detected (Kaye et al., 
1991; Kaye et al., 1998). This is the major metabolite f serotonin in the brain and body 
and is thought to reflect extracellular serotonin co centrations. This finding thus could be 
indicative of an ‘overactive’ serotonin system in eating disorders, which in turn could be 
caused by an increased function of the TPH2 gene. 
 The TPH2 gene was also one of 182 candidate genes that were investigated for 
association with AN in another large collaborative study (Pinheiro et al., 2010). In this 
study 5151 SNPs (43 SNPs within the TPH2 gene) were evaluated in 1085 participants with 
AN and 677 controls. After accounting for multiple testing, there were no statistically 
significant associations for any individual SNP. Noassociation was found between the 
measured TPH2 SNPs and AN, but rs1473473 was not genotyped in this s udy. The extent 
of the linkage disequilibrium between rs1473473 andthe genotyped SNPs is not known, a 
small linkage disequilibrium could explain why the association with TPH2 was not found 
in this study. 
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 The LD block that TPH2 rs1473473 tags spans across part of the TPH2 gene, and is 
ended by a recombination hotspot on one side. Therefor  it is highly likely that this SNP is 
in LD with a functionally relevant variant(s) in the TPH2 gene. Rs1473473 is not in LD 
with known TPH2 mutations (Haavik et al., 2008). TPH2 SNPs in LD with rs1473473 
however, have been associated with a suicidal mental condition in Finnish men (Zhou et al., 
2005), with antidepressant response in depressive pati nts (Peters et al., 2004), and with 
allelic mRNA expression imbalance in sections of the human pons (Lim et al., 2007), 
indicating that genetic variation at this locus may contribute to mental conditions and could 
influence gene function.  
 To find yet unidentified functionally relevant vari nts with an effect in eating 
disorders, the TPH2 gene could be sequenced in eating disorder cases and family members, 
for example by exon resequencing to detect rare or low frequency variants of medium 
effect (Gloyn & McCarthy, 2010; Johansen et al., 2010). Since a multitude of genes belong 
to the serotonin pathway, measuring the presence and activity of serotonin either in blood 
or in cerebrospinal fluid will probably not be a good representation of the TPH2 gene per se 
(Kaye et al., 1998; Savelieva et al., 2008). A reliable way to evaluate the activity of the 
TPH2 gene is by measuring mRNA expression levels in the brain (Lim et al., 2007). A 
difficulty of this approach is that brain tissue is required. When investigating gene 
expression in eating disorders it is important to differentiate between the secondary effects 
of malnutrition (for example due to fasting in AN) from effects of the disorder itself. The 
inclusion of a recovered eating disorder group in these studies therefore seems to be a 
prerequisite, which makes this approach even more difficult. Translational models might 
offer a solution for this problem. 
 Previously, a full phenotypic evaluation of the TPH2 knock-out mouse was performed 
(Savelieva et al., 2008). The mice appeared largely normal both in appearance as well as 
behavior. In general the results indicated that the rol  of serotonin appears to be modulatory 
instead of essential in behavior. However, the results of one behavioral test suggested 
increased obsessive/compulsive behavior in the TPH2 knock-out mice. This is an 
interesting finding, since a substantial comorbidity between eating disorders and obsessive-
compulsive disorder is present (Bulik et al., 1997; Lilenfeld et al., 1998).  
 This is the first genetic study that used SV as a phenotype. This phenotype was chosen 
because there is no a priori reason to believe that a DSM eating disorder diagnosis 
represents a more ‘genetic’ syndrome than underlying core behaviors or traits. Twin studies 
have shown that binge-eating and vomiting represent more genetically mediated symptoms 
(heritability estimates ranging between 8 and 80), while genetic factors did not appear to 
have any effect (heritability estimate of 0) on theundue influence of weight and shape on 
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self-evaluation represents (Bulik et al., 1998; Reichborn-Kjennerud et al., 2003; Reichborn-
Kjennerud et al., 2004b; Reichborn-Kjennerud et al., 2004a; Sullivan et al., 1998a; Wade et 
al., 2008b; Wade & Bulik, 2007). Because the reliability of the measurement of SV is high 
and the heritability of this behaviour is higher, as opposed to binge eating, it was decided to 
select cases based on this core behaviour in the study described in chapter 5 (Sullivan et al., 
1998a; Wade et al., 2000a).  
 The selection of candidate genes in chapter 5 repres nts a choice from a larger set of 
possibilities. Another plausible candidate gene would have been Opioid Receptor Delta-1, 
since association with this gene was also observed and confirmed in two large studies 
(Bergen et al., 2003; Brown et al., 2006). This wasnot the case for the genes encoding 
Serotonin Receptor 2A and the Serotonin Transporter, which have been studied most 
intensively in eating disorders (see Table 1.4). Of course many alternatives exist for the 
novel candidate genes STMN1 and TPH2 that were currently selected. However, with the 
sample sizes of the current study design (Figure 7.1) only a few candidate genes could be 
evaluated with a good coverage rate while retaining adequate statistical power.  
 Despite this selection, the statistical power in the GenED study was limited. Depending 
on the minor allele frequency the study had adequate power (85% power at an alpha level 
of 0.05, log-additive or allelic model) to detect effects sizes ranging between 1.45 and 1.8 
for AN and ranging between 1.48 and 1.85 for SV. This could explain why previously 
reported associations between BDNF, HTR1D and AN were not observed in this study 
(Bergen et al., 2003; Brown et al., 2006; Ribases et al., 2004; Ribases et al., 2005). The 
meta-analysis of TPH2 rs1473473 had adequate power (85% power at an alpha level of 
0.05, log-additive or allelic model) to detect effect sizes of at least 1.25 for AN and 1.4 for 
SV. This approach has led to a robust association of the TPH2 SNP rs1473473.  
 Performing candidate gene studies is an outdated appro ch to identify susceptibility 
genes for eating disorders. However, at the time that this study was designed it was the 
available method for performing this kind of research. Since the aetiology of eating 
disorders is largely unknown, genomewide association studies are more appropriate for 
finding candidate genes in these disorders. These studie  rely on the assumption that 
linkage disequilibrium enables one SNP to act as a surrogate marker for association to other 
sequence variants in the same region (Freimer & Sabatti, 2007). Currently the Genetic 
Consortium of Anorexia Nervosa is conducting a genomewide association study in a large 
group of female participants who meet DSM-IV criteria for AN and a group of female 
controls, all of European ancestry. The GenED study also takes part in this consortium. 
Although this is a huge step forward in identifying plausible candidate genes, the 
heterogeneity of eating disorders, including AN, should be kept in mind. Substantial 
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differences in genetic and environmental contributions to component symptoms of AN 
suggests that we may be obscuring our ability to deect loci that contribute to risk by 
focusing on a contrived and heterogeneous condition. Incorporating additional phenotypes 
within this study might lead to interesting findings, although the multiple testing issue 
should be taken into account. Additional phenotypes can be core symptoms of eating 
disorders, like binge eating and SV, but also personality features associated to eating 
disorders, like perfectionism and impulsivity. 
 
The link between TPH2 and personality features 
 
The substantial heritability of AN and SV may in part be explained by heritable aspects of 
perfectionism and impulsivity, which are consistently associated to eating disorders (Cassin 
& von Ranson, 2005). Both perfectionism and impulsivity remained present after 
recovering from an eating disorder (Bastiani et al., 1995; Kaye et al., 1998; Lilenfeld et al., 
2000; Srinivasagam et al., 1995; Wagner et al., 2006). In addition, elevated levels of 
perfectionism were observed in relatives of individuals with AN and BN (Lilenfeld et al., 
2000; Woodside et al., 2002). These findings suggest that perfectionism and impulsivity 
may be of potential aetiological relevance for eating disorders.  
 Chapter 6 explored the hypothesis that genetic variation in the TPH2 gene explains part 
of the overlap between eating disorders, perfectionism and impulsivity. In the phenotypic 
analyses, earlier observations that patients with AN and/or SV score different from healthy 
controls on perfectionism and impulsivity, as measured by the Multidimensional 
Perfectionism Scale (Frost et al., 1990) and the Dickman Impulsivity Inventory (Dickman, 
1990) were confirmed. To study the involvement of four TPH2 SNPs, that were associated 
to AN or SV previously (chapter 5), in perfectionism and/or impulsivity in the general 
population, genetic association analyses were performed in a random twin-based control 
group (N=512) with perfectionism and impulsivity items from the Youth Self-Report 
(Levinson, 2005; Verhulst et al., 1997). The minor allele of rs1473473 (OR =1.49, 95% CI 
1.02-2.17, p=0.04) and rs1007023 (OR=1.60, 95% CI 1.08-2.36, p=0.02) were more 
frequent in impulsive controls. In the eating disorder case group (N=267), an association to 
Dysfunctional Impulsivity, a subscale from the Dickman Impulsivity Inventory, was 
observed for both rs1007023 (OR=1.79, 95% CI 1.01-3.17, p=0.05) and rs1473473 
(OR=1.83, 95% CI 1.08-3.08, p=0.02). The degree of perfectionism was not associated to 






Figure 7.2 The link between TPH2, impulsivity and eating disorders. The observed associations between TPH2 
and impulsivity (chapter 6), TPH2 and eating disorders (chapter 5), impulsivity and eating disorders (chapter 6), 
and perfectionism and eating disorders (chapter 6) a e depicted with the arrows. The TPH2 gene leads to higher 
impulsivity which in turn might make people more susceptible for an eating disorder. An alternative explanation, a 
third factor that is affected by TPH2, and which in turn influences both impulsivity and eating disorders is 
presented by the dashed arrows. 
 
 In Figure 7.2 the results from the analyses are summarized. Both impulsivity and 
perfectionism were associated to eating disorders. TPH2 showed an association with eating 
disorders (AN and SV) and with impulsivity. Possibly there is a causal relation, thus that 
genetic variation at the TPH2 gene leads to higher impulsivity which in turn will make 
people more susceptible for developing an eating disor er. Another explanation is that 
TPH2 affects another unknown factor, which influencs both impulsivity and eating 
disorders. To evaluate whether the association between TPH2 and impulsivity is underlying 
the association with eating disorders a longitudinal prospective study design (following up 







p < 0.02–0.05 
 
p < 0.001 
OR: 1.25-1.34 
p < 0.009 – 0.013 
p < 5 x 10-10  
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the low prevalence of eating disorders and the complex nature, it will be difficult to conduct 
this study. To overcome this, a more prevalent intermediate phenotype, for example DEB 
discussed in chapter 3 and 4, could be used. Another approach to test for causality is by 
adjusting the case-control association analysis for the impulsivity phenotype. Because the 
Youth Self Report impulsivity item was only measured in a small subset of the eating 
disorders cases, we did not have sufficient power to adjust the previous case-control 
association analyses with impulsivity scores.  
 In addition to perfectionism and impulsivity, there are other established risk factors for 
eating disorders that might predispose to their development, like negative self-
evaluation/low self-esteem, negative body image and weight concerns (Jacobi et al., 2004). 
It would be interesting to find out whether one or several shared factors are underlying this 
overlap between personality features and eating disor ers, and whether these factors have a 
genetic or an environmental background. Large population-based twin studies can be used 
to investigate these questions. 
 A limitation of the study design used in chapter 6 is that although there is overlap in 
the features that were phenotyped in the cases from the GenED study and the NTR controls, 
the questionnaires used to measure these features are not identical (Figure 7.1). Extensive 
perfectionism and impulsivity phenotypes were available for the participants with an eating 
disorder, whereas the available phenotypes in the NTR controls were based on single items. 
It is possible that despite the considerable correlation between these instruments they do not 
measure the same underlying construct. By recruiting the control women without eating 
disorders we tried to overcome this limitation. The questionnaires administered to this 
group were identical to the questionnaires used in the GenED study. However, because no 
DNA was collected from these women the utility of this group was limited (Figure 7.1). 
Therefore the association with Dysfunctional Impulsivity scale could not be evaluated in 
controls without an eating disorder. 
 The observed differences in perfectionism and impulsivity scores between participants 
with an eating disorder and controls without an eating disorder indicate that currently ill 
individuals are more impulsive and highly perfectionistic. Although measurement 
invariance with respect to disease state was not tested (the framework described in chapter 
3 can be used to do this), it is likely that the scales do not measure exactly the same 
underlying trait in both groups (both within patient subgroups and between patients and 
controls). For example, someone who regularly engages in self-induced vomiting (a quite 
dysfunctional impulsive behavior), may have another opinion or standard on dysfunctional 
impulsivity compared to somebody who does not engage in self-induced vomiting. These 
persons will probably respond in a different matter preceding their illness or after recovery. 
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The previously reported elevated levels of perfectionism and impulsivity in recovered 
patients however, point out that the differences in perfectionism and impulsivity are not 
entirely disease state-dependent and may be an underlyi g trait preceding eating disorder 





In future research identical phenotypes will be avail ble for a substantial group of cases 
from the GenED study and for random participants from the NTR. This will increase the 
possibilities for conducting studies into genetic associations, phenotype correlations and the 
way these influence the development of eating disorers. A major limitation of the study 
design thus far used is that questionnaires used in GenED and NTR controls were not 
identical (Figure 7.1). Both studies are however still ongoing which enable us to complete 
the data.  
 It will be interesting to evaluate the influence of disease-state on the performance of 
the used measurement instruments, by investigating measurement invariance (as discussed 
in chapter 3). For the Multidimensional Perfectionism Scale (Frost et al., 1990) and the 
Dickman Impulsivity Inventory (Dickman, 1990) these analyses can be performed in the 
cases from the GenED study and the controls without an eating disorder (group 1 and 3 
depicted in Figure 7.1). In the future, it will also be possible to test for measurement 
invariance in the combined sample of GenED cases and NTR controls, not only for 
perfectionism and impulsivity but also for other pesonality features which are measured 
within the NTR survey.  
 Besides perfectionism and impulsivity there are other personality features that possibly 
predispose to the development of eating disorders, like negative self-evaluation/low self-
esteem, negative body image and weight concerns (Jacobi et al., 2004). Because different 
types of eating disorders are characterized by a different combination of these features (for 
example high perfectionism, low self-esteem and negative body image in AN), it will be 
interesting to examine the overlap of these features, including the overlap with different 
types of eating disorders or different eating disorder symptoms (e.g. binge eating, SV). 
Within the twin sample of the NTR it will be possible to examine whether these features 
have a common background, and whether genetic or environmental influences are 
underlying this overlap. Furthermore the twin design can be used to disentangle the 
direction of causation, for example phenotypic causation models (Duffy & Martin, 1994; 
Heath et al., 1993) and the co-twin control design (Cederlof et al., 1977; Kendler et al., 
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1993). The first method is a nested model of the bivariate Cholesky decomposition, in this 
approach the correlated traits need to have different modes of inheritance. In the co-twin 
control design relative risks for one feature (e.g. perfectionism) would be compared 
between unrelated individuals discordant for another feature (e.g. impulsivity), DZ twins 
discordant for impulsivity, and MZ twins discordant for impulsivity. 
 The next step is conducting genomewide association s udies to identify genetic loci 
that influence the susceptibility for eating disorders, but also the susceptibility for the 
combined phenotype of predisposing personality featur s. As was shown in chapter 6, 
perfectionism and impulsivity scores are different in eating disorder cases compared to 
controls, and the same is expected for the personality features mentioned above. In order to 
detect genes that are involved in these personality features in the absence of disease, 
genomewide association studies should be performed in the twins from the NTR or in 
family members of eating disorder cases. As part of the GenED study first degree family 
members of participating individuals with an eating disorder are also approached to 
participate in the study. Currently, phenotype and genotype data of 161 relatives of 64 
eating disorder cases have been collected. Besides for genetic association studies, this 
family sample can also be used to perform phenotypic studies. It can be questioned whether 
family members of eating disorder cases show elevated levels of for example perfectionism 
and impulsivity. Furthermore, in the combined sample of cases and relatives it can be 
examined whether these features are familial. 
 When genetic loci are identified by the genomewide association studies, these genes 
will have to be followed-up. In the first step more (preferably) functionally relevant 
variants within that gene will be measured. Subsequently, the gene will be sequenced to 
find yet unidentified variants that can explain theobserved association. A recommended 
approach for genes associated to eating disorders is xon resequencing in severe cases and 
matched healthy controls, to detect rare or low frequency variants of medium effect (Gloyn 
& McCarthy, 2010; Johansen et al., 2010). In addition o newly identified genes based on 
genomewide association studies, the same approach will be used to follow up the 
association with the TPH2 gene in the future. 
 Once it is established that a gene is involved in either eating disorders or a 
predisposing personality feature, the activity and function of this gene can be tested by 
using translational models, like knock-out mice. Possibly these mice show a difference in 
behavior compared to wild-type mice, which can be rel vant for the studied phenotype in 
humans. In addition to knock-out mice, the activity-based anorexia (ABA) or semi-
starvation induced hyperactivity model (Kas et al., 2009), a translational model for AN, can 
be used to test the activity of the identified gene.  
General discussion 
120 
 Finally, in the future more studies regarding gene- vironment interaction (G x E), 
whereby a person’s genes may influence how sensitive he or she is to the effects of the 
environment, should be performed. This interaction c uld be a potential explanatory model 
in eating disorders (Bulik, 2005). Despite the fact that practically every young girl in 
Western society is exposed to cultural standards of slenderness and attractiveness and the 
majority of them is or has been on a diet, only a sm ll number ever develops an eating 
disorder. Possibly dieting will only trigger the development of eating disorders in girls with 
a large genetic vulnerability for these disorders. The underlying molecular processes of G x 
E, with genes mediating an individual’s risk to forexample stressful life events, may be 
elucidated by studying epigenetics (Feinberg, 2008; Schroeder et al., 2010). Epigenetics is 
the study of inherited changes in phenotype or gene expression caused by mechanisms 
other than changes in the primary underlying DNA sequence. These epigenetic alterations 
are potentially reversible and accessible for drug t eatment. Recent findings suggest that the 
transmission of vulnerability for depression from parent to offspring could occur, in part, 
through the epigenetic modification of genomic regions that are implicated in the regulation 
of stress response and related processes such as neurogenesis, like the glucocorticoid 
receptor and brain-derived neurotrophic factor (McGowan et al., 2009; Schroeder et al., 
2010). Expectancies with relation to benefits for future personalized diagnostics and 
therapies for psychiatric disorders from this relatively new form of genetic research are 
high. Epigenetic changes might also be involved in eating disorders. To examine these 
changes epigenetic studies can be performed in currently ill or recovered patients with 




Genetic research as discussed in this thesis will improve the knowledge regarding the 
genetic background of eating disorders. Once the pathways involved in these disorders and 
in the associated personality features are elucidated, prevention and treatment can be 
improved. Phenotypic studies into the shared background of eating disorders and 
personality features will enable us to make a risk profile for eating disorders. This will 
increase the chance of early recognition, and improve prevention strategies.  
 The knowledge that certain genes are involved in eating disorders could be used to 
predict the outcome of the disease if genetic variants will be found with sufficient 
predictive effect sizes. Carrying a number of risk alleles might worsen the prognosis of the 
eating disorder, because specific behaviors or eating disorder features are influenced by 
these genes (Hetrick et al., 2008; Maguire, 2008). Treatment programs could be adjusted 
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and improved based on this knowledge. Furthermore, knowledge regarding the genetic 
aetiologies may open pathways for novel drug targets. Since the prevalence of eating 
disorders is relatively low, pharmaceutical companies may not invest in the development of 
medications to cure or mask genetic effects specific for these disorders. However, since 
there is evidence for shared genetic vulnerability between eating disorders, depression and 
anxiety (Keel et al., 2005; Kendler et al., 1995; Wade et al., 2000b; Wade et al., 2004), 
genes that contribute to this spectrum of disorders might become targets for medical 
interventions.  
 Also, an increase in knowledge regarding the extent to which disorders are influenced 
by genetic vulnerability may help to decrease the sigma associated with such disorders. It 
can relief the burden of guilt with which many parents of eating disorder patients struggle 
(Enten & Golan, 2009; Jacobi et al., 2004; Le Grange et al., 2010). In addition, this 
knowledge could also change and ameliorate the attitudes towards individuals suffering 












In this thesis, a series of studies were conducted to investigate different aspects of the 
genetics of eating disorders. Eating disorders are distinguished into anorexia nervosa (AN), 
bulimia nervosa (BN) and eating disorders not otherwise specified (EDNOS). Chronicity 
and mortality of patients with eating disorders are mong the highest of all psychiatric 
illnesses. Despite substantial efforts to identify causal pathways for AN and BN, very little 
is known about the aetiology of eating disorders  
 Chapter 2 reviews the different studies that have been performed to explore the 
biological background of eating disorders. Family studies have shown that AN and BN are 
strongly familial, and that familial aetiologic factors appear to be shared by both disorders. 
Twin studies mainly focussed on broader phenotypes or subthreshold eating disorders. 
These studies consistently yielded moderate to substantial heritability estimates for both 
AN (ranging between 48 and 76%) and BN (ranging betwe n 30 and 83%). However, due 
to the low prevalence of both disorders, and subsequently the small numbers of affected 
twins, the statistical power, even when using broader phenotypes, was far from adequate. 
Genomewide screens have demonstrated linkage peaks for AN on chromosomes 1p33-36 
and 4q13, for AN including behavioral covariates on chromosomes 1q31, 2p11 and 13q13, 
and for BN on chromosomes 10p13, and 14q22-23. Many ge etic association studies have 
been conducted in eating disorders, in which genetic variation within a candidate gene is 
compared between cases and controls. Nearly all of these studies did not lead to any 
definite conclusion. Typical of the association studies in this field is the excess of small, 
discrepant studies.  
 In chapter 3 we evaluated whether the disordered eating behavior (DEB)-scale was 
comparable between men and women. We described five i ferent steps of a multi-group 
discrete factor analysis accumulating into a model f complete measurement invariance, 
which was applied in a sample of 1195 adolescent me and 1507 adolescent women from 
the Netherlands Twin Registry (NTR). DEB was the sum score of four items on clinical 
features from different eating disorders: dieting, fear of weight gain, importance of body 
weight or shape on self-evaluation and binge eating. For DEB, the model of full 
measurement invariance with respect to sex (model 5), did not fit the data well. If this 
model had fitted, the probability of a certain response on a given item would have been the 
same for all participants with the same value on the underlying trait (DEB) regardless of the 
sex of the participant. However, this was not the case. The underlying common factor might 
not be the only source of difference between the sex s with respect to the four items. The 
sum score based on the four eating disorder items therefore cannot be taken to represent 
exactly the same underlying trait in men and women. This means that sex differences in this 
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sum score might be due to measurement bias instead of a true difference in the underlying 
trait.  
 In chapter 4 we reported the results of a bivariate twin study on DEB and body mass 
index (BMI) in 474 monozygotic twin pairs (194 male nd 280 female pairs), 310 dizygotic 
twin pairs (140 male and 170 female pairs), and 45 incomplete twin pairs (22 men and 23 
women) from the NTR. The sibling group was comprised of 69 brothers and 115 sisters. 
Because the DEB items were not measurement invariant with respect to sex (chapter 3), the 
genetic analyses were performed separately in men and women. Twin-, cross-twin, and 
twin-sibling correlations indicated that a large part of the variance in both DEB and BMI 
was explained by genetic factors, and that genetic components were underlying the overlap 
between DEB and BMI in women. The bivariate analysis showed that DEB is a highly 
heritable trait in women (a2=0.65) and moderately heritable in men (a2=0.39), whereas BMI 
is highly heritable in both women (a2=0.80) and men (a2=0.76). The remaining variance in 
both traits was explained by unique environmental factors. In addition, additive genetic 
factors were responsible for the total overlap betwe n the two characteristics, yielding a 
genetic correlation of 0.43 in women and 0.51 in men. Despite the overlap between BMI 
and DEB, the majority of the genetic influences on DEB were due to genetic effects that are 
independent of BMI in women as well as men. 
 Based on the overview of genetic studies presented i  chapter 2 and the update given in 
chapter 1, it is clear that the serotonin pathway hs mostly been indicated as relevant in the 
development of eating disorders, because of its involvement in a broad range of biological, 
physiological and behavioral functions, for example body weight regulation, eating 
behavior, perfectionism, impulsivity and obsessionality. But the involvement of many other 
candidate genes has also been studied in eating disorder . So far the only association with a 
‘hypothesis based’ candidate gene that has been observed in at least two large association 
studies was between brain-derived neurotrophic factor and AN. From a ‘hypothesis free’ 
approach the associations with two candidate genes have been observed in at least two large 
studies, namely serotonin receptor 1D and opioid receptor delta 1.  
 In chapter 5, we evaluated the association of 25 SNPs from four candidate genes 
serotonin receptor 1D (HTR1D), stathmin (STMN1), brain-derived neurotrophic factor 
(BDNF) and tryptophan hydroxylase 2 (TPH2), with both AN and eating disorders 
characterized by self-induced vomiting (SV). First, we performed genetic association 
analyses in cases from the GenED study (182 AN cases nd 149 SV cases) and random 
controls from the NTR (N=607). A nominal significant association (p<0.05) was observed 
for TPH2 rs1473473 in AN as well as SV. This SNP was subsequently tested for replication 
in a meta-analysis with two additional independent eating disorder case-control samples 
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from Germany and the Netherlands together providing 887 AN cases, 306 SV cases and 
1914 controls. For the minor C-allele (frequency 0.16) of TPH2 SNP rs1473473 a 
significant association was observed in the meta-analyses with both AN and SV. We 
observed an OR of 1.25 (95% CI 1.06-1.47, p<0.009) for AN, and an OR of 1.34 (95% CI 
1.06-1.69, p=0.013) for SV. The OR for the combined group of ANand/or SV cases 
(n=1073) was 1.24 (95% CI 1.06-1.44, p<0.006). Based on the genotype frequencies of the 
TPH2 SNP rs1473473 we expected a dominant effect to be underlying the association. 
Therefore, we evaluated the association with this SNP in the combined case-group under a 
dominant genotypic model. Homo- and/or heterozygous carriers of the minor allele of 
rs1473473 had a higher risk of either AN or SV (OR=1.38, 95% CI 1.16-1.64, p<0.0003). 
The TPH2 gene encodes the main rate-determining enzyme in the synthesis of serotonin in 
the brain (Zill et al., 2007). Serotonin is involved in satiety, anxious and obsessional 
behavior, mood, and impulse control, features all linked to eating disorders (Kaye, 2008; 
Lucki, 1998). 
 Chapter 6 explored the hypothesis that genetic variation in the TPH2 gene (associated 
to a higher risk for AN and/or SV in chapter 5), explains the overlap between eating 
disorders, perfectionism and impulsivity by performing three analyses. In the extensive 
phenotypic analyses, we confirmed earlier observations that participants with AN and/or 
SV score different from healthy controls on perfectionism and impulsivity as measured by 
the Multidimensional Perfectionism Scale and Dickman Impulsivity Inventory. To study 
the involvement of four TPH2 SNPs in perfectionism and impulsivity in the absence of 
disease, genetic analyses were performed in a random twin-based control group (N=512). 
We observed an association with the Youth Self Report item on impulsivity for two SNPs. 
The minor allele of rs1473473 (OR =1.49, 95% CI 1.02-2.17, p=0.04) and rs1007023 
(OR=1.60, 95% CI 1.08-2.36, p=0.02) were more frequent in impulsive controls. Next, we 
tested whether these two SNPs were also associated to impulsivity (as measured by the 
Dickman Impulsivity Inventory) in an eating disorde case group (N=267). An association 
was observed for both rs1007023 (OR=1.79, 95% CI 1.01-3 17, p=0.05) and rs1473473 
(OR=1.83, 95% CI 1.08-3.08, p=0.02). Genetic variation at the TPH2 gene thus appe red to 

















Genetische factoren bij eetstoornissen 
 
Het is nog onvoldoende bekend waarom mensen eetstoornissen ontwikkelen. Wel is 
gebleken dat er niet één oorzaak is, maar dat verschillende factoren een rol spelen bij het 
ontstaan van deze ziekten. Eén van deze factoren is erfelijkheid. In dit proefschrift hebben 
we meerdere studies uitgevoerd om meer te leren over de rol van erfelijkheid en genen in 
relatie tot eetstoornissen. 
Eetstoornissen hebben grote negatieve gevolgen op het leven van mensen die eraan 
lijden en van mensen in hun omgeving. De mortaliteit van deze stoornissen is hoog en de 
prognose is slecht. Deze ziekten worden gekenmerkt door een grote kans op terugval na 
behandeling en een groot deel van de patiënten met een eetstoornis is vier tot tien jaar later 
nog niet hersteld. In het handboek voor psychiatrische stoornissen (DSM-IV) worden drie 
eetstoornisdiagnoses onderscheiden, namelijk anorexia n rvosa, boulimia nervosa en 
eetstoornis niet anderszins omschreven (zie kader 9.1). Het grootste deel van de 
eetstoornispatiënten (ongeveer 60%) behoort tot deze laatste groep. 
Er is veel overlap in de symptomen van de verschillende eetstoornissen. Zo worden 
verschillende vormen van eetgestoord gedrag en attitudes gedeeld tussen eetstoornissen, 
zoals bijvoorbeeld de rol die lichaamsvorm en gewicht spelen in de manier waarop men 
zichzelf beoordeelt en zelfopgewekt braken. Daarnaast is het niet ongebruikelijk dat 
mensen tijdens hun leven voldoen aan verschillende etstoornis-diagnoses. Over 
risicofactoren is bekend dat het vrouwelijk geslacht, zwaarlijvigheid in de kindertijd, 
ernstige bezorgdheid over gewicht en lichaamsvorm, negatieve zelf-evaluatie (laag 
zelfvertrouwen), lijnen, perfectionisme en mogelijk impulsiviteit betrokken zijn bij het 
ontstaan van eetstoornissen.  
Het menselijk lichaam bestaat uit verschillende weefs ls (huid, spier, bloed, vet etc.), 
die opgebouwd zijn uit cellen. In iedere celkern ligt het erfelijk materiaal (DNA) verdeeld 
over 23 chromosoomparen opgeslagen. Een gen bestaat uit een stukje DNA binnen een 
chromosoom en draagt de informatie voor een specifieke erfelijke eigenschap in een cel. 
Alle genen samen bepalen het functioneren van de cellen waaruit de mens is opgebouwd. 
Genen zijn grotendeels volledig identiek tussen mensen, maar er is ook variatie. Deze 




In dit proefschrift wordt een serie studies beschreven waarin de verschillende aspecten van 
genetica van eetstoornissen onderzocht worden. In totaal zijn drie verschillende studie 
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populaties gebruikt om de onderzoeken in uit te voeren. Allereerst de ‘Genetics of Eating 
Disorders’ (GenED) populatie, bestaande uit een grote groep Nederlandse 
eetstoornispatiënten. De tweede studiepopulatie bestaat uit tweelingen en hun familieleden 
van het Nederlands Tweelingen Register (NTR). Als derde is een populatie van volwassen 
Nederlandse vrouwen zonder een eetstoornis gebruikt.  
 
Kader 9.1 Kenmerken verschillende eetstoornissen 
Anorexia nervosa wordt gekenmerkt door ernstig ondergewicht, een intense angst voor 
gewichtstoename en een gestoorde beleving van gewicht of lichaamsvorm. Anorexia 
nervosa wordt onderverdeeld in twee subtypes: het beperkende type en het 
eetbuien/purgerende type. In tegenstelling tot het eetbuien/purgerende type, zijn 
personen met het beperkende type niet geregeld bezig met eetbuien of purgerende 
maatregelen, zoals zelf-opgewekt braken of het misbruik van laxeermiddelen. 
 
Belangrijke symptomen van boulimia nervosa zijn het herhaaldelijk optreden van 
eetbuien (gemiddeld 2x per week in de afgelopen 3 maanden) gevolgd door inadequaat 
compensatoir gedrag (zoals braken, misbruiken van laxeermiddelen en overmatig 
bewegen) om de toename in gewicht te voorkomen. Bovendien wordt het oordeel over 
zichzelf in onevenredige mate bepaald door lichaamsvormen en/of gewicht. Bij boulimia 
nervosa wordt een onderscheid gemaakt tussen het purgerende type (regelmatig bezig 
met o.a. zelfopgewekt braken of misbruik van laxeermiddelen) en het niet-purgerende 
type (andere inadequate compensatoire gedragingen zoals vasten of overmatige 
lichaamsbeweging worden toegepast).  
 
De groep patiënten met een etstoornis niet anderszins omschreven b staat uit: 1. 
personen die niet voldoen aan één van de criteria voor anorexia of boulimia nervosa; 2. 
personen die een combinatie hebben van criteria van zowel anorexia als boulimia 
nervosa; 3. personen met een eetbuistoornis, gekenmerkt door herhaaldelijke episodes 
van eetbuien (gemiddeld twee keer per week in de afg lopen 6 maanden) in afwezigheid 
van inadequaat compensatoir gedrag.  
 
Overzicht ander onderzoek naar genetische achtergrond eetstoornissen 
 
Hoofdstuk 2 is een overzichtsartikel van studies naar de genetische achtergrond van 
eetstoornissen die zijn uitgevoerd tot en met 2005. Familie studies laten zien dat anorexia 
en boulimia nervosa vaak binnen bepaalde families voorkomen. Daarnaast is het risico op 
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het krijgen van zowel anorexia als boulimia nervosa verhoogd in familieleden van personen 
die één van beide stoornissen hebben. In tweelingstudies worden de overeenkomsten en 
verschillen tussen ééneiïge (genetisch identiek) en tw eeiïge (genetisch gezien 50% gelijk) 
tweelingparen gebruikt om te berekenen hoe groot de erfelijke en omgevingsinvloeden zijn 
voor een bepaalde aandoening. Uit deze studies blijkt dat 48 tot 76% van de individuele 
variatie in anorexia nervosa verklaard wordt door genetische factoren, voor boulimia 
nervosa ligt dit percentage tussen de 30 en 83%.  
 Om chromosomale locaties op te sporen waarin zich nog onbekende belangrijke genen 
bevinden die het ontstaan van anorexia en boulimia nervosa kunnen verklaren, zijn 
zogenoemde koppelingsstudies uitgevoerd. Dergelijke koppelingsstudies worden gedaan 
binnen families waarin de ziekte vaker voorkomt, bijvoorbeeld in aangedane broer en/of 
zusparen. Omdat 50% van het DNA tussen broers en zussen gelijk is, is de verwachting dat 
zodra beide zussen anorexia nervosa hebben ze ook genvarianten zullen delen die anorexia 
nervosa veroorzaken. Door heel veel van dit soort paren uit verschillende families te 
onderzoeken kan er worden bekeken welk deel van het DNA door al deze paren vaker 
gedeeld wordt dan wat op basis van toeval wordt verwacht. Zo kunnen er bepaalde 
chromosomale gebieden worden gevonden die ‘gekoppeld’ zijn aan de ziekte. In eerder 
uitgevoerde koppelingsstudies is voor anorexia nervosa bewijs voor koppeling gevonden in 
gebieden op chromosoom 1, 2, 4, en 13, en voor boulimia nervosa op chromosoom 10 en 
14. 
 Associatie studies worden uitgevoerd om te onderzoeken of een specifiek gen, waarvan 
wordt gedacht dat het een rol speelt bij een bepaalde ziekte, ook werkelijk betrokken is bij 
deze ziekte. In deze studies wordt onderzocht of varianten van dit gen vaker voorkomen bij 
een groep aangedane personen (patiëntengroep) in vergelijking tot een groep niet-
aangedane personen (controlegroep). In dat geval is er sprake van associatie. Er zijn veel 
associatiestudies uitgevoerd in de verschillende eetstoornissen. Doordat in de meeste 
uitgevoerde associatie studies in eetstoornissen klei e patiënten- en controlegroepen zijn 
onderzocht, zijn er veel tegenstrijdige resultaten g vonden. Op basis van grotere 
associatiestudies lijken serotonine receptor 1D, opioid receptor D1 en brain-derived 
neurotrophic factor geassocieerd te zijn met eetstoornissen. 
 
Vergelijkbaarheid vragenlijst eetgestoord gedrag 
 
In hoofdstuk 3 wordt een methode beschreven om de vergelijkbaarheid van een 
meetinstrument (vragenlijst/interview) tussen groepen (op basis van geslacht, leeftijd etc.) 
te onderzoeken. Als toepassing van deze methode werd onderzocht of mannen en vrouwen 
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de ‘disordered eating behavior’ (DEB)-schaal op dezelfde wijze invullen of interpreteren. 
De DEB-schaal is opgebouwd uit vier losse items die ied r een aspect van eetgestoord 
gedrag meten, namelijk: lijnen, angst voor gewichtstoename, belang van lichaamsgewicht 
en –vorm bij zelf-evaluatie en eetbuien. Door de score op deze vier items op te tellen, krijg 
je een totaal score die iets zegt over de mate van ‘verstoring van eetgedrag’ van die 
persoon. Het idee is dat mensen die geen of weinig ‘eet estoord’ gedrag vertonen een 
lagere score op alle vier de items hebben dan mensen die meer of veel ‘eetgestoord’ gedrag 
vertonen, ongeacht hun geslacht. Als nu bijvoorbeeld blijkt dat de ‘niet-eetgestoorde’ 
mannen op slechts drie van de vier items laag scoren, terwijl de ‘niet-eetgestoorde’ 
vrouwen op alle vier de items laag scoren, dan is er dus een sekse-verschil in hoe de DEB-
schaal de mate van ‘eetgestoordheid’ meet. Met andere woorden de DEB-schaal is dan niet 
meetinvariant met betrekking tot geslacht. Om deze me tinvariantie van de DEB-schaal te 
testen, werd een discrete factor analyse bestaande uit vijf opeenvolgende stappen 
uitgevoerd in een steekproef van 1195 adolescente mannen en 1507 adolescente vrouwen 
van het NTR. De DEB-schaal bleek niet volledig meetinvariant te zijn, het is onduidelijk of 
gevonden sekse-verschillen in de DEB score werkelijke verschillen tussen mannen en 
vrouwen weerspiegelen in ‘eetgestoordheid’ of een gevolg zijn van de meetafwijking in de 
schaal. Op basis van de DEB-schaal zijn mannen en vrouwen dus niet vergelijkbaar, en in 
toekomstige analyses moeten deze groepen apart worden meegenomen. 
 
Erfelijkheid eetgestoord gedrag en BMI 
 
Is de mate van eetgestoord gedrag erfelijk, en in welke mate zijn genetische factoren die 
van invloed zijn op deze mate van eetgestoord gedra ook van invloed op BMI? De 
tweelingstudie die uitgevoerd is om deze vragen te beantwoorden wordt beschreven in 
hoofdstuk 4. Hiervoor werden gegevens van een grote groep tweeling n (474 ééneiïge, 310 
tweeeiïge tweelingparen en 45 losse tweelingen) en hun broers en zussen (69 broers, 115 
zussen) van het NTR gebruikt. Omdat de DEB-schaal niet meetinvariant was met 
betrekking tot geslacht (hoofdstuk 3) werden de analyses apart uitgevoerd voor mannen en 
vrouwen. Uit de bivariate tweelinganalyses bleek dat 65% van de individuele variatie in 
eetgestoord gedrag verklaard werd door genetische factoren in vrouwen, in mannen was dit 
percentage 38%. De erfelijkheid van BMI was hoog in zowel vrouwen (80%) als mannen 
(76%). De overlap tussen de mate van eetgestoord gedra  n BMI werd verklaard door 
genetische factoren, er werd een genetische correlatie van 0.43 in vrouwen en 0.51 in 
mannen gevonden. Ondanks deze overlap, werd het merndeel van de genetische invloed 
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op de mate van eetgestoord gedrag verklaard door genetische factoren die geen rol speelde 
bij BMI in mannen en vrouwen.  
 
Associatie studie van kandidaatgenen in anorexia nervosa en zelfopgewekt braken 
 
In hoofdstuk 5 wordt een associatie studie beschreven waarin de rol van verschillende 
kandidaatgenen in anorexia nervosa en in eetstoornisse  gekenmerkt door zelfopgewekt 
braken worden onderzocht. Zelfopgewekt braken is een b langrijk klinisch symptoom bij 
verschillende eetstoornissen, dat in hoge mate erfelijk b paald blijkt te zijn. In deze studie 
werden vier kandidaatgenen onderzocht, serotonine rec ptor 1D (HTR1D), brain-derived 
neurotrophic factor (BDNF), tryptophaan hydroxylase 2 (TPH2) en stathmine (STMN1). 
HTR1D en BDNF werden gekozen op basis van resultaten uit eerdere studies. TPH2 speelt 
een belangrijke rol binnen het serotonine systeem. Dit systeem is betrokken bij 
verschillende biologische, fysiologische en gedragsfuncties die een rol kunnen spelen bij de 
ontwikkeling van een eetstoornis, zo is serotonine van invloed op de regulatie van 
lichaamsgewicht, eetgedrag, maar ook op psychische kenmerken zoals perfectionisme, 
impulsiviteit en obsessief gedrag. STMN1 ligt in een gebied op chromosoom 1 waarmee 
eerder koppeling was gevonden met anorexia nervosa. Verder speelt dit gen een rol in angst 
en angstgevoelens bij zowel muizen als mensen.  
 Voor de associatie studie werden 25 varianten binnen de vier kandidaatgenen (HTR1D, 
BDNF, TPH2 en STMN1) in twee patiëntgroepen van de GenED populatie (182 patiënten 
met anorexia nervosa en 149 patiënten met een eetstoornis gekenmerkt door zelfopgewekt 
braken) vergeleken met 607 vrouwen van het NTR. Voor één variant (rs1473473) binnen 
het TPH2 gen werd een associatie gevonden met beide patiëntgroepen. Voor replicatie, 
werd vervolgens onderzocht of deze variant ook een associatie liet zien in een meta-analyse 
met twee andere onafhankelijke eetstoornis populaties uit Duitsland en Nederland. De 
studiepopulatie voor deze analyse bestond inclusief de GenED populatie uit totaal 887 
anorexia nervosa patiënten, 306 patiënten met een etstoornis gekenmerkt door 
zelfopgewekt braken en 1914 vrouwen uit de algemene b volking. In deze analyse bleek 
rs1473473 ook geassocieerd met anorexia nervosa en eetstoornissen gekenmerkt door 
zelfopgewekt braken. Voor de zeldzame variant van rs1473473 werd een odds ratio van 
1.25 voor anorexia nervosa en een odds ratio van 1.34 voor zelfopgewekt braken gevonden. 
Dit betekent dat dragers van de zeldzame variant een v rhoogd risico hebben op het 
ontwikkelen van anorexia nervosa en eetstoornissen gekenmerkt door zelfopgewekt braken. 





Perfectionisme en impulsiviteit bij de associatie tussen eetstoornissen en TPH2 
 
Hoofdstuk 6 onderzoekt de hypothese dat genetische variatie in h t TPH2 gen (geassocieerd 
met eetstoornissen, hoofdstuk 5) de overlap tussen perfectionisme, impulsiviteit en het 
voorkomen van eetstoornissen kan verklaren. Allereerst werd getoetst of patiënten met een 
eetstoornis (GenED populatie) anders scoren op perfectionisme- en 
impulsiviteitsvragenlijsten in vergelijking met volwassen vrouwen zonder een eetstoornis. 
Patiënten met een eetstoornis bleken zeer perfectionistisch en impulsief te zijn in 
vergelijking met de groep zonder eetstoornis. Vervolgens werd binnen een groep van 512 
vrouwen van het NTR de associatie tussen vier TPH2-varianten en een enkel 
perfectionisme- en impulsiviteitsitem getoetst. Twee varianten (rs1473473 en rs1007023) 
waren geassocieerd met een hogere impulsiviteitscore (odds ratio’s 1.49 en 1.60). Ten slotte 
werd onderzocht of deze twee varianten ook een associatie met impulsiviteit lieten zien in 
een groep van 267 eetstoornispatiënten.Voor beide genvarianten werd een associatie 
gevonden met hogere impulsiviteitsscores (rs1007023, odds ratio 1.79; rs1473473, odds 
ratio 1.83). Genetische variatie in het TPH2 gen lijkt dus invloed te hebben op impulsiviteit, 
wat de kwetsbaarheid op het ontstaan van anorexia nrvosa of eetstoornissen gekenmerkt 
door zelfopgewekt braken kan beïnvloeden. 
 
Conclusie en toekomst 
 
In hoofdstuk 7 worden de belangrijkste bevindingen uit de voorgaande hoofdstukken 
besproken, verder worden mogelijkheden voor toekomstig onderzoek en klinische 
implicaties toegelicht. Het is duidelijk dat het genetisch onderzoek bij eetstoornissen, 
vergeleken met andere psychische en somatische aandoeni gen, nog in de kinderschoenen 
staat. Het veld wordt nog steeds gekenmerkt door vele kl ine associatie studies naar 
bepaalde kandidaatgenen, met tegenstrijdige bevindingen als resultaat. Doordat 
eetstoornissen weinig voorkomen onder de bevolking, is het noodzakelijk dat 
onderzoeksgroepen wereldwijd meer samenwerken om onderzoek te kunnen doen in 
grotere groepen. Daarnaast maakt de opkomst van genoomwijde associatie studies het 
uitvoeren van kandidaatgen studies achterhaald. Met name wanneer er nog weinig over de 
etiologie van een ziekte bekend is, zoals bij eetstoornissen, zijn genoomwijde associatie 
studies een goede methode omdat genetische varianten verspreid over het hele genoom (alle 
chromosomen) in één keer worden getoetst op associatie. Binnenkort worden de resultaten 
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van een grote genoomwijde associatie studie in anorexia nervosa verwacht, uitgevoerd door 
het Genetic Consortium of Anorexia Nervosa waarvan de GenED studie ook deel uitmaakt.  
 De bevinding dat een variant binnen het TPH2 gen geassocieerd is met anorexia 
nervosa en met eetstoornissen gekenmerkt door zelfopg wekt braken lijkt robuust. Het is 
niet duidelijk wat de functie van variant rs1473473 is. Heeft deze variant zelf invloed op de 
activiteit van het gen, of weerspiegelt het de werking van een functionele variant in de 
buurt? Om deze vraag te beantwoorden zal het TPH2 gen beter onderzocht moeten worden, 
bijvoorbeeld door meer varianten binnen dit gen te meten of door het gen te sequencen (het 
uitlezen van het hele stuk DNA waaruit het gen is opgebouwd). Verder is het ook 
interessant om de activiteit van dit gen te onderzoken door de zogenaamde expressie in de 
hersenen te meten.  
Naast het genotype is het belangrijk om naar de fenotypes gerelateerd aan 
eetstoornissen kijken. De verwachting is dat genen ni t van invloed zullen zijn op een 
volledige eetstoornis diagnose, maar eerder een effct zullen hebben op onderliggende 
gedragskenmerken, zoals perfectionisme, zelfopgewekt bra en en impulsiviteit (zie 
hoofdstuk 5 en 6). Naast perfectionisme en impulsiviteit zijn er ook andere 
gedragskenmerken gerelateerd aan eetstoornissen, zoals negatieve zelf-evaluatie/laag 
zelfvertrouwen, negatief lichaamsbeeld en zorgen over het gewicht. In de toekomst is het 
belangrijk om te onderzoeken of de overlap tussen deze gedragskenmerken en 
eetstoornissen wordt verklaard door één of meerdere ond rliggende factoren, en in hoeverre 
deze factoren door genetische of omgevingsinvloeden worden verklaard. Tweelingstudies 
kunnen hierin een belangrijke bijdrage leveren. 
 Een ander belangrijk aspect is het meetinstrument va  het betreffende 
(gedrags)kenmerk. Als in grote groepen mensen vragenlijst n of interviews worden 
afgenomen om de mate van aanwezigheid van een bepaald kenmerk vast te stellen, is het 
wel essentieel dat het meetinstrument vergelijkbaar is tussen bijvoorbeeld man en vrouw, 
oud en jong, maar ook tussen ziek en gezond. Met onze studie (beschreven in hoofdstuk 3) 
waren we de eerste die binnen het eetstoornisveld hebben gekeken naar de meetinvariantie. 
Dus ondanks het feit dat somscores van eetstoornisschalen vaak worden gebruikt om 
groepen te vergelijken, is nooit eerder vastgesteld of deze schalen wel werkelijke 
verschillen laten zien of dat het om een meetafwijking gaat.  
 Op korte termijn zijn de klinische implicaties van het genetisch onderzoek in 
eetstoornissen niet zo groot. Het kan helpen om het stigma omtrent eetstoornissen te 
verminderen en om het schuldgevoel van ouders te verlicht n. Op de lange termijn, als 
meer duidelijk is over de etiologie en betrokkenheid van specifieke genen bij 
eetstoornissen, kunnen preventie-activiteiten en behandeling worden verbeterd (zgn. 
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‘matched care’). Betere risicoprofielen op basis van genen en persoonlijkheidskenmerken 
zouden kunnen worden opgesteld voor eetstoornissen, zodat de kans op een vroege 
ontdekking van de stoornis groter wordt. Daarnaast zouden genen kunnen worden gebruikt 
als voorspellers van het verloop en de uitkomst van de ziekte. De behandeling zou hier 
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Appendix A: DSM-IV criteria for eating disorders 
 
Anorexia nervosa  
A. Refusal to maintain body weight at or above a minimally normal weight for age and 
height (e.g., weight loss leading to maintenance of body weight less than 85% of that 
expected; or failure to make expected weight gain during period of growth, leading to 
body weight less than 85% of that expected).  
B. Intense fear of gaining weight or becoming fat, even though underweight.  
C. Disturbance in the way in which one's body weight or shape is experienced, undue 
influence of body weight or shape on self-evaluation, or denial of the seriousness of the 
current low body weight.  
D. In postmenarcheal females, amenorrhea, i.e., the abs nce of at least three consecutive 
menstrual cycles. (A woman is considered to have amnorrhea if her periods occur 
only following hormone, e.g., estrogen, administration.)  
 
Specify type:  
Restricting Type: during the current episode of Anorexia Nervosa, the person has 
not regularly engaged in binge-eating or purging behavior (i.e., self-induced 
vomiting or the misuse of laxatives, diuretics, or enemas)  
Binge-Eating/Purging Type: during the current episode of Anorexia Nervosa, the 
person has regularly engaged in binge-eating or purging behavior (i.e., self-
induced vomiting or the misuse of laxatives, diuretics, or enemas) 
 
Bulimia nervosa  
A. Recurrent episodes of binge eating. An episode of binge eating is characterized by both 
of the following:  
(1) eating, in a discrete period of time (e.g., within any 2-hour period), an amount of 
food that is definitely larger than most people would eat during a similar period of 
time and under similar circumstances  
(2) a sense of lack of control over eating during the episode (e.g., a feeling that one 
cannot stop eating or control what or how much one is eating)  
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B. Recurrent inappropriate compensatory behavior in order to prevent weight gain, such 
as self-induced vomiting; misuse of laxatives, diuretics, enemas, or other medications; 
fasting; or excessive exercise.  
C. The binge eating and inappropriate compensatory behaviors both occur, on average, at 
least twice a week for 3 months.  
D. Self-evaluation is unduly influenced by body shape nd weight.  
E. The disturbance does not occur exclusively during episodes of Anorexia Nervosa.  
 
Specify type:  
Purging Type: during the current episode of Bulimia Nervosa, the person has regularly 
engaged in self-induced vomiting or the misuse of laxatives, diuretics, or enemas  
Nonpurging Type: during the current episode of Bulimia Nervosa, the person has used 
other inappropriate compensatory behaviors, such as fasting or excessive exercise, but 
has not regularly engaged in self-induced vomiting or the misuse of laxatives, diuretics, 
or enemas 
 
Eating disorder not otherwise specified 
Eating disorder not otherwise specified includes disorders of eating that do not meet the 
criteria for any specific eating disorder.  
1. For female patients, all of the criteria for anorexia nervosa are met except that the 
patient has regular menses. 
2. All of the criteria for anorexia nervosa are met except that, despite significant weight 
loss, the patient's current weight is in the normal range. 
3. All of the criteria for bulimia nervosa are met excpt that the binge eating and 
inappropriate compensatory mechanisms occur less than twice a week or for less than 3 
months. 
4. The patient has normal body weight and regularly uses inappropriate compensatory 
behavior after eating small amounts of food (e.g., self-induced vomiting after 
consuming two cookies). 
5. Repeatedly chewing and spitting out, but not swallowing, large amounts of food. 
6. Binge-eating disorder is recurrent episodes of binge eating in the absence if regular 













Appendix B: Overview of genetic association studies performed since 2005 with adequate statistical power. 
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